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PREFACE
We intend this book to serve several functions. First, we want to
make the field of epigenetics accessible to lay readers. Second, and
more importantly, we want to excite further interest and concern
regarding the social, ethical, legal, health, and policy implications
that this field will have for all arenas of our lives. Third, we want
to arm our readers with knowledge and wariness so that they can
understand and critique the nuanced debates that will inevitably
arise when costs and benefits must be weighed: while the effects of
epigenetics upon us as individuals may be subtle, the demographic
implications and costs are huge.
The book is organized into discrete sections, each of which can be
read on its own, although we recommend reading the first chapter
as a primer to get the general gist of the picture, implications, our
concerns, and agenda. Given the extensive ramifications of
epigenetics to most realms of our lives, students of public health,
ethics, law, medicine, biology and philosophy will find the
contents useful, interesting, and engaging.
We have highlighted some of the technical terms and included a
glossary, and the end of each chapter terminates with a noncomprehensive list of questions and solutions intended to stimulate
thought and debate.
Each chapter has been reviewed and assessed by experts in the
field. We have endeavored to check our facts and references
rigorously, and to ensure the originality of our work. We hope you
will find the effort of reading stimulating, provocative, and
rewarding.

ix

Chapter 1
Not Your Mendelian Genetics…
(Your genome is far from Mendel’s pea plants)
Michael Crawford, Melissa Woghiren, Kendall Diemer,
and Kaela Scott

Abstract
The DNA sequences that encode our genes interact with
and are regulated by associations with many other molecules,
and this constellation of players regulates how we respond to
our environment. The sequence of DNA itself remains
unchanged: the additional factors that package the genome into
chromosomes create a dynamic architectural structure that
modulates DNA activity and accessibility. More recently, it has
become clear that the reverse is also true - our experience of
our environment and social relations record and inscribe
changes to the way that our genes behave, and this in turn has
implications for our future health. In the years since the human
genome was sequenced, it has become apparent that this higher
order of architectural organization is much more complex and
subtle than formerly acknowledged. An ever-expanding list of
influences impinge upon it, and the changes that are installed
are referred to as the: epigenome, epigenomic/epigenetic
imprint, or sometimes simply as imprinting. Some of the
packaging and behavioral changes are transient, and others may
persist to affect our health decades later. Some might even
transmit to our offspring. The diverse influences that modify
1

our epigenome include: eating habits, socio-economic status,
education level, drugs, and toxin exposure to name but a few.
Since an individual’s epigenetic status can affect health
decades - even generations later - the social, medical, ethical,
and demographic impact of epigenetics are likely to be huge.
We introduce the breadth of influences that need to be
considered, and outline our agenda for discussion.

1.1 Introduction: What is Epigenetics?
Have you ever stopped to wonder why identical twins are
never completely identical? When watched closely, unique
characters become apparent. As individuals, they may differ in
preferences of dress, foods, and what interests them most. They
grow and develop their own quirks and differences that amplify
with age. This is often written off as the result of different
experiences, molding them through development… But what about
variances in health? What can be said of the identical twin who
develops bipolar disorder or is highly susceptible to depression
while their counterpart is not? If they share the same genomes,
then why are they not identical in every respect? For that matter,
why does a 1700s painting of my father-in-law’s ancestor look like
the descendent managed to transport back through time to pose in
dress-up clothes for the portrait?
The genes for facial
characteristics should have been diluted 1 in 32. Something has
always been missing in our understanding of how genomes and
inheritance function. These discrepancies present us with questions
that may now be answered through the involvement of an
additional layer of information encoding and inheritance: the
epigenome.
For biologists, a surprising feature of the Human Genome
project was the degree to which it required constant revision of our
definition and understanding of what constitutes a gene. Nature is
subtle, and the genome turned out to be much more richly
2
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elaborate than originally understood. We discovered that genes
were more varied, complicated, and surprising in their structure
and function that anybody could have foreseen. Despite our
fascination with these units of heredity, it is clear that another
adjustment, this time of seismic proportions, is presently
underway: biologists and physicians are coming to grips with an
additional level and order of information encoding - the
epigenome. The epigenome may explain familial tendencies to
diabetes, obesity, addictions, or even certain social behaviors. The
implications of this new science are vast. For example, your health
might be affected by what your grandparents ate, or when they
started smoking. Your future health disposition might be affected
by the season of your birth, or the socioeconomic status of your
parents. Even schooling matters…not only for your own sake, but
perhaps also for your descendants.
The epigenome affects how DNA is architecturally bound
into chromosomal form and how genes are regulated. This
architectural modification of packaging turns out to have dynamic
and interesting implications not merely for how our genes behave,
but consequently for how we are primed to respond to stressors.
Moreover, the complex code of modifying factors involved appear,
in some instances, to be heritable, and this is forcing a
reassessment of our appreciation of the intricacies of heredity.
The epigenome can be thought of as a malleable stamp that
massages gene behaviour in pervasive but subtle ways. It is an
integral part of the routine regulation of gene activity. The ink of
this stamp comprises a complex mix of accessory protein and RNA
molecules that decorate and reconfigure chromosomes in response
to changing environmental demands. They alter chromosomal
architecture so that specific combinations of genes are predisposed
to be active or silent. Our genome responds to, and in some cases
records its interaction with the environment through this dynamic
epigenetic re-packaging. DNA sequence fidelity remains
untouched, but the genes are induced to behave differently, turning
3

on or off in different patterns. When it is heritable, this change in
DNA packaging is referred to as the epigenetic or epigenomic
imprint. The bands that you see in images of chromosomes reflect
attributes of this packaging – some large areas are densely packed,
others less so. Importantly, epigenetic marks alter the way that
your genome behaves without altering the sequence of DNA itself.
For example, with the exception of the unmatched X and Y sex
chromosomes in males, we all normally inherit paired
chromosomes - one from each parent. By virtue of their location on
paired chromosomes, our genes are similarly present as two copies.
Even if you were to sequence the paired copies of a particular gene
and found their DNA to be identical, they might behave differently
depending upon which parent they were inherited from. The gene
copy inherited via a maternal chromosome might be active, and the
copy inherited via the paternal chromosome might be silent.
Many factors impinge upon the epigenome to turn genes
on, off, or somewhere in between. We now know that the changes
they install can have consequences for patterns of long term and
even trans-generational health. Imagine the benefit for future
generations if nutritional scarcity could prime human eggs and the
consequent embryos (ie; subsequent generations) to grow larger
and more efficient placentas without requiring genetic changes?
Imagine if these changes could be installed within a generation?
This, in fact, happens… While changes to our own long-term
health might be subtle, when measured in aggregate, the thousands
or millions of individuals that constitute a community potentially
translates to huge demographic and societal costs. Consequently,
our understanding of epigenomic health will have important
implications for medicine, social justice, ethics, law, social policy,
privacy, and economics.

1.2 Why Do We
Epigenetics?

Need to be
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When the impetus for epigenetic changes is caused by
stressors, a period of starvation for example, epigenetics provides a
powerful evolutionary advantage: it deploys a tool that records the
challenge and can prime genes to efficiently respond to similar
threats in the future. The issue for public health is that the
challenges met at one point of life, or in one generation, might not
be appropriately answered when epigenetic programming meets
different circumstances in the future. In other words, a metabolic
program installed to provide support during times of scarcity might
instead, during times of plenty, predispose to obesity, diabetes, and
heart disease. The news is not all bad. We are not necessarily
slated to be the victims of our ancestral metabolic and
environmental histories: many of the factors that influence your
epigenetic status are controllable, and some are even reversible. A
non-comprehensive list includes: quantity and quality of diet;
socioeconomic status; social environment; quality of parental care;
educational experience; prescribed and illegal drug use;
geographical/environmental exposure to contaminants; and stress.
Epigenetics presents a challenge when the stimulus for
change is the product of inadvertent manipulation by medical
procedures and prescriptions, contamination by pollutants, or
adverse and transient social or geographical conditions. Since
individuals control neither the origin and behaviour of their
parents, the care that they receive as children, nor the quality of the
environment into which they are born, epigenetic health will
inevitably become entangled with issues of social and
environmental justice - these will require intervention or regulation
at the political level.
Clearly most of the items on our list of epigenetic
influences carry a social, ethical, legal, economic and political
dimension. The costs of ignoring epigenetic threats are likely to be
long-lived and expensive: who should bear them? Individuals,
society, or future generations? Who should be responsible for a
person’s epigenetic state? Solely the individual? If we each inherit
5

the baggage of our parents’ metabolic and social crimes and
misdemeanors, is it fair that we be responsible for the attendant
costs? How should we be empowered to rectify deficits - should
we be granted privileged access to the medical histories of our
progenitors? Should our children have access to our own? Should
we impose sanctions for overfeeding children if the consequences
of their weight and inactivity might last generations? And what
about the environmental, social, and economic actors over which
we hold no sway? Where do the boundaries for freedoms and
obligations lie? If an industry inadvertently creates a product or
waste that affects our epigenetic state, but this is undiscovered for
decades, who is liable, and who should make redress? Can a
balance be found that will protect exposed populations without
drastically stifling innovation? Establishing precisely where to
place the onus of responsibility and costs among individuals,
businesses, governments, and society will be thorny issues.
An intelligent response to both preventive and remedial
epigenetic health is obtainable, but requires a sophisticated
understanding of the influences and outcomes, as well as a
comprehensively mounted and politically inclusive response. Key
to this will be education. Epigenetics provides additional and firm
data to support social investments that will address long term
economic and productivity imperatives while simultaneously
addressing issues of social and environmental justice.
1.3 The Challenges of Understanding and Studying
Epigenetics
Unlike genes, an epigenomic mark can change from cell to
cell. This makes it difficult to assess an individual’s overall
epigenetic status. For example, some epigenetic marks might be
accessible via a blood sample, others only through a biopsy of
specific tissues such as brain, or liver, or muscle. Moreover, the
complexity and combinatorial nature of epigenetic modifications
means that there are different patterns of packaging changes that
6
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can produce the same end result, and there are also many shades of
grey in between “on” and “off” insofar as gene activity is
concerned. Epigenetic marks act a little like a complicated audio
volume knob that can muffle or blast a signal from a gene, with
every increment in between. Being dynamic, epigenetics also
change with age, and can sometimes be enhanced or even reversed
by multiple influences. Finally, in some cases, an imprint might be
transmissible to offspring: this is not always the case – some
epigenetic marks are pervasive, others are highly tissue-specific
and exclude eggs, sperm, and future generations. The basic
mechanics of epigenetics, the complexity of the combinatorial
code that it embodies, and how it can be experimentally or
diagnostically assessed are covered in Chapter 2. This chapter will
be helpful to understand the diversity and nuances of the
mechanics, but it will not be necessary for understanding the gist
and implications of ensuing chapters. We also include some
further information on specific diagnostic strategies for the
adventuresome reader with a recent biology background – these
latter technical sections of Chapter 2 are not necessary for
understanding subsequent chapters.
There is a wealth of data that links specific epigenetic
mechanisms revealed in animal models (mice and rats in
particular) to environmental cues. The same trends are seen in
human epidemiological studies, however many of the larger social
conclusions have relied upon inferences drawn by comparing
animal and human studies. Not all organisms necessarily respond
to environmental and epigenetic challenges in the same way, and
there is an inherent risk in applying the mechanisms discerned in
rodents to trends revealed by retrospective epidemiological studies
in humans. That said, persuasive data is emerging to link specific
epigenetic changes in humans to particular dietary or other
challenges. In short, the data is looking good and delivers the
message that we need to address epigenetic effects and health in a
serious, comprehensive, and sustained manner.
7

1.4 The Astonishing Range of Effects
Examples of how epigenetic architectural modifications can
affect cellular activity, or even how they can offer avenues for
treatment, are especially evident in emerging studies on cancer
(outlined as a concrete example of how the mechanisms of
epigenetics can operate in Chapter 3). Since cancer is a genetic
disease caused by mutation, any mechanism that alters gene
behaviour has the potential to exacerbate or to mitigate the
damaging effects of DNA mutations. The profound influence of
the epigenome in cancer biology is an area of intense research, and
already diagnostic, prognostic, and treatment opportunities are
being developed. For example, epigenetic changes can signal
specific changes in cell behaviour that have diagnostic and
prognostic value. Indeed some of these epigenetic changes are
deleterious and are coming to be known as “epimutations.” But
wouldn’t it be lovely to circumvent a genetic mutation by
encouraging epigenetic behavior modifications that can rectify or
compensate for a problem? As promising as these avenues might
be, the question of just who will have access to the resources to
diagnose and mitigate health via epigenetic tools will prove to be a
socially, ethically, and economically challenging question.
We should not become obsessively nervous about this
attribute of our biology: in all seriousness, stress itself can modify
the epigenome. Rather, we will argue that a little foreknowledge
and preventative maintenance can go a long way to improving
quality of life through to our declining years and on through to our
children. Demographically, however, there is an urgent need to
make immediate, comprehensive, though relatively modest
investments in nutrition, health, as well as legal, social, and
educational structures: these investments could mitigate much
larger long-term costs. Case in point, as we will see in Chapter 4,
periods of starvation or over feeding can alter the epigenome to
influence a person’s health status decades later, and can even
8
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transmit across generations: apparently you are what your
grandparents ate! By the same token, contemporary parents need
to exercise care regarding what and how much they feed their
children - it could have an effect upon prospective grandchildren.
Should parents be regulated or taxed regarding the burdens they
might be placing upon the future? What defines child- and
generational-abuse? Should individuals enjoy the freedom to
indulge in risky behaviour even before they become parents when
there may be long term costs? Alleviating nutritional challenges,
and educating stakeholders becomes a matter not merely of social,
but also of generational justice.
Factors that can influence our epigenome surround us –
they are ubiquitous. This means that the compounded effects of
these influences can be hard to separate and to distinguish from
one another. We are coming to realize that xenobiotics, such as
drugs and environmental toxins, affect how our DNA is packaged
and how it behaves. The number of studies that have examined
long-familiar drugs and toxins and found profound epigenetic
effects is expanding in a startling way. Drugs and their excreted
metabolites, pesticides transmitted via our food and water supply,
manufacturing and production contaminants - all of these
categories of chemical are known to elicit deleterious and longterm epigenetic damage. Providing environmental justice will
demand that we pay attention to geographical, political, legal,
regulatory, economic and even to cultural frameworks in a manner
that is much more long-viewed and cautious. The trick will be to
achieve these objectives without stifling creativity and innovation
(Chapters 5, 8). For example, like nutritional challenges,
manufactured products might elicit an effect that remains hidden
for decades or even generations. The legal implications of this lag
time in terms of product and manufacturing liability are profound.
If epigenetic effects are not seen for decades, how can litigation
successfully compensate affected individuals: statutory limits
might have expired; businesses might have closed or sub-licensed
9

production and responsibility; the state of knowledge at the time of
manufacture might not have been sufficient that a business could
reasonably have been expected to appreciate the risk; or the
epigenetic modifications that are produced could be hard to link
causally due to the complex and combinatorial susceptibility of the
epigenome to multiple influences (Chapter 8).
For example, as we are coming to realize, the burden of
toxicants leaking into the environment can exert unforeseen
consequences upon our reproductive health, and most
predominantly through endocrine disruption. Fungicides, the
excreted metabolites of prescribed hormones and drugs, and
bisphenol A, are just a few of the compounds documented to affect
us, but the recent dimension of epigenetic harms they cause should
give us reason to pause (Chapters 5, 6).
The endocrinology of birth is complex, so in retrospect, it
should have come as no surprise that factors affecting conception,
and the manipulations attendant with fertility and birth, such as in
vitro fertilization, hormonal priming, Caesarian section, induced
labour, breast feeding decisions, also have discernable epigenetic
effects upon human infants (Chapter 6). The relative novelty of
technologies associated with assisted reproduction means that
potential long-term effects upon the human epigenome are still
unknown – the first generation of “test-tube” babies is only just
now beginning to produce its own children. Will late life health
changes and cross-generational effects be seen? It is too early to
say. Preliminary manipulations of rodents suggests that care and
caution need to be exercised, and close monitoring of procedures
should be required of physicians in a field that, in many countries,
deploy proprietary practices. At the very least, long term
monitoring of the health of progeny derived by artificial means
would seem to be prudent.
Are there some individuals who should be dissuaded from
propagating? Should people be taxed according to the likely
burden to society that they might transmit, and how would their
10
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past behaviour be assessed and quantified in terms of risk? As preconception and prospective parents, what do we owe to our
hypothetical offspring? What obligations does society owe to us
and to them? How should multigenerational interests be balanced?
Not all influences are chemically direct: how we are
socialized plays a role in epigenetic health. As will see in Chapter
7, the addictions, stress, and violence that often attend poverty can
have devastating long-term consequences that ensure more of the
same in subsequent generations. One mitigating influence – the
number of years that you attended school! A reassuring note: if
you are reading this, you might already be a member of an
epigenetically privileged cohort – school really is good for your
epigenetic health!
If we are willing to concede that epigenetics plays an
important role in our lives, then we must also admit that
information regarding the behaviour and health of our ancestors as
well as ourselves is important both to our future health as well as
to our children. Who should have access to that information? And
even if medical, genetic, and epigenetic records are kept
confidential, how much can be inferred about our epigenetic status
from: surveys of our browser history; educational affiliations;
parental data footprint; geographical location and history; marital
status; dietary preferences; religious affiliation and practices (diet
as well as communal comfort or stress); and hobby or sports
activities? So your internet usage indicates that you play electronic
games or stream videos for hours on end… should you be as
insurable as your neighbor the yoga fitness instructor? Your
telephone record suggests that you lived near an industrial park
when you were a child – does your father’s socioeconomic status
and your exposure to heavy metals mean that you are more likely
to suffer cancer, depression, or cardiovascular disease as an adult?
Should prospective employers have the right to make use of this
commonly available information to make inferences regarding the
cost of your health benefits and the potential number of sick days
11

that you might be disposed to take? Privacy will be a much more
complicated right to protect regarding epigenetic health and social
data than perhaps any other feature of your medical history
(Chapter 9).
1.5 An Agenda for Change
Each chapter concludes with a short list of provocative
questions, as well as some solutions that should give you pause to
either consider or worry. Neither list is intended to be
comprehensive, but both should help to expand the horizons under
consideration. In Chapter 10, we sum up by discussing some
practical steps forward that will encourage stakeholders to become
cognizant and engaged with the implications of their life styles,
histories, and choices. While many of the issues that we will
address (social, health, legal, and geographical justice) already
have common currency in debate, nevertheless epigenetics will
provide impetus to consider these matters more urgently – their
ramifications do not reside merely in the present or near term
futures – they are of generational consequence. Moreover, they are
all linked by a biological mechanism, and this suggests a need for
careful and comprehensive coordination to maximize benefit.
Since epigenetics is evolving rapidly as a science, and the
procedures for studying it are still somewhat young, our toolkit for
understanding, tracking, and evaluating will no doubt continue to
evolve.

12

Chapter 2
A Beginner’s Guide to the Mechanisms
and Assessment of Epigenetics
Natalie Gosselin and Curtis Foreman
Abstract
Epigenetics refers to the decoration and remodeling of
chromosomal material to both package and regulate the behaviour
of enfolded genes. This repackaging is dynamic, complex, and
involves many different proteins and RNA molecules. Together
these players interact with DNA to make architectural changes, but
the changes alter gene behaviour without altering DNA sequences.
The combinatorial possibilities of factors involved in this process
exceed the informational complexity of the DNA that comprises
our genomes. This chapter outlines the different interacting
structural proteins and enzymes, as well as the diverse set of RNA
molecules that help to modulate chromosomal form and function.
It is helpful to get feeling for the diversity and complexity of
epigenetic packaging options in order to understand some of the
challenges that researchers and physicians face when trying either
to define an individual’s epigenetic status, or to clarify how their
epigenetic status is affected by environmental stimuli. The
technical challenges are several fold. First, different cells can carry
different epigenetic imprints, and even in a single organ, similar
cells can reach the same epigenetic effect by different paths.
Second, epigenetic imprints are susceptible to many different
13

influences – it is hard to define specific causes and effects. Third,
some epigenetic states are transient, others are less so. Fourth,
depending upon which tissue experiences epigenetic reprogramming, the effect may be heritable or not. Fifth, some
epigenetic states might be reversible. Lastly, epigenetic states
change with age. We conclude in section 2.6 with a list of
assessment tools used in epigenetics. This last section provides
technical details for the interested. If the technology does not
interest you, relax… it is not necessary to understand how these
tools function to understand the rest of the book.

2.1 Introduction to Epigenetic Mechanisms.
Deoxyribonucleic acid (DNA) is the hereditary material of all
non-viral organisms on earth. It is found in every living cell, and
each living thing has a unique DNA sequence that distinguishes it
from every other. DNA sequences are the major focus of studies
ranging from biology, to medicine, pharmacology, and heredity.
Recently, this perspective has been challenged by the discovery of
epigenetics. Epigenetics is the study of stable changes in the
packaging of the genome that are independent of any changes to
the genome sequence itself (Berger et al. 2009). A huge variety of
epigenetic modifications can occur, and these changes engender a
new informational “code” that augments and modulates the
activity and information carried by DNA nucleotide sequences.
Epigenetic changes, like DNA itself, can also convey information
in a heritable manner. By regulating the packaging of DNA,
epigenetic mechanisms regulate gene activity, and in a real sense,
mediate and inscribe a record of the genome’s interaction with its
experience and environment.
The structure of DNA is one that is familiar to many, even
those uninvolved in the study of biology: two strands of
nucleotides are coiled into a double-helix. While this is the basic
structure of DNA at the simplest level, it does not fully reflect the
14
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way that DNA is packaged in a cell. The DNA double-helix is
itself coiled around complexes of cellular proteins known as

nucleosomes (Figure 2.1). Each nucleosome is composed of eight
histones comprised of four pairs of: H2A, H2B, H3 and H4
(Figure 2.2).
Figure 2.1: The structure of DNA wrapped around histones.
DNA (shown in purple) wraps two times around each
nucleosomal protein complex in a reiterative pattern
reminiscent of pearls on a string.

Figure 2.2: Histone proteins compose the nucleosome. Each
nucleosome contains two each of histones H2A, H2B, H3, and
H4.

Afterwards, an even higher order of architectural
complexity is established by interactions with multiple accessory
proteins and RNA molecules that serve as a scaffold to further coil
and organize DNA/nucleosomes.
The genes encoded by DNA are functional in the sense that
15

they code for either protein or RNA molecules that will
themselves carry out a function in the cell. The ordered complex
of DNA, RNA, and protein that resides in the nucleus of the cell
and that constitutes a chromosome is called chromatin. Loosely
packed chromatin is known as euchromatin, whereas tightly
packed chromatin is called heterochromatin. The degree to which
DNA is wrapped around nucleosomes and other proteins/RNA
largely determines the extent to which the embedded genes can be
exposed, active, and expressed. When DNA is wrapped around
nucleosomes loosely, it is easier to activate the genes that are
located in that region. Conversely, DNA that is tightly wound
around nucleosomes can form a more densely packed architecture
that inhibits the activation of encompassed and even neighboring
genes. This packaging can prevent gene activation by excluding
factors, such as activating proteins called transcription factors, that
are necessary for genes to turn on and to serve as the template to
transcribe RNA. These alternatively wound conformations of
chromatin constitute opposite ends of the spectrum of activity.
Chromatin can, however, exist on a spectrum of varying levels of
compaction, not only the aforementioned polar-opposite states (on
versus off). In other words, chromatin packaging can vary gene
activity like a volume knob: on, off, and all levels in between.
We will briefly outline some of the players in this differential
packaging of genes. If you have the interest and fortitude to get
more technical, the attributes of each are expanded in Sections 2.2,
2.3 and 2.4. The nucleotide bases that comprise DNA can be the
site of a modification known as methylation. In particular, one
of the four nucleotide bases, known as cytosine, is a base that may
be decorated by addition of a small methyl group in vetebrates
such as ourselves. Methylation of DNA is typically associated
with a repressed chromatin state, however the effect depends on
the location of the methylation (Bird and Wolffe 1999). This will
be discussed further in section 2.2.
DNA decoration by methyl groups can alter the suite of
16
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proteins that are recruited to chromatin, and moreover, some of
these proteins can themselves also be modified. For example,
each histone in the nucleosome has sites on it that can also be
modified: histones can be methylated, acetylated, phosphorylated,
ubiquitinated, glycosylated, and/or SUMOylated. It is not
necessary to know what all these different modifications are to
understand that there is quite a repertoire of possibilities given
than several of these features can be altered at multiple sites, in
combination, over the span of a single histone molecule.
Methylation of histones, like methylation of DNA, is associated
with tight packaging and repressed gene activity, whereas
acetylation is associated with activation of the region of
associated DNA. However, the large variety of histone
modifications that occur can induce different effects when
combined in various ways. Section 2.3 will expand further upon
histone modifications and their epigenetic effects on gene
expression, however it is safe to say that the complexity of histone
modifications in combination may comprise a code more complex
and subtle than that of DNA itself.
Other actors can play a role in modifying gene packaging –
we will briefly list some of them here, and then expand upon them
later in Section 2.4 for the truly curious. Long noncoding RNA
(lncRNA) molecules are those RNA molecules that can have
either a repressive or expressive effect on regions of the genome.
A famous example of a lncRNA is involved in X-chromosome
inactivation in the cells of females. The human genome is
optimized to work best with a certain number of active genes:
males have only one X chromosome and a very much smaller Y.
The X carries many more genes than the Y chromosome, so a type
of gene dosage must be achieved to compensate for the gender
difference. Since human females are born with two Xchromosomes, one must be inactivated by compaction (into what
is called a Barr body). The lncRNA involved in this case is called
XIST. Where this RNA molecule attaches and decorates a
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chromosome, that chromosome is packaged to within an inch of
its life and it remains, to all intents and purposes, quiescent.
lncRNA molecules provide gene regulation in ways that proteins
cannot (Lee 2012).
MicroRNA (miRNA) molecules are smaller RNA molecules
that associate with a protein and RNA complex to either cleave an
RNA transcript or halt protein synthesis (Schwarz et al. 2003).
They tend to bind to targets with a degree of promiscuity, so one
individual miRNA can regulate the products of multiple genes
(Lim et al. 2005).
miRNAs are themselves regulated by circular RNA
(circRNA) molecules. These RNAs are resistant to miRNAmediated degradation due to their circular shapes. They have the
ability to bind miRNA molecules and to sequester them, thereby
preventing them from performing their full function (FrancoZorrilla et al. 2007). RNA species and their effects on epigenetics
will be discussed further in section 2.4, but as you might perceive,
the combinatorial complexity of these gene packaging components
(proteins, lncRNA, miRNA, and circRNA) is vast.
Since the epigenetic changes discussed in this chapter alter
the packaging, behavior, and responsiveness of genes to
challenges and environmental cues, they have many implications
for human health. In order to use epigenetic information to
diagnose and characterize diseases, there must be a way of
assessing the state of these modifications. Assessment of
epigenetic states is described in section 2.5.
2.2 DNA Methylation.
2.2.1 Methylation and CpG dinucleotides.
The four nucleotides that make up DNA are: cytosine,
guanine, adenine, and thymine (C, G, A, and T). In a DNA strand,
nucleotides can be joined in any linear sequence, but when DNA
assembles into a double stranded duplex, each nucleotide in one
strand binds a complementary nucleotide on the other (A to T and
18
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C to G; Figure 2.3).

Figure 2.3: Cytosine and guanine form bonds across double
helices. Cytosine followed by guanine along the length of a DNA
strand constitutes a CpG site.

DNA methylation involves the addition of a methyl group. A
methyl group is simply a carbon atom bound to three hydrogen
atoms denoted CH3. DNA methylation occurs only on the
cytosines (C’s; Figure 2.4), and specifically when the cytosines
reside beside a guanine (G). The methylation sites are known as
CpG dinucleotides or islands. In double stranded DNA, the
complementarity of base pairing (C-G, and T-A) means that on the
opposite strand, a CpG sequence will sit across from a CpG
sequence oriented in the opposite direction. CpG sites occur
throughout the genome, and the majority of them are methylated.
The methylation of these CpG dinucleotides is important because
they provide stability to DNA and silence regions of the DNA that
must remain stable and inactive. An example of silenced DNA
are retrotransposons: these are remnants of viral DNA that
inserted into our ancestors’ genomes. These CG-rich regions have
been kept from harming us by methylation-mediated gene
silencing.
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Figure 2.4: The structure of cytosine and 5-methylcytosine. The
methyl group is shown in green as an addition attached to
carbon five of cytosine. CpG dinucleotides are typically not
methylated when they occur in regions of the genome that
contain active genes or gene regulatory regions called
enhancers and promoters. Repression of genes by DNA
methylation is a common cause of diseases such as cancer, but
also occurs as a natural part of the mechanism to turn genes off
when they are not needed.

2.2.2 DNA Methyltransferases (DNMTs).
DNA methylation is carried out by proteins known as DNA
methyltransferases (DNMTs). These proteins are enzymes that
catalyze the addition of methyl groups to cytosines. There are two
main varieties of DNMTs: de novo methylases and maintenance
methylases. De novo methylases are those that add methyl groups
onto previously unmethylated DNA. Maintenance methylases are
DNMTs that maintain the methyl pattern of DNA as it is
replicating. DNA is replicated in a semi-conservative manner:
each of the two strands of DNA provides a template for the
synthesis of a new, complimentary strand of DNA during
replication. While the template strands will continue to carry the
original methylation pattern, the newly-synthesized strands will be
free of methylation until acted on by maintenance methylases
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(Klose and Bird 2006).
As mentioned previously, DNA methylation typically has a
repressive effect (Bird and Wolffe 1999). If methylation occurs on
a gene, it usually acts to recruit the suites of protein necessary to
compact that region, and this in turn represses expression of the
gene. This effect can vary. Not all DNA regulatory regions
activate genes – some repress. If methylation occurs in a
repressive regulatory region of DNA, it would inhibit the
repression and thus the gene would be activated. Moreover, it is
often the case that genes are regulated by the interactions of
several different proteins with different DNA regulatory sites.
Methylation could preferentially inhibit one interaction while
facilitating another. For these reasons, it cannot be assumed that
methylated DNA is necessarily repressed.
2.2.3 Methyl Binding Proteins (MBPs).
Methyl groups are relatively small when considering the size,
scope, and complexity of a DNA molecule, or indeed a DNA
sequence that might encompass tens of thousands or even a
million nucleotides. While methyl groups have the ability to
directly block some proteins (such as transcription factors) from
binding to DNA, their main action occurs through the recruitment
of accessory and metabolic proteins to form a complex. Proteins
that recognize methylation marks specifically are methyl-binding
proteins (MBPs). MBPs recognize methylated DNA, and recruit
other protein and RNA factors to this region to assist in
remodeling and repression. Some proteins that may be recruited
by MBPs are histone-modifying proteins, which will modify
neighboring histones, and thereby further propagate and amplify
the change caused by DNA methylation. MBPs provide a link
between DNA methylation and histone modifications, as well as
overall chromatin state changes (Jones et al. 1998).
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2.2.4 Demethylation.
DNA demethylation is a controversial topic.
Some
investigators believe that it plays a critical role in balancing DNA
methylation states, whereas others deny it. One mechanism that is
proposed for demethylation is the conversion of 5-methylcytosine
to 5-hydroxymethylcytosine (Figure 2.5). This is carried out
through the action of a group of enzymes known as Ten-Eleven
Translocation proteins (TETs) (Tahiliani et al. 2009). Other
mechanisms of active demethylation have been proposed but most
are not widely accepted. A mechanism of passive demethylation
has received more approval. Passive demethylation means that
demethylation is occurring simply due to lack of maintenance of
the methylation status. This means that DNA is replicated without
the methyl marks being replaced as the new strands of DNA are
synthesized during cellular proliferation. This task is normally
carried out by maintenance methylases. Without maintenance
methylases, demethylation occurs (Klose and Bird 2006).

Figure 2.5: Demethylation can occur through a 5-hydroxymethylcytosine intermediate.

2.3 Histone Modifications.
2.3.1 Nucleosome and histone structure.
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As was previously discussed, DNA wraps around assemblies
of histone proteins to form nucleosomes (Figure 2.1).
Approximately 147 base pairs of DNA wrap around each
nucleosome, with up to 80 base pairs separating one nucleosome
from the next. Histones each have an amino terminal tail that is
pointed outwards away from the nucleosome and is available to be
modified.
2.3.2 Histone Acetylation.
Acetylation involves the addition of an acetyl group. The
addition of an acetyl group to histones neutralizes the positive
charge on the lysine amino acid residues of the histone. This
positive charge is usually a driving force for interaction of
histones with negatively-charged DNA. Without the positive
charge, the attraction between the histones and DNA relaxes,
altering the intimacy of their interaction, and thereby also
increasing the availability of DNA for interaction with other
factors – in essence, genes are now available to be activated.
Addition of acetyl groups is mediated by histone
acetyltransferases (HAT) (Roth et al. 2001). Removal of acetyl
groups is typically performed by histone deacetylases (HDACs)
(Grozinger and Schreiber 2002). Both HATs and HDACs are key
enzymes in regulating chromatin structure through modification of
histones. HDACs have been shown to combine with MBPs to
form a larger complex in response to DNA methylation.
Association between HDACs and methyl binding proteins would
stimulate histone deacetylation in regions of DNA that have been
methylated. This is consistent with the idea that acetylation
causes a more relaxed, activated chromatin state, whereas
deacetylation is associated with a more repressed and inactivated
state.
2.3.3 Histone Methylation.
Histone methylation is similar to DNA methylation in that
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methyl groups are added. They are different in terms of what
proteins mediate these processes. Recall that DNA methylation
occurs through the action of DNMTs (DNA methyl transferases).
Histone methylation is carried out by two different types of
enzymes depending upon the site of the methylation. Histone
methylation occurs on either arginine or lysine amino acid
residues. The addition of methyl groups onto arginines is done by
protein arginine methyl transferases (PRMTs) (Lee et al. 2005).
Lysines can be mono-, di-, or tri- methylated (Figure 2.6, 2.7)
(Lachner et al. 2004). This process is mediated by histone lysine
methyltransferases (HKMTs) (Lachner et al. 2003)). Conversely,
demethylation can also occur from both arginines and lysines,
through multiple different mechanisms. Arginine demethylation
occurs through deiminases which convert methylated arginine to
another amino acid called citruline (Bannister, 2005). Lysine
demethylation occurs through the action of an enzyme called
lysine-specific demethylase 1 (LSD1) (Shi et al. 2004). The
methylation state of histones can have varying effects on the
resultant gene expression depending upon the site of methylation
and other modifications that may be present.
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Figure 2.6: Modifications that occur on lysine amino acids. A
Lysine in its native state. B Acetylated lysine. The acetyl group
is shown in blue. C-E Mono-, di-, and tri-methylated lysines.
The methyl groups are shown in green.
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Figure 2.7: Methylation can occur on arginine amino acids.
Methyl group is shown in green.

2.3.4 Phosphorylation.
Phosphorylation is probably the most commonly discussed
protein modification. It is mediated by histone kinases which add
a phosphate group onto proteins. Phosphorylation occurs on
serine (Figure 2.8), threonine, and tyrosine amino acids.
Dephosphorylation is carried out by protein phosphatases.
Histone phosphorylation typically causes an increase in gene
expression or a general loosening of chromatin in the region.

Figure 2.8: The structure of serine before and after
phosphorylation. Phosphate group is shown in red.
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2.3.5 Ubiquitination.
Ubiquitination is the addition of ubiquitin groups onto a
protein. Ubiquitin is unlike any of the previously mentioned
histone modifications in that it is not a small molecule. Rather, it
is a large peptide (protein sub-fragment) that represents a
significant addition to a histone protein if added. Ubiquitin groups
highlight or mark a protein for degradation and removal. The
outcome of ubiquitination can be either positive or negative in
terms of overall gene expression in that region (Muratani and
Tansey 2003).
2.3.6 SUMOylation.
SUMOylation is the addition of SUMO groups to the
histones. SUMO groups are, like ubiquitin, peptides. These have
an exclusively repressive outcome. They achieve this by either
blocking acetylation from occurring at the site of SUMOylation or
by recruiting HDACs to remove acetyl groups (Yang et al. 2004).
In some contexts, SUMO groups compete with ubiquitin.
2.3.7 Combinatorial aspect.
The above-described modifications can occur in
combinations. The outcome with respect to DNA packaging,
conformation, and activity depends upon the various
modifications that are present. Detection of an acetyl group on a
histone does not necessarily mean that gene expression is
occurring in that region. All other modifications that are also
present in that same region must be taken into consideration.
Histone modifications are referred to as combinatorial for that
reason. Indeed, the “histone code” is liable to be more varied and
complex than the sequence of DNA itself..
2.4 RNA Species.
2.4.1 Overview of ncRNA.
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There are many species of RNA that can exert functions
themselves without being translated into protein. RNA molecules
known as messenger RNA (mRNA) are those that are translated
into protein (Figure 2.9). However, there are other types of RNAs
that do not get translated into protein such as transfer, ribosomal,
and telomeric RNA (tRNA, rRNA, and telRNA), to name a few.
These latter are involved in the machinery of protein synthesis and
consolidation of the structural ends of chromosomes without
themselves encoding a protein. These functional RNA molecules
are broadly classified as noncoding RNA (ncRNA). This is
because they are RNA molecules that do not encode a protein, but
perform a different function in cellular life. Finally, there is a
constellation of new RNA species that are now being discovered
and that play an important role in epigenetics.

Figure 2.9: The Central Dogma of molecular biology.
Illustrated is the transcription of DNA into transient RNA
molecules that act as messengers for the translational coding of
protein molecules.
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While proteins are very important in cellular processes,
noncoding RNA molecules are
not to be overlooked.
Interestingly, only around 1% of the genome transcribes mRNA
that encodes proteins, whereas somewhere between 70% and 90%
of the genome is transcribed into non-coding RNA at some point
(Lee 2012). RNA molecules can be transcribed from almost
anywhere in the genome, including areas that overlap with known
protein-encoding genes. The speculation is that there are around
ten noncoding RNA molecules transcribed from within the span of
any “regularly” coding gene (Lee 2012). This means there is a
huge volume of DNA that is being transcribed, the product of
which has yet to be understood and characterized for the most
part. Some lesser-understood ncRNA molecules are those that are
implicated in epigenetic mechanisms.
These include long
noncoding RNA (lncRNA), microRNA (miRNA), and circular
RNA (circRNA), which will all be discussed for the remainder of
this chapter.
2.4.2 lncRNA.
Long noncoding RNA molecules are RNA molecules that are
not translated into protein, and are not associated with either
regular cellular processes (such as tRNA and rRNA) nor are they
characterized by specific cleavage and folding patterns (as is
miRNA) (Ernst and Morton 2013). They can be thousands of
nucleotides long. Long-noncoding RNA molecules are known for
being allelic in nature (Lee 2009). This means that regulation by
lncRNA can be specific to one of either the maternally inherited or
paternally inherited chromosome. This can be illustrated by the
example of X-inactivation in females. We know that females
carry two X chromosomes, as opposed to the X and Y carried by
males. The Y chromosome is very small compared to the X. In
order to compensate for having double the genetic complement of
men (and thereby preserve a correct “dosage” of functional
genes), women turn off one X chromosome via a process known
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as X-chromosome inactivation. The mechanism by which this
occurs involves a very important lncRNA known as Xist (Brown
et al. 1992). The key in X chromosome inactivation is that one
chromosome must be fully compressed and shut down whereas the
other is fully active; there cannot be any variability in the
expression from either one. This is known as allelic specificity
(Lee 2009).
The way that RNA molecules are able to achieve such a high
level of specificity is because of the way they are produced, their
stability, and the way they are compartmentalized and stored in
specific regions. RNA molecules are nucleic acids, just like DNA.
In this sense they have a sequence, and this can bind to
complementary sequences of DNA to interact with only specific
target sequences, in this case DNA. There are many proteins that
bind to DNA: numerous examples can be found among the
transcription factors (DNA activating and repressing proteins).
The difference between proteins and RNA is that proteins
typically recognize short DNA sequences to bind, whereas RNA
molecules are able to bind to long sequences, giving them a
specificity that proteins may lack (Lee 2012).
DNA is an extremely stable molecule. It needs to be, since it
will direct cellular activities throughout the life of the cell. RNA
on the other hand, is a labile molecule. It is synthesized to pass a
message along, either to encode proteins or to fulfill one of many
other functions. Once it has done this, it often needs to be
removed immediately from circulation by degradation. This is an
aspect of lncRNA that is manipulated in certain biological
processes, ie: those that require brief signaling or signaling
specific to the site of RNA transcription. This is how lncRNA is
able to act in an allelic manor. In the case of X-activation and
other cases, lncRNA is degraded almost as soon as it is made.
This means that it doesn’t have an opportunity to diffuse away
from the site of synthesis; the lncRNA is likely to act near the X
chromosome from which it is transcribed, not upon a neighboring
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chromosome (Sun, 2006). Furthermore, even if small amounts of
lncRNA are actually able to diffuse from their site of synthesis,
the rates of degradation by cellular machinery ensures that
concentrations would likely become insufficient for remote
activity (Lee 2012).
lncRNA molecules can also restricted to a distinct region of
action via the binding of tethering proteins. Tethering proteins
will bind to RNA molecules during synthesis and anchor them to
that region thereby preventing diffusion away from the target
DNA sequence (Lee 2012).
In the example of the lncRNA involved in X chromosome
inactivation, the Xist lncRNA specifically recruits proteins
involved in chromatin repression. This is what causes the
inactivation of the chromosome (Wutz 2011). However, it is not
always true that lncRNA will silence any given region. In fact,
there are lncRNA molecules that are involved in turning on
expression of DNA (Lee 2012).
While there has been a lot of research focusing on various
lncRNA molecules in recent years, it is still unclear what their
importance is to the cell. Most of the hypotheses derive from
experiments where certain lncRNA are turned off. Many of these
experiments do not result in a noticeable change in cell physiology
leading many to speculate that lncRNA molecules have redundant
functions (Lee 2012). More research is needed to clarify the
functional importance of most lncRNA molecules.
2.4.3 miRNA.
MicroRNA (miRNA) molecules are much shorter than
lncRNA molecules, and once processed, they average roughly 23
nucleotides per molecule (Bartel 2004). Their action is specific
and targeted to repress genes. The way that miRNA molecules
function is through interaction with a complex known as an RNAinduced silencing complex (RISC) (Schwarz et al. 2003).
miRNA molecules are formed through the folding of an initial
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RNA transcript and then its subsequent cleavage to produce a
double-stranded RNA molecule, one strand of which will be
recognized by, and pair with, the RISC. Together, RISC and the
miRNA bind to a specific protein-encoding mRNA . The miRNA
provides the sequence specificity to target specific mRNA
molecules (Schwarz et al. 2003). While there is some specificity
in gene targeting, there are miRNA molecules that can recognize
up to hundreds of different gene products – in other words, related
families of mRNA sequences (Bartel 2009; Shukla et al. 2011).
Most miRNA molecules bind to the untranslated region (UTR) of
an mRNA. If multiple mRNA sequences share a conserved UTR
motif, then one miRNA can recognize any one of these mRNA
molecules (Lim et al. 2005).
When the RISC/miRNA complex binds to a target mRNA
molecule, there are different fates that can arise for the mRNA.
Binding can stimulate the RISC complex to cleave the proteinencoding mRNA molecule, effectively precluding production of
the protein. This typically occurs when the miRNA and mRNA
sequences are very similar so that binding is strong. Alternatively,
when binding is weaker, the RISC and miRNA complex will bind
to the mRNA and then either: halt translation of the mRNA
through the ribosomes (protein factories); allow more miRNA to
bind; or send the mRNA for processing and eventual degradation
(Baulcombe 2004). Regardless, the fate of the mRNA is to be
either destroyed or at least not translated, meaning the product of
that gene is effectively turned off.
2.4.4 circRNA.
As we saw above, miRNA molecules regulate genes at a posttranscriptional level. The genes that encode miRNA are
themselves subject to regulation like any other gene, including
those that encode proteins. However, there is another layer of
activity that regulates the levels of miRNA. This level requires
circular RNA (circRNA) molecules. circRNAs have the ability to
32

Epigenetics Mechanisms and Techniques

bind miRNAs and to inhibit them. Their circular structure allows
them to bind miRNA without being rendered susceptible to
degradation via the mechanism that miRNA uses to induce mRNA
cleavage (Franco-Zorrilla et al. 2007).
Currently, our
understanding of circRNA molecules is limited, but it appears to
promise another layer of complexity to be considered when
analyzing gene regulation and epigenetics.
Through this chapter we’ve seen various RNA species that
can interact and regulate one another, as well as various genes.
The interactions are summarized in Figure 2.10.

Figure 2.10: The Central Dogma of molecular biology with
feedback and interactions between RNA species.
DNA is
transcribed into a pool of different RNA species. The traditional
mRNA is still translated into protein. miRNA and lncRNA inhibit
protein-encoding mRNAs. circRNA potentially reverses this by
inhibiting the miRNAs. lncRNA can also effect the DNA directly,
either by affecting transcription of new RNA molecules, or by
physically covering DNA or altering its shape sufficient to preclude
interaction with other protein or RNA factors.
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While DNA and proteins are typically the most discussed
components contributing to chromatin structure, this section
describing the impact of RNA on epigenetics has hopefully
provided some enlightenment about why RNA is an equally
important player in the regulation of gene expression and
chromatin structure.
2.5 Introduction to the Assessment of Epigenetic
States.
Understanding the molecular subtleties of epigenetics is
one thing, assessing these epigenetic marks in a way that advances
the field is quite another. Before diving into the gory details of
epigenetic assessment techniques there are some preliminary
difficulties with epigenetic assessment as a whole, especially
when it comes to human subjects. Firstly, epigenetic states are
dynamic and can vary substantially between different tissue types.
For example, epigenetic patterns change with age, and at different
rates in different tissues. This means that a mouth swab of oral
epithelial cells is not representative of the epigenetic status of the
whole body - epigenetic marks might affect only a single gene in a
single cell type. If that cell type happens to reside in the brain,
then a blood test will tell you nothing. From a human patient’s
point of view, this might mean uncomfortable prospect of biopsies
of sensitive tissues like liver, brain, or gonad. Imagine having to
request a brain biopsy from a living colleague to test for
epigenetic effects (although there may be some colleagues in
whom the lost material passes unnoticed!). Furthermore, if you do
not know in advance which gene or suite of genes are liable to be
affected by epigenetic changes, it can be hard to design a test to
screen for effects. That said, if epigenetic changes are detected in
blood samples, they do not necessarily covey information
concerning organs, nor whether the imprint will have been
transmitted to the germ line for propagation to future generations.
Finally, as will become clear in the ensuing chapters, many
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different influences act upon the epigenome, so establishing a
discrete causal link can be very difficult – there are simply too
many confounding factors at play.
Even presupposing the availability of a tissue sample, what
is to be epigenetically assessed? DNA methylation, histone
modification, regulating RNA species, etcetera? In most cases,
there is far too little scientific literature to systematically narrow
down which epigenetic path to take. It is also not feasible to
collect sufficient tissue sample and have the financial resources to
perform all tests. Furthermore, one should also consider how
much of an effect the biopsy itself may have on the epigenome of
the tissues implicated.
The second issue is that the definition of epigenetics is not
static, but rather is ever evolving, much like the definition of a
gene has over the last few decades. Some believe that epigenetics
must be considered heritable (Berger et al. 2009). Others believe
that only mechanisms that change chromatin structure should be
considered to be epigenetic (Bird 2007). Perhaps the safest
definition is one that conveys the notion that absolutely any
mechanism that changes the expression of a gene, and that that
doesn’t involve change in nucleotide primary sequence, is
epigenetic. Adopting the latter definition, the possibilities of
“what is epigenetics?” becomes nearly endless.
Finally, given the number and complexity of potential
DNA methylation sites, as well as the innumerable ways in which
histones and other chromatin proteins may be modified, it may
often be hard to assess the meaning of the state of a DNA
sequence or its associated histones. For example, a single gene
might have a half dozen or more CpG islands available for
methylation, and different numbers and arrays of them might be
methylated (or not) in different cells even within the same tissue.
Without even having approached the evaluation of histone
modifications, the epigenetic code is already complex and subtle.
To make this section brief, only two putative epigenetic
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modifications have been explored for assessment, methyl DNA
and histone modification. These assessment techniques may be
used on all tissues using very small sample (biopsy) quantities.
One exception is the strategies that employ bisulfite treatment to
identify methyl DNA: this used to require a substantial amount of
sample tissue, but the technique is now very much more efficient.
The importance of epigenetic assessment is apparent in the
correlation of epigenetic marks with predispositions to, and
involvement in, disease. Indeed, a better understanding of the role
of epigenetics in disease may facilitate the discovery of
preventative measures, accurate prognostic assays, treatments, or
even cures. Epigenetic assessment is facilitated by specialized
biomolecular techniques that are capable of identifying methylated
DNA regions, genes under the control of modified histone
proteins, and epigenetically active RNA species.
These
techniques include DNA amplification by polymerase chain
reaction (PCR), DNA sequencing, and immunoprecipitation
(IP). Often, these techniques are used in combination. This chapter
will cover the basics of today’s popular epigenetic assessment
techniques, and identify their limitations and some ramifications
from the consumers’ point of view.
2.6 Methylated DNA (MeDNA) Assessment
DNA methylation (MeDNA) is one of the best
understood epigenetic markers with a plethora of assessment
techniques, many involving the bisulfite treatment of DNA. A
simple approach is to use restriction enzymes to cut the genome
into manageable sizes. One variation of this approach employs
restriction enzymes that have a differential ability to cut at
methylated CpG sites. A sample can be digested, and depending
upon where it is methylated, differently sized fragments will be
cut. The strategy is then either to visualize these differences on a
gel, cut them out, and then clone/sequence them, or, to use
polymerase chain reaction (PCR) to amplify the fragments
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following the addition of adapter sequences to their ends. In this
latter instance, the PCR sequences can be cloned or sequenced
(Esteller 2005).
Another strategy requires that methylated C’s be
chemically converted to make them stand out. Bisulfite converts
any unmethylated cytosine residues in DNA to uracil (Frommer et
al. 1992). These changes can be then be detected by conventional
DNA sequencing or PCR (polymerase chain reaction) approaches
– comparisons are made to DNA samples that have not been
bisulfite treated, and this highlights the nucleotides that must have
been methylated (and protected from bisulfite conversion).
Treating DNA with bisulfite to find methylated C’s is analogous
to using a black light used to find bodily fluids on surfaces and
clothes. Since the base pair complement of uracil is converted to
adenine instead of guanine, sequencing techniques are ideal for
accurately locating unmethylated cytosines within DNA.
Unfortunately, bisulfite treatment also degrades a large portion of
the initial DNA template, and this reduces its effectiveness with
scarce DNA samples (Grunau et al. 2001). Another limitation is
that 5-hydroxymethylcytosine, like 5-methylcytosine, is also
resistant to bisulfite treatment. This is a problem since the
consequence of 5-hydroxymethylcytosine on gene transcription is
different from 5-methylcytosine as described earlier. The Tet
family of enzymes (Section 2.2) may mitigate this problem by
converting 5-hydroxymethylcytosine to 5-carboxylcytosine that is
read as a thymine when sequencing bisulfite treated DNA.
An alternative to sequencing bisulfite treated samples, is to
use polymerase chain reaction (PCR) conditions that will
discriminate between untreated and bisulfite-converted sequences.
Depending upon the DNA primers used to amplify a target
sequence, bisulfite treated sequences can alter whether or not the
sequence can amplify – a comparison of PCR products on a gel
will tell you if the target sequence was originally methylated or
not (Figure 2.11).
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Figure 2.11: Flow chart of methyl DNA (MeDNA) assessment by
MSP. Methyl specific PCR takes advantage of a PCR technique
using methylated CpG island specific primers for the rapid
assessment of DNA methylation status.

Bisulfite treated DNA opens many doors to PCR and
sequencing techniques.
The difference between PCR and
sequencing is that PCR amplifies targeted DNA sequences
thousands of times until they are abundant enough to be visually
detectable, while sequencing is the systematic identification of
each nucleotide base in the sequence. Bisulfite sequencing
benefits from being more in the way of a brute-force approach –
you do not necessarily need to know anything about the DNA
sequences to begin with – you can capture sequence data in an
unbiased manner. DNA enrichment was initially required for this
treatment due to severe degradation of DNA from bisulfite
treatment and these clones had to be amplified for any direct
sequencing sensitivity. Any kind of cloning is labor intensive and
expensive, thus other sequencing techniques are now preferred
(Tost and Gut 2007). Unlike the old method of bisulfite
sequencing (dideoxy chain termination), pyrosequencing does not
require enrichment of DNA and it is therefore not quite as labor
intensive (Tost and Gut 2007). Nucleotide incorporation is
identified and reported by a light signal as a complementary
sequence of DNA is polymerized by sequencing enzyme. The
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light signal intensity may then be quantified. The trade-off is that
the technology itself is expensive and the sequence read length is
short – 300-500 base pairs instead of the 1000 base pairs formerly
achievable.

Figure 2.12: Flow chart of MeDNA assessment by BSP.

Bisulfite specific PCR, unlike MSP, amplifies upstream regions
of DNA with primers not containing possible methylated CpG
islands. The products produced are then assessed by using a
secondary rapid technique.

Essentially two PCR techniques are commonly used:
methyl specific PCR (MSP) (Figure 2.11) and bisulfite specific
PCR (BSP) (Figure 2.12). The key difference between the two is
primer composition. MSP includes CpG sites in their primers and
BSP does not. Due to the nature of MSP primers, a PCR product
is observed when a CpG site is methylated (Herman, 1996). If the
template is unmethylated then the MSP primer would not
hybridize to the template DNA resulting in an absent PCR product
as shown in Figure 2.11. PCR products are DNA fragments
resolved on agarose or acrylamide gels into singular bands. This
is a cheap and fast 5-methylcytosine assessment of a single or
small collection of genes. The limitation of MSP is that the
template DNA sequence must be known in order to design primers
(Herman et al. 1996). Other problems arising from any PCR
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technique is non-specific primer hybridization which requires
careful annealing temperature optimization for each primer set.
Figure 2.13: The figure represents a melting curve using
methylation specific high resolution melting (MS-HRM) of two
BSP PCR products. The red melt curve is representative of the

PCR product that contained a methylated cytosine and therefore
requires a higher temperature to dissociate the double stranded
DNA to single strands. The red product lacked one or more
methylated cytosines and acquired the weaker uracil bases
resulting in a lower temperature melt curve.

The power of BSP is that it does not require detailed
knowledge of a gene or genes of interest. Primers may be
designed for highly repetitive DNA sequences that do not include
CpG islands. Excellent examples are the Alu elements. Alu
sequences are often found upstream from many genes’ nontranscribed regions including the promoter, repressor, and
enhancer domains that may be littered with CpG islands (Yang,
2004). After PCR, the DNA fragments can be subjected to methyl
DNA (MeDNA) assessment using a variety of techniques
including: sequencing, Southern blot analysis, combined bisulfite
40

Epigenetics Mechanisms and Techniques

restriction analysis (COBRA), and methylation specific high
resolution melting (MS-HRM).
 Southern blots allow a MeDNA specific DNA primer
conjugated to a fluorescent or radioactive reporter to probe
a collection of DNA fragments that have been previously
immobilized on a membrane.
 COBRA uses a CpG island-specific restriction enzyme
approach (Xiong and Laird 1997). Restriction enzymes
reduce PCR products to smaller fragments by double
stranded breaks. The number and size of these fragments
of bisulfite treated DNA containing methylated CpG
islands will differ from those without methylation. The
restriction enzyme approach is easy, accurate, fast and
cheap.
 Finally, another technique involves methyl sensitive high
resolution melting (MS-HRM). This techniques takes
advantage of the differential melting properties of DNA
based on nucleotide length and composition (Wojdacz and
Dobrovic 2007). A higher cytosine-guanine composition
present in bisulfite-treated methylated CpG island DNA
fragments will result in a higher melting temperature than
unmethylated CpG island fragments.
Figure 2.13
illustrates this phenomenon as a melt curve with the y axis,
dF/dT, representing the change in fluorescence over
change in temperature. In this instance, the fluorescent
molecules are designed to fluoresce only when bound to
double stranded DNA: as the temperature increases the
DNA melts into single stranded DNA, and fluorescence
declines in proportion. The increased cytosine and
guanine content results in a higher melting temperature
due to the triple bond between them, resulting in more
energy required to break compared to double bonds
formed by thymine or uracil and adenine. Like COBRA,
MS-HRM is relatively fast, easy, cheap and very accurate
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at determining methylated CpG islands at a locus
(Wojdacz, 2007).
The previously discussed techniques are often combined
for confirmation and accuracy of results. As an example, MSP
amplified fragments may be subjected to pyrosequencing for
methylated CpG island confirmation (Shaw et al. 2006).
Combined techniques may also elucidate additional information of
a DNA sample such as methylation heterogeneity when
combining pyrosequencing with MS-HRM (Candiloro et al.
2011). Most importantly, combining BSP and sequencing
techniques results in global methylation assessment (Yebra and
Bhagwat 1995). Global methylation has great significance in
medical diagnostics since cancers often exhibit a particular
methylation signature that is detectable in blood samples (Delpru,
2013).
Other MeDNA global assessment techniques that do not
require
bisulfite
treatment
include
methyl
DNA
immunoprecipitation (MeDIP) and methyl binding domains
(MBD). The two use the similar concept of isolating digested
methylated DNA by binding 5-methylcytosine and immobilizing it
and the attached DNA sequence – this can later be processed and
analyzed (Jacinto et al. 2008) (Fig. 2.14).
 MeDIP uses an antibody approach and MBD utilizes
proteins that bind preferentially to 5-methylcytosine. To
help conceptualize immunoprecipitation imagine the
following: When fishing, a fisherman wants to catch a
particular fish (5-methylcytosine) and to do this he will use
a specialized bait (antibody). Once the fish is caught the
fisherman will use rod and line to isolate the fish
(immunoprecipitation). Isolated DNA may then be subject
to sequencing or a microarray (Palmke et al. 2011).
Microarrays use a myriad of microscopic complementary
DNA spotted and dried in arrays on a glass – each spot
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might potentially bind specific sequences present in your
sample. There may be hundreds to thousands of distinct
DNA sequences spotted on a slide. Your DNA sample of
interest can be PCR amplified, fluorescently labeled, and
then incubated upon the microscopic dots. Complementary
strands stick to each other: since your sample DNA is
labeled, a fluorescent signal can be detected and linked to a
known sequence upon the array. These experiments
provide a massive amount of information. Microarrays are
often used in medical diagnostics since they provide
comparative information between two cell types, for
example, those deriving from cancer and normal tissue
(Palmke et al. 2011). The drawbacks of microarrays are
not inconsiderable: they are expensive; results may be
inconsistent; the massive amount of information they
provide is not necessarily useful; and validation and
analysis of results can take a long time (Chagovetz and
Blair 2009).
There are not many methods outside of chromatin
immunoprecipitation (ChIP) for assessing the epigenetic states of
histones (Huebert et al. 2006; Pillai and Chellappan 2009). ChIP
uses the same isolation strategy as MeDIP, but with a different
target using a different bait. In this technique, a DNA sample
prepared so that multiple species that are 146bp long can be crosslinked to nucleosomes: the exposed DNA between nucleosomes is
then degraded. Once the cross-linked DNA is immobilized on the
nucleosomes, antibodies are used to specifically recognize and
bind to particular histone modifications; some antibodies will
recognize acetyled histones, other will bind methylated,
SUMOylated, ubiquitinated, glycosylated, or phosphorylated
histone. The repertoire of antibodies available for this approach is
quite large and specific. For example, there are reagents available
that are sufficient to discriminate between histone H3 methylation
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at the 4th, 9th, and 27th amino acid position on the protein, and
even between different methylation sites at each of those positions
etc.. This might give you a glimmering of how varied and
complex the combinations of modifications can be.
Figure 2.14: Flow chart of histone modification assessment by
immunoprecipitation. Antibodies are designed to target a
specific histone modification like in this example, histone
methylation.
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Epigenetic
assessment
technique

Mechanism

Information provided
by technique

Direct bisulfite DNA sequencing of
sequencing
clonal vectors following
bisulfite treatment

Methylome in its entirety,
global MeDNA, and
single gene MeDNA
assessment

MSP

DNA amplification of
template DNA via CpG
containing primers after
bisulfite treatment

Single gene MeDNA
assessment

BSP

DNA amplification of
template DNA via nonCGI containing primers
after bisulfite treatment

Global MeDNA and
single gene MeDNA
assessment

Pyrosequencing

Short read sequencing
technique involving a
luminescent reporter

Global MeDNA, single
gene MeDNA, and global
gene identification under
a histone modification
assessment

MeDIP/MBD

Immunoprecipitation of
DNA containing methyl
cytosine which is then
probed or sequenced

Global MeDNA and
single gene MeDNA
assessment

ChIP

Immunoprecipitation of
targeted histones with
desired mark followed
by sequencing of crosslinked DNA

Global gene identification
under a histone
modification

Table 2.1: Summary of epigenetic assessment techniques
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Whatever DNA/histone combination is then bound and
precipitated by antibody is then cleaned up and the DNA is uncross-linked and made available for analysis by sequencing or
microarrays (Huebert et al. 2006; Pillai and Chellappan 2009).
146bp sequences are more than enough to identify which gene or
genes are associated with the targeted histone modification. Much
work to be done with regard to assessing histone modifications.
In yeast alone there are 51 conformations of modifications
identified by mass spectrometry (Jiang et al. 2007). Different
combinations also have different implications on gene expression
(Jiang et al. 2007). Linking histone modification assessment data
with genetic expression will be quite the undertaking, but it will
greatly expand our understanding of the role of combinatorial
histone modifications in gene expression.
2.7 Conclusions
Epigenome analysis is liable to be fraught with many of
the same challenges and concerns that were elicited by genome
sequencing. For example, who should have access to data, and
under what circumstances? How will privacy be protected, and
how long will samples and data be stored? If direct-to-consumer
epigenome testing kits become available, how will they be
regulated, and how will individuals be taught to employ and
interpret them with intelligence, caution, and integrity? Will it be
possible to quantify an individual’s epigenome given that all
tissues and cells within that person are liable to carry a slightly
different imprint? Or will generalized and averaged assays be
sufficient to indicate general health trends? If epigenomes can
change with time and experience, will this immensely complex
fingerprint ever find utility to identify and characterize people?
Epigenetics is a quickly growing field of biology, but there
is still much more to be explored. Individuals interested in getting
their methylome assessed will not only have to consider which
tissues to assess but also when, since methylation patterns differ
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between tissues and over time. For example, 5-methylcytosine
deamination is a product of aging and accumulates over time.
Perhaps at some stage some people will advocate that we assess
the global methylation status of an individual’s gametes before
they manifest the intent to reproduce? This practice would ensure
that epigenetically healthy material is inherited by the offspring,
and this would help to indicate corrective dietary measures, or to
minimize the transmission of possibly deleterious transgenerational effects (Chapter 5). However, after assessment
should individuals commit to life changing decisions based on
what is, after all, relatively dynamic information? There is also
the issue of financially disadvantaged populations: should money
determine who can afford the expense of a methylome
assessment? Who should pay to mitigate epigenetic harms? What
should be done for the equal opportunity of epigenetic
assessment? These ethical issues are of the realm of eugenics and
are discussed in Chapter 8.
In summary, epigenetic tools are abundant for global
MeDNA, single gene MeDNA and global histone modification
assessment. However, the analysis of the massive amounts of data
they provide has not yet matured into something suitable for
solving today’s ethical, legal, and scientific complications.
Provocative Questions
 How can an epigenome be characterized if the marks that
differentiate cell are so complex and varied?
 Since epigenetic imprints vary from cell to cell, and tissue
to tissue, will biopsies be required from every tissue type?
 If an epigenome is to be modified by drugs or diet, given
the aforementioned constraints, how will success be
monitored?
 Who will bear the cost of assessing an individual’s
epigenome, and will simple blood tests become
sufficiently sophisticated to provide generalized prognostic
47

information?
 Given the rapidly changing and complex methods of
assessment, how will non-specialists, such as physicians
ever manage to keep abreast?
 Given that there are many different epigenetic routes for
cells to reach a particular endpoint, is there value in trying
to assess an epigenomic imprint? Will a result that
comprises averaged status be informative?
 Will it be possible to predict whether or not a person’s
epigenetic status will convey to the next generation?
Should such an attempt be made?
 How will the huge datasets derived be housed and secured
from intrusion?
 Given that an individual’s epigenomic imprint changes
with time, how often should their imprints be re-assessed?
 How will the cost to benefit balance of epigenetic testing
be assessed?
Possible Solutions








Given the epidemiological scale, longevity, and transgenerational effects of epigenetics, resources should be directed
to developing comprehensive, accessible, and reliable methods
to assess epigenetic imprints.
Multiple and representative samples should be assessed
globally to define variation between individuals, genders, ages,
economic strata, geographical areas, and genetic backgrounds.
Education of policy makers, health officials, medical
practitioners, as well as science and health teachers should be
updated to include consideration of epigenetic effects and
mechanisms.
Economists, medical practitioners, ethicists, and social
scientists should be engaged to evaluate the relative costs and
benefits of epigenetic assessments and interventions for both
individuals and for society at large.
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Chapter 3
Cancer: An Example of Epigenetic Peril
and Promise
By Sandy Zakaria, Marisa Market, Jessica Hebert
Abstract
Cancer epigenetics offers a good introduction to how
both the mechanisms and tools of epigenetics are utilized by
clinicians and researchers to unravel new possibilities for
diagnosis, prognosis, and manipulation (treatment). For example,
hyper-methylation appears to play a role in silencing tumor
suppressor genes, while the overexpression of some miRNA
genes exacerbates this condition. We discuss how epigenetic
markers can serve as indicators of tumor aggression and
progression. By screening for these epigenetic markers (like
lowered global methylation status and a loss of acetylation and
methylation on histone proteins), a more accurate diagnosis and
prognostication of tumor character and stage can be made.
Finally, by manipulating epigenetic states via either global or
target-specific means, prospective therapies for cancer treatments
have potential to offer effective solutions to formerly intractable
problems.

3.1 Introduction
Over the past decade, research into cancer epigenetics has
begun to reveal the mechanisms by which normal cells adopt
cancer phenotypes. In 2000, a consistent relationship was shown
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between DNA hypermethylation (many methyl groups attached) in
tumor suppressor genes and cancer phenotypes (Esteller et al.
2000; Bygren et al. 2001): aberrant methylation and acetylation
patterns are now known to contribute to cancer. Epigenetic
analysis permits researchers to examine cancer profiles by
comparing normal to cancer cells (Hedenfalk et al. 2001). More
recently, global hypomethylation (few methyl groups attached),
was identified in all cancer cells (Kaneda et al. 2004). We now
know that carcinogenesis is governed in part by epigenetic
mechanisms in which the degree of hypermethylation of tumor
suppressor genes, the level of global hypomethylation, and
aberrant histone modifications are indicative of cancer
development and progression. The importance of epigenetics as a
causative agent in cancer will be assessed in this chapter, as well as
its importance for prognosis and treatment.
3.2 How Epigenetic Mechanisms Induce Cancer
Development and Progression
Epigenetic mechanisms of methylation and acetylation
modify the structure of DNA, histones, and miRNA (microRNA)
and can, on occasion, lead to cellular malfunction (Esteller 2007;
Suzuki et al. 2012). The same epigenetic mechanisms that control
normal functions can be deregulated to induce uncontrollable cell
growth and rapid proliferation. If this happens, the newly attained
cellular functions can produce cancer cells that will compromise
the health of the individual. Examples of this can be seen in Figure
3.1.
An individual’s DNA is susceptible to epigenetic
modification at cysteine residues as mentioned in Chapter 2. When
cysteine residues become modified with methyl groups, this will
lead to a new epigenetic signature (Esteller 2007). In general,
hypermethylation will decrease gene expression and downstream
gene targets, whereas hypomethylation will increase gene
expression and downstream gene targets.
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3.2.1 DNA Hypermethylation of Tumor Suppressor Genes
Cancer cells display elevated methylation at the CpG sites
of tumor suppressor genes. Tumor suppressor genes encode
proteins that maintain the integrity of numerous cellular processes,
but especially those that are involved in cell division or
programmed cell death (apoptosis). The gating of entry into either
division or death is critical to normal cellular function.

Figure 3.1 Stages of carcinogenesis I-V.
Stage I: the epigenome is unaltered allowing for normal function
of cells. Stage II: epigenetic modifications occur to encourage benign cell
proliferation. Stage III: genetic and epigenetic modifications begin to
accumulate and cells will adopt a more aggressive and invasive phenotype.
Stage IV: cancer cells are transformed into malignant cells due to an
increasing accumulation of genetic and epigenetic modifications and now
have the potential to migrate through circulatory system. Stage V: cancer
cells exit bloodstream to establish a secondary tumor site and begin to
proliferate. Accumulations of epigenetic modifications such as
hypermethylation of tumor suppressor genes and miRNA, global DNA
hypomethylation, and aberrant histone modification will compound and
amplify and the genome will in turn become more unstable. Cancer cells
will attain a malignant phenotype that will adopt invasive and aggressive
cellular properties.

When tumor suppressor genes become hypermethylated,
their activity is down-regulated and they are often silenced. As a
result, aberrant cellular processes develop, such as premature cell
cycle entry, avoidance of apoptosis, defects in DNA repair, and
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impaired cell adhesion. All of these processes will contribute to
cancer formation and progression (De Carvalho et al. 2012).
Tumor suppressor genes are not merely essential for
regulating the cell cycle, but they are consequently vital for
maintaining genome stability. A well-studied tumor suppressor
gene known as TP53 is needed to ensure proper cellular genetic
composition before cellular division. The role of this gene’s
encoded protein, p53, ensures genetic integrity and stability of
cells thereby minimizing the possibility that gross genetic and
chromosomal anomalies will be passed down to daughter cells. An
in vivo study has shown that p53 function is essential for tumor
prevention and cellular senescence (Agarwal et al., 1995; Qian
and Chen 2013). The antitumor activity of p53 is essential. Cells
that have suppressed p53 activity via hypermethylation will lose
genetic integrity and stability. Other tumor suppressor genes that
operate to regulate the cell cycle such as retinoblastoma (RB) and
p16 can also be subjected to methylation of their regulatory regions
to induce gene silencing (Murao et al. 2006). For example, in
cutaneous squamous cell carcinoma, tumorigenesis is associated
with hypermethylation of RB/p16 pathways (Murao et al. 2006).
Tumor suppressor genes such as CDH1 and CDH13 are
needed for cellular adhesion to maintain the complex architecture
of cells as they form organized tissues (Graff et al. 1995; Toyooka
et al. 2001). Several types of cancer can arise when CDH1 and
CDH13 are hypermethylated. The silencing of CDH1 and CDH13
affects downstream genes in their respective signal cascades, and
this causes cells to lose adherence to their neighbours.
Subsequently, cells acquire the ability to migrate and metastasize
to establish secondary sites of growth elsewhere via the circulatory
system. According to the National Cancer Institute, an individual
with ovarian cancer that has metastasized has a 5 year survival rate
of 44% whereas an individual with ovarian cancer that has not
metastasized has a 92% chance of survival after a 5 year period.
The consequence of hypermethylating CDH1 and CDH13 is that
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cancer cells become more aggressive and invasive, thereby
dramatically decreasing survival rates. Hypermethylation of CDH1
is associated with metastasis 74% of the time in these tumors
(Yeucheng et al., 2006)
DNA repair mechanisms ensure the integrity of the
genome. Tumor suppressor genes that are responsible for DNA
repair mechanisms can fail to work properly when they are
hypermethylated at CpG sites. Without proper repair functionality,
cells cannot overcome mutations that arise within their genome,
and they become even more susceptible to mutations and this
contributes to carcinogenesis. For example, hypermethylation is
apparent in the BRCA1 gene that is associated with breast and
ovarian tumors, and the DNA repair gene hMLH1 is
hypermethylated in colorectal, endometrial, and gastric tumors
(Esteller et al. 2001; Esteller 2005).
3.2.2 Global DNA Hypomethylation of Epigenomes
Tumor suppressor genes aside, most regions of the tumor
epigenome have a trend of global DNA hypomethylation.
Epigenomes of cancer cells undergo a decrease of DNA
methylation of approximately 20-30% compared to normal cells
(Esteller 2005). Epigenetic hypomethylation is also a critical factor
for maintenance of genome integrity. For example, normal
methylation of the epigenome is needed to silence repetitive
sequences left by ancestral viral invasions such as transposable
elements (Esteller 2005). These viral remnants constitute almost
42% of our genome, and are normally kept stable and inactive by
methylation. When hypomethylation occurs, these ancient viral
sequences can become mobile and take chunks of chromosome
with them as they translocate, leading to the chromosomal
translocations that are a hallmark of mutation and cancer (Esteller
et al. 2001; Esteller 2005). Mobilized sequences can also have dire
effects upon gene expression when they re-insert into a random
location that might include a formerly intact and vital gene: this
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can either disrupt the “host” gene’s regulation or its function
(Walsh et al. 1998). Chromosomes require special organization of
their middles and ends (centromeres and telomeres).
Hypomethylation of centromeric regions of DNA can enhance
susceptibility to the formation and progression of tumor cells by
disrupting chromosomal segregation during mitosis – daughter
cells receive abnormal numbers or parts of chromosomes, and this
also enhances the descent to gross mutational disruption (Esteller
2005).
In addition, the loss of methylation of other genes, such as
those encoding growth factors or cell cycle regulators, will induce
aberrant cell growth and division leading to carcinogenesis. For
example, global DNA hypomethylation can reduce the methylation
status of imprinted genes (IGF2 and H19) to result in their
overexpression whereby they contribute to carcinogenesis (Esteller
2005).
Even though the degree of global DNA hypomethylation is
an indicator of tumorigenesis and progression, global
hypomethylation initially exerts its effect through only a minority
of affected genes (Esteller 2005; Fraga et al. 2005). Later, the
hypomethylation of many genes and transposable elements have
consequences that are, ultimately, reflected in increased rates of
mutation, chromosomal degradation, and tumor progression.
The assessment of an individual’s global methylation
status should be interpreted very carefully as there is a tendency to
lose methylation with age (Dunn 2003). This makes it difficult to
calibrate relationships when considering hypomethylation as a
driver of carcinogenesis. For example, two mouse lines that were
deficient in two different genes were crossed and then a tumor
assessment was made. The first mouse line possessed a disrupted
gene for the enzyme DNMT1: it could not attach methyl groups to
cysteine residues and this resulted in hypomethylation of several
gene regions (Esteller 2005). The second mouse line had a genetic
mutation in the tumor suppressor gene adenomatous polyposis coli
58

Cancer Epigenetics –Promise and Perils

or APC. This mutation predisposed mice to develop colon tumors
(Esteller 2005). Data was collected that showed two separate
outcomes: decrease in colon tumor formation and increased risk
for the formation of lymphomas (Laird et al. 1995; Gaudet et al.
2003).
Correlation studies prove an existing relationship between
hypomethylation and carcinogenesis. Whether hypomethylation is
a consequence or causative factor of cancer likely depends upon
the initial genes targeted by the disruption, and the genetic context
within which these disruptions occur.
3.2.3 Histone Modifications
The packaging of DNA around histones into nucleosomes
is particularly important for the expression of genes (Chapter 2).
To review briefly, histones comprise a family of five proteins: H1,
H2A, H2B, H3, and H4. These histone proteins can be subjected to
posttranslational modifications to affect the intimacy of their
interaction with DNA sequences and thereby regulate expression
of multiple genes at once (Herranz and Esteller 2007; Davie,
1998). Most commonly, histone tails extending from H3 and H4
proteins are epigenetically manipulated by methylation and
acetylation. As explained in Chapter 2, methylation of histone
terminal tails causes DNA configurations around histone proteins
to inhibit gene expression whereas acetylation of histone terminal
tails relaxes nucleosomal configuration to promote gene expression
(Herranz and Esteller 2007). The combination of histone
modifications present in our epigenome, by virtue of the number of
ways that histones are modified, is quite complex. These
modifications are sometimes referred to as the histone code, and
the combinations and information carrying capacity they embody
exceeds the informational capacity of the genome’s DNA
sequence!
A common feature of cancer cells is an epigenetic
modification of H4 histones. H4 histones can be subjected to
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numerous modifications at the N-terminus tail. Specifically, many
cancer cells have a loss of trimethylation at lysine 20 and a loss of
acetylation at lysine 16, predominantly where the histone
associates with repetitive DNA sequences (Fraga et al. 2005). The
degree of loss of acetylation and methylation at histone H4 dictates
tumor progression: larger decreases in acetylation and methylation
correspond to higher a degree of tumor aggressiveness (Fraga et al.
2005). These histone modifications can therefore provide a
predictive indicator for aggressive cancers. Generally, aberrant
histone modification appears to be responsible for aberrant
epigenetic status in the cancer epigenome (Fraga et al. 2005). For
example, acetyltransferase recruitment to H4 histone was
decreased near the tumor suppressor TP53 gene, thereby silencing
the tumor suppressor activity of p53. Abnormal functions of
methyltransferases, such as MLL, have also been linked to
malignant cancer phenotypes (Fraga et al. 2005).
In hematological cancers, chromosomal translocation can
arise from dysfunction of histone acetyltransferases such as EP300,
CREBBP, NCOA2, MYST3 and MYST4 (Rodriguez-Paredes and
Esteller 2011). Also, histone modification enzymes can interact
with other proteins to induce hematological and solid cancers. For
example, EP300 and CREBBP can associate with oncoprotein E1A
and SV40 large T antigen to cause hypoacetylation of histone 3 at
lysine 18 (Rodriguez-Paredes and Esteller 2011). This change to
the epigenome results in the activation of genes that allow for
cellular growth and proliferation (Rodríguez-Paredes et al. 2001).
Furthermore, genetic mutation of EP300 is correlated with
increases in malignant transformation phenotypes in colorectal,
gastric, breast, and pancreatic tumors (Gayther et al. 2000). The
overexpression of histone deacetylases such as HDAC1, HDAC2,
and HDAC6 also play a role in tumorigenesis (Rodriguez-Paredes
and Esteller 2011).
Histone methyl modification enzymes have many
downstream gene targets that encourage cell transformations. It is
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estimated that 80% of infant leukemia cases and 5-10% cases of all
other lymphocyte leukemia cases result from a methyltransferase
atypically interacting with 50 gene targets (Rodriguez-Paredes and
Esteller 2011). These leukemia promoting genes will elicit
abnormal recruitment of enzymes to histone 3 – lysine 79
(Krivtsov and Armstrong 2007; Rodriguez-Paredes and Esteller
2011). The overexpression of histone methyltransferase is also
seen in other cancer profiles. For example, extra recruitment of
enzymes to histone 3 – lysine 27 effectively produces an
overexpression of the methyltransferase EZH2 in prostate and
breast cancer. Also, studies show SMYD3, a histone 3 – lysine 4
methyltransferase, is overexpressed in colorectal cancer
(Rodriguez-Paredes and Esteller 2011).
Recently, a relationship between the extent of aberrant
histone modifications and DNA methylation has been elucidated.
For instance, the loss of histone acetylation and the loss of histone
methylation on histone 3 – lysine 9 will result in the recruitment of
DNA methyltransferase 1 to the regulatory regions of genes and
increase DNA methylation (Herranz and Esteller 2007). We must
infer that not only does methylation of DNA allow for histone
modifiers to be recruited to the neighbourhood, but that the reverse
is true as well -histone modifiers also help to regulate methylation
of DNA.
3.2.4 Hypermethylation of miRNA Genes
miRNA are small non-coding RNA molecules. They
constitute approximately 22 nucleotides and have the ability to
affect gene expression post-translationally (Suzuki et al. 2012). As
we saw in Chapter 2, miRNA have the ability to bind to mRNA
molecules via complementarity to either inhibit activity or to
promote degradation of the targeted mRNA (Suzuki et al. 2012).
miRNA genes can be subjected to epigenetic modifications such
as hypermethylation which will silence them, and indirectly permit
the expression of the targeted mRNA. Evidence suggests that
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miRNA silencing is involved in cancer formation and progression.
For example, the down regulation of expression of miRNA-15,
miRNA-16, and miRNA let-7 by hypermethylation are linked to
chronic lymphocytic leukemia and Ras oncogene expression.
miRNA expression patterns are also linked to histone modification.
miRNA molecules were assessed in control and acute
lymphoblastic leukemia patients. Acute lymphoblastic leukemia
patients showed: hypermethylation at CpG islands of thirteen
miRNA; high prevalence of histone marks that reduce gene
expression (dimethylation of histone 3 – lysine 9); and low
prevalence of histone marks that allow for gene expression
(trimethylation of histone 3 – lysine 4) compared to control
patients (Roman-Gomez et al. 2009).
The miRNA-124 family has tumor suppressor properties
since miRNA-124 regulates the cell cycle. Aberrant function of
miRNA-124 leads to activation of cyclin-dependent kinase 6,
inducing cancer cells to enter the cell cycle and allowing for
inactivation of the tumor suppressor Rb gene by phosphorylation
(Lujambio and Esteller 2007; Lujambio et al. 2007; Agirre et al.
2009). Epigenetic silencing via hypermethylation of miRNA-124 is
apparent in 70% of colorectal cancers (Suzuki et al. 2012). miRNA124 are also hypermethylated in acute lymphoblastic leukemia
where miRNA-124 methylation status is indicative of higher
mortality rates (Agirre et al. 2009).
An essential role of the miRNA-34 family is to target p53
pathways. miRNA-34 can be subjected hypermethylation at its CpG
sites: this causes cells to grow uncontrollably and permits
avoidance of apoptosis (Suzuki et al. 2012). Silencing of miRNA34 is prevalent in many types of cancers; oral, esophageal, gastric,
colorectal, pancreatic, breast, lung and renal cancer (Suzuki et al.
2012). The miRNA-34 family has two main classes: miRNA-34b
and miRNA-34c. When they become methylated, metastasis as well
as higher reoccurrence and mortality rates can result (Wang et al.
2011).
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The miRNA-9 family also plays a role as a tumor
suppressor: methylation within CpG sites of its promoter is
prevalent in breast and pancreatic cancers (Suzuki et al. 2012). In
gastric cancer, methylation of miRNA-9 is correlated with
increased metastasis, proliferation, and invasion (Lujambio et al.
2008). Other mi-RNA molecules that act as tumor suppressors are
miRNA-1, miRNA-125b, miRNA-129-2, miRNA-137, and miRNA145. All are found to be methylated at CpG sites and are associated
with several cancers (Suzuki et al. 2012).
3.3 Clinical Applications of Epigenetics in the Field of
Oncology
DNA methylation and histone modification patterns
provide indicators for carcinogenesis - they are signposts of tumor
stage, and they can identify tumour sub-type and provide
prognostic measures for treatment. An individual’s susceptibility to
cancer is dependent upon various factors including; the degree of
DNA hypermethylation of tumor suppressor genes, the global
hypomethylation of genes, or the extent of aberrant histone
modifications. Since cancer cells have specific epigenetic marks
associated with development and progression, these marks will
have great utility in the field of clinical oncology for cancer
detection, and ultimately, for pharmacoepigenetics (RodriguezParedes and Esteller 2011).
3.3.1 Cancer Cell Detection
Sample DNA and histones can be assessed for epigenetic
marks to characterize an individual’s epigenetic susceptibility to
cancer, or for the presence of abnormal cells. Technological
advancements have provided the methods to assess the DNA
methylation status of normal versus cancer cells (RodriguezParedes and Esteller 2011). In some cases, non-invasive samples
can be obtained to assess epigenetic status (Laird 2003). For
example, feces can be collected from colorectal patients, urine can
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be collected for bladder cancer assessment, and sputum can be
collected for lung cancer assessment (Rodriguez-Paredes and
Esteller 2011). Early detection methods are based upon the
principle that hypermethylation of select CpG sites occurs early in
tumorigenesis. Hypermethylation of CpG sites has been detected
early in tumor suppressors p16INK4a, p14ARF and MGMT, which are
involved in colorectal cancer development (Rodriguez-Paredes and
Esteller 2011). Increased DNA methylation of tumor suppressor
genes may be an indicator for cancer progression.
Early detection methods are also very useful for individuals
who inherit genetic risks for cancers such as mutations in BRCA1
and BRCA2 (Rodriguez-Paredes and Esteller 2011). Early
screening could improve timely detection and increase survival
rates. Also, aberrant histone modifications are present in low grade
prostate tumors (Esteller 2007). For example, the most promising
early detection biomarker for prostate cancer is the
hypermethylation of the GSTP1 gene. The specificity of the
GSTP1 gene to prostate cancer as compared to tumor tissues such
as breast, liver, and kidneys makes GSTP1 ideal (RodriguezParedes and Esteller 2011). Approximately 80-90% of CpG sites
are hypermethylated in GSTP1 in prostate cancer and obtaining
biological specimens such as urine or serum is relatively simple
(Brooks et al. 1998; Rodriguez-Paredes and Esteller 2011). Finally,
GSTP1 hypermethylation is not found in benign proliferating cells
but only in pre-malignant and malignant cells making GSTP1 a
specific marker for malignant prostate cancer. Presumably the
repertoire of markers will expand to the extent that physicians will
also be able to differentiate between the prostate tumours that need
immediate attention, and those that can be left in situ
3.3.2 Tumor Prognosis
Tumor prognosis is a measurement taken to assess the
characteristics and severity of a tumor. A tumor prognosis
evaluation is based upon levels of DNA methylation and histone
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modification. For example, DNA hypermethylation of tumor
suppressors DAPK, p16INK4a, and EMP3 are correlated with tumor
invasiveness in lung, colorectal and brain cancer (Esteller 2007).
Technological development in the field of epigenetics has allowed
for the development of prognostic dendrograms where levels of
global DNA can be assessed using CpG arrays (Rodriguez-Paredes
and Esteller 2011). Prognostic dendrograms have identified unique
and useful markers of aberrant methylation patterns in lung cancer
reoccurrence and metastasis in colorectal patients (RodriguezParedes and Esteller 2011). In breast cancer, the degree of histone
modification is an important factor in tumor prognosis. Individuals
who have low to moderate levels acetylation at histone 3 – lysine
18, acetylation at histone 4 – lysine 12, dimethylation at histone 3
– lysine 4, trimethylation at histone 4 – lysine 20, and
dimethylation at histone 4 – arginine are classified with a poor
prognosis (Chervona and Costa 2012). It was also discovered that
histone modifying enzymes are responsible for certain tumor
characteristics. The over-expression of the methyltransferase
EZH2, which methylates histone 3 – lysine 27, results in tumor
aggressiveness and poor prognosis in breast cancer patients
(Chervona and Costa 2012). Several other specific histone
modifications are seen in lung, prostate, leukemia, esophageal,
gastric, kidney, liver and pancreatic cancers that are reflected in
poor patient prognosis (Chervona and Costa 2012).
3.3.3 Pharmacoepigenetics
The field of pharmacoepigenetics uses an assessment of an
individual’s epigenetic architecture to evaluate the best method for
cancer treatment options. For example, hypermethylation of the
MGMT gene is associated with chemoresistance. In normal cells,
the DNA repair enzyme MGMT repairs the damage caused by
chemotherapeutic drugs, however, in cancer cells with
epigenetically silenced MGMT, the protein is unavailable to repair
the mutations. Therefore, a strategy that epigenetically silences
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MGMT might make tumors more susceptible to chemotherapy
drugs (Baylin and Jones 2011). Other hypermethylated DNA repair
genes can be used to predict or modify chemotherapy response.
These include the MLH1 response to cisplatin treatment in lung
cancer, and WRN response to irinotecan treatment in colorectal
cancer (Rodriguez-Paredes and Esteller 2011). In short, epigenetic
mechanisms can be used both to assign the most effective
chemotherapy to individuals, as well as to bend a tumor’s
epigenetic characteristics to make it more susceptible to treatment.
3.3.4 Epigenetic Marks for Therapeutic Drugs
Therapeutic drugs can be used to target aberrant DNA
methylation and histone acetylation (Figure 3.2). This is
accomplished by inhibiting enzymes responsible for DNA
hypermethylation to re-activate tumor suppressor genes and
prevent global histone acetylation in cancer cells. Demethylating
drugs that inhibit DNA methyltransferase activity such as 5-azacytidine or 5-aza-2-deoxycytidine (Decitabine) are promising in
this regard. Success has been seen in treating acute promyelocytic
leukemia, however, the lack of specificity of the drug target is an
issue (Herranz and Esteller 2007). In large doses, demethylating
drugs can non-specifically demethylate genes in normal cells and
contribute to overall global hypomethylation: the consequence of
these “off target” effects are unknown.
Hypoacetylation can be reversed to the original epigenetic
state via inhibition of histone deacetylases. Histone deacetylase
drugs fall into four classes: hydroxamates (TSA and SAHA), short
chain fatty acids (valproic acid), cyclic peptides (desipeptide) and
benzamides (MS-275) (Herranz and Esteller 2007). These drugs
have antitumour activity by causing cellular differentiation, cell
cycle arrest in G1/G2, and apoptosis. They have been successful in
treating hematological cancer and solid tumors (Herranz and
Esteller 2007).
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Figure 3.2 Mechanisms of epigenetic drug treatment.
Epigenetic drugs are used for cancer therapy where inhibition of
enzymes can induce epigenetic changes. Inhibiting DNMT (DNA
methytransferase) through epigenetic drugs will prevent the
recruitment of methyl groups to DNA that can be useful for preventing
hypermethylation of tumor suppressor genes. Inhibiting HMT and
HDM (Histone methylation modifiers); HDAC and HAT (histone
acetylation modifers) can prevent aberrant histone modifications that
contribute to carcinogenesis. For example, loss of trimethylation at
lysine (K) 20 and a loss of acetylation at lysine 16 on H4 histones, a
hallmark of cancer cells, can be manipulated by epigenetic drugs to
restore original epigenetic architecture.

The most promising demethylating drug to date is Zebularine.
Zebularine, an oral drug, is chemically stable and has low toxicity
in normal cells (Yoo et al, 2004; Cheng et al., 2004a; Cheng et al.,
2004b). Using 5-aza-2-deoxycytidine, there is an impressive 4054% response rate in myelodysplastic syndrome patients. The
high response rate to 5-aza-2-deoxycytidine has encouraged the
FDA to approve it for patients with myelodysplatic syndrome.
Clinical trials of histone deacetylases are also showing great
promise. Phase one trials with depsipeptide show a partial response
with minimal side effects in patients unresponsive to conventional
chemotherapy treatments (Herranz and Esteller 2007). Also,
clinical trials of valproic acid and SAHA are in the final phase:
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SAHA has been found to have antitumour activity in solid and
hematological cancers (Herranz and Esteller 2007).
3.4 Conclusions
Presently, there is evidence for several correlations that
confirm environmental toxins as a causative factor for the
development and progression of cancer. Environmental toxins such
as bisphenol A, RDX, contaminated drinking water, air pollution,
benzene, chromium, aluminum, mercury, lead and pesticides have
the ability to alter epigenetic mechanisms (Hou et al. 2012).
Statistics suggest that thirteen million people die annually from
environmental toxins, where 24% of these deaths are preventable
(Hou et al. 2012). DNA methylation and/or histone modification
are providing a causative link between environmental exposure and
cancer. Eliminating all possible environmental toxins would be
difficult: society is supported by commerce which is fueled by the
products that utilize many of these toxic chemicals. Nevertheless,
it is unethical to knowingly expose individuals to chemicals with a
proven causative link to cancer. Therefore, government subsidies
and grants should be directed to epigenetic research in order to
elucidate epigenetic mechanisms and to develop new therapies.
Epigenetics has proven to be an early biomarker for cancer
development, an indicator of tumor progression, and a predictor of
pharmacological efficacy. Governments and policy makers should
recognize that epigenetics has huge potential to become a powerful
detection method and eventually, to be used in treatments for
cancer. Health care systems will ultimately have to provide
epigenetic testing to the public to permit early detection and
improved treatment outcomes at reduced costs to the health system
and the affected individual. Funding can also provide opportunities
to improve current DNA demethylation and histone deacetylase
drugs, which have shown great success in clinical trials. Overall,
epigenetic mechanisms must be regarded as the mechanism that
links the environment and cancer. As such, epigenetics offers a
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unique and useful tool for diagnosis, prognosis, and treatment.
Provocative Questions
 Will epigenetics facilitate a personalized assessment and
treatment of cancer?
 What will the cost of epigenetic screening be? Who would
have access? When would indviduals be screened? Given
that an epigenome changes over life, how often will testing
be necessary?
 Where would the information be stored? How would it be
protected?
 So much potential… So little information – Are epigenetic
marks causative or coincidental?
Possible Solutions
 Research needs to be directed to differentiating causative
versus merely associational relationships between
epigenetics and cancer
 We need to develop faster, cheaper, and more efficient
ways to assess an epigenome.
 All stakeholders need to be consulted on how data will be
stored, analyzed, and shared. Confidentiality protocols
need to be ensured.
 The field is fast moving – physicians, patients, and policy
makers need to enjoy a mechanism to provide timely and
pertinent education, intervention and treatment.
 There should be more clarity regarding intellectual property
rights – should they be restricted to drug products, or will
confusion reign with respect to ownership of mechanisms
elucidated (much like patent law vacillated over the status
of newly discovered genes)
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Chapter 4
Dietary Epigenetics: Are You What
Your Parents Ate?
Lina Chaker, Roni Hetzel, Kaela Scott, and Marisa
Market
Abstract
The epigenome can be modified by many different factors, one
of which is diet. This chapter focuses on both acquired and inherited
nutrition-dependent epigenetic modifications that occur within or
across generations. We begin by differentiating between acquired and
inherited epigenetic modifications. Intra-generational and intergenerational epigenetic effects are considered acquired, while transgenerational epigenetic effects are considered inherited. Intragenerational refers to effects seen in the same generation as the
environmental change; inter-generational refers to effects seen in their
children, likely exposed either in utero or as precursor gametes; transgenerational refers to effects seen in future generations that were not
exposed, even as gametes, to the environmental change. This chapter
proceeds by exploring the multivariate diseases, such as obesity,
diabetes, eating disorders, Crohn’s, and Coeliac disease, that can be
associated with nutrition-dependent epigenetic modifications.
Specifically, potential trans-generational epigenetic effects are
examined through two retrospective studies: the Dutch Famine and the
Överkalix cycles of overfeeding and malnutrition. These studies are
compared to established epigenetic data available from rodent studies.
By examining the pattern of disease development in people exposed to
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different nutritional conditions during different periods of development,
a link can be established between nutrition and the epigenome. The
inherent weaknesses of retrospective studies in humans are then
discussed. Finally, we address some of the ethical and social
implications that dietary and lifestyle decisions might convey to our
progeny and to society at large.

4.1 Introduction
It is common sense that what you eat today will affect your
health tomorrow. What may not be commonly acknowledged,
however, is that nutritional challenges experienced by your parents
or grandparents could lead to health consequences for you as an
adult. The method by which this is likely to occur is through
modification of your parents’ or grandparents’ epigenome (via
certain mechanisms that are discussed in Chapter 2), which leads
to alterations in your own gene expression. Therefore, it is
epigenetics or other non-genetic mechanism that provides a likely
explanation for how nutritional challenges or surpluses can exert
effects upon individuals much later in life, as well as between
parents and offspring, and onwards through to subsequent
generations.
Acquired vs. Inherited Epigenetic Changes
Broadly speaking, epigenetic changes can either be acquired or
inherited. In order for an epigenetic change to be considered
acquired, the epigenome must be directly affected by an
environmental event. Thus, if an adult, child, fetus, or even the
gametes that eventually give rise to an individual are exposed to an
insult that results in epigenomic modification, this would be
considered an acquired epigenetic change. This last point might be
a bit confusing, and understanding the process and timing of
gametogenesis will make it easier to understand how the gametes
of a fetus may acquire an epigenetic change. Gametogenesis is the
process by which haploid gametes (egg or sperm) are produced
from diploid germ cells. Although the purpose of oogenesis
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(development of eggs) and spermatogenesis (development of
sperm) is the same, these processes differ in many ways, including
developmental timing. In females, oogenesis begins in the fetus
and egg development is soon arrested in Meiosis I – a sort of
suspended animation that stores the egg in nearly mature form until
it is needed. Thus, females have gametes already present while
they are growing as fetuses in utero. While the bulk of eggs are
stored this way, recent research has also discovered oogonial stem
cells are responsible for the development of some eggs into
adulthood as well (White et al. 2012). By contrast, males initiate
spermatogenesis when the primordial cells go into meiosis during
their slow growth period, just before puberty (Pembrey et al.
2006). Thus, sperm are not present in the male fetus during
gestation. Therefore, it is possible for a female to be exposed to an
environmental change at any time throughout her life, from fetus
through to adulthood, and for this change to affect her gametes
through epigenetics. This change to the epigenome of her gametes
will then lead to an altered epigenome being expressed in her
children (Figure 4.1). Hence, even though her children were not
present during the environmental change, the prospective effects
on their epigenome are still considered to be acquired because the
gametes that led to the creation of her children were present during
the environmental challenge. In males, the environmental
challenge is most likely to exert a long term effect in progeny if it
occurs during the pre-pubertal slow growth phase of development,
or to a lesser extent, afterwards into adulthood. This concept is
examined in more detail in Section 4.4 under Trans-generational
Mechanisms.
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Figure 4.1: The environment has a direct effect on all three generations.

Figure: 4.2: Environmental changes during specific times in
gametogenesis, the meiotic formation of the gametes (sex cells or germ line
cells), could theoretically modify sex chromosome epigenetic imprints
(Pembrey et al. 2006). The left image depicts a change transmitted through
a parent to the first generation F1; thus the change is inherited since it
occurs first in the F1 cell precursor to gametes. The F1 cell that gives rise
to the gametes may have been exposed at any point in its development. The
right image depicts a change after gametogenesis, where the mature
gamete is directly affected by the environmental stimulus and transmits the
effect to the next generation, the F2s.

Inherited epigenetic changes, however, refer to changes that occur
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in one generation and are passed on to future generations via germ
cells not yet present at the time of challenge. Therefore, inherited
epigenetic effects are passed on to offspring due to epigenetic
changes that occurred in pre-gametic cells, which then become
gametes (Burdge et al. 2011). Figure 4.2 highlights the differences
between epigenetic changes that occur in pre-gametic cells and
those that occur in gametes.
Intra-, Inter-, and Trans-generational Epigenetic Effects
The differences between acquired and inherited epigenetic
modifications help us to distinguish between intra-generational,
inter-generational, and trans-generational epigenetic effects (Figure
4.3). Intra-generational and inter-generational epigenetic effects
are both considered to be acquired, despite the different way that
they develop. In either case, the changes to the epigenome are
induced de novo (spontaneously) within a single lifespan, thus
affecting only the exposed individual. However, it is the type of
environment that induces these changes that separates the meaning
of these two terms. Intra-generational effects occur within the
exposed individual’s lifespan, and result in later life changes. For
example, the food you eat or the pollution to which you are
exposed could lead to effects some years later. Contrastingly, intergenerational effects are due to changes that are imposed during the
gamete or fetal stage of life (ie; direct exposure but before birth):
the environmental challenges are transmitted to the gametes or
fetus via the parental environment. Parental environmental stresses
upon the sperm or egg that eventually contribute to a new person
define one sub-category. Another sub-category arises when the
change is installed in embryos in utero. This latter is also known as
developmental or fetal programming (Gabory et al. 2011). An
example of these effects would be a situation in which the food a
mother ate while she was pregnant elicited an epigenetic change in
the fetus that resulted in her child having an altered phenotype. In
either instance, epigenetic changes would not necessarily be passed
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to future generations and therefore could not be considered transgenerational.
Finally, trans-generational epigenetic effects are inherited
and therefore they occur in one generation and are passed down to
the offspring, and onward through successive generations (Skinner
and Guerrero-Bosagna 2009). The mechanisms by which
epigenetic modifications lead to intra-, inter-, and transgenerational effects will be discussed in the following sections.

Figure 4.3: A change occurring in the mother’s somatic cells will not
affect the fetus; it is an acquired change and called intra-generational.
Likewise, a change occurring in the fetal somatic cells will not affect its
gametes; it is an acquired change and called intergenerational.

With
respect
to
nutritional-dependent
epigenetic
modifications, a period of malnutrition or surplus food would be
considered to be the epigenetic “event” or “challenge” that we
have been referring to. This chapter focuses on these changing
nutritional circumstances and the role that diet plays in the
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modification of the epigenome and consequently, upon gene
expression. How changes to the epigenome can contribute to the
development of multivariate diseases, including obesity, diabetes,
eating disorders, Crohn’s disease, and Coeliac disease, is also
examined. This is done primarily through the analysis of
retrospective studies.
Simply put, our nutritional status alters the packaging of
our DNA on a continuous basis, and this in turn alters the
behaviour of genes. Especially when the conditions during the time
of challenge do not reflect conditions later in life, our near-, midand long-term predisposition to disease is altered as well. Although
some experimental information (molecular characterization of
epigenetic states) is available in mammals regarding the influence
of environmental shifts on the phenotypes of successive
generations (Burdge et al. 2011), the majority of our knowledge
comes from retrospective studies. In this field, two historical
cohorts are of particular interest, the Dutch Famine cohort and the
Swedish Överkalix cohort. Finally, we will conclude by outlining
possible consequences and ethical concerns that epigenetic data
may pose for society.

4.2 Intra-generational Epigenetic Effects
Intra-generational epigenetic effects are an important
contributing factor to the development of certain multivariate
diseases over the lifetime of a person. Obesity and its related
condition, diabetes, are both considered global epidemics and
major public health concerns by the World Health Organization
(WHO 2014a; WHO 2014b). While it is true that unhealthy eating
habits and a sedentary lifestyle are contributing factors, there are
multiple additional influences that contribute to the pathology of
these diseases, some of which may include epigenetic changes.
(Melzner et al. 2002; Lefterova et al. 2008; Nielsen et al. 2008;
Vucetic et al. 2012).
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4.2.1 Obesity
In the U.S., more than one third of adults are obese (have a
body mass index (BMI) above 30 kg/m2). In addition, another third
are classified as overweight (have BMI of 25-30 kg/m2) (CDC
2014a; CDC 2014b). Worldwide, obesity has nearly doubled since
1980 and more than 10% of the world’s adult population is
currently obese (WHO 2014a; WHO 2014b). Being overweight
presents as a major risk factor for the development of heart disease,
hypertension, stroke, certain types of cancer, and diabetes
(specifically type 2 diabetes mellitus), which encompass some of
the leading causes of preventable death (WHO 2014a; WHO
2014b).
Although
obesity
arises
from
biophysiological,
psychological, social, and economic factors, epigenetic factors
appear to modify physiological processes and to contribute to
obesity at the cellular level. Adipogenesis is the key physiological
process in fat tissue production by which lipocyte precursors
become mature adipocytes (fat cells). A transcription factor called
peroxisome proliferator-activated receptor gamma (PPARγ) is
considered to be a master regulator of adipogenesis and it activates
a large suite of other genes to produce a mature adipocyte
(Lefterova et al. 2008; Nielsen et al. 2008). This master regulator
of fat cell growth seems to be regulated by and causes some of its
effects through epigenetic mechanisms. The promoter of PPARγ is
demethylated during adipogenesis, and as a consequence, it
activates itself and other targets by increasing the transcription of a
histone monomethyl transferase (Fujiki et al. 2009; Wakabayashi
et al. 2009).
The dysfunction of epigenetically regulated appetite and
reward pathways in the brain may also play a role in obesity.
Dopamine is a key player in the reward pathway, and is
synthesized in response to a pleasure-invoking stimulus. A chronic
high fat diet reduces the activity of dopaminergic pathways in the
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brain, which means that an individual needs to eat more in order to
receive a sufficient feeling of pleasure and reward (Vucetic et al.
2012). An epigenetic explanation is offered by a study in which
rats were fed a high fat diet. They displayed, along with decreased
reward circuitry, DNA methylation associated repression of the
promoters of genes involved in dopamine synthesis and transport
(Vucetic et al. 2012). A high fat diet in rats has also been shown to
decrease the expression of the transmembrane opioid receptor
(μOR), decreasing the pleasure stimulus that results from eating
and thus requiring that a person eat more to enjoy a certain reward
level (Vucetic et al. 2011). This decreased expression is correlated
with repressive features such as increased DNA methylation,
increased H3K9 methylation and decreased H3 acetylation
(Vucetic et al. 2011).
Leptin, the hormonal product of the Ob(Lep) gene, is
produced in adipose tissue and plays a significant role in
monitoring the “appetite center” of the brain’s hypothalamus
(Figure 4.4) (Cripps et al. 2005). The leptin gene has CpG islands
in its promoter that can control its expression epigenetically
(Melzner et al. 2002). In pre-adipocytes, there is a high degree of
DNA methylation and no expression of leptin, whereas mature
adipocytes express leptin, correlating with promoter demethylation
(Melzner et al. 2002). Constantly high levels of leptin may impair
its function in inhibiting appetite via hypothalalmic receptors,
however, more research is necessary to fully understand the
connection between obesity and the epigenetic regulation of leptin
(Ling and Groop 2009).
Our final example of a possible physiological mechanism
by which epigenetics may promote obesity through acquired intragenerational modifications may be through maternal “flavour
preference” (Mennella et al. 2004). This phenomenon is thought to
occur during the period of breastfeeding where flavours/fats
ingested by the mother are carried through to the milk (Mennella et
al., 2001). Early exposure to specific flavours may alter certain
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neurological processes that then lead to a distinctive pleasure
reinforcement response when the food is consumed later in life
(Delport and Pollard 2010). Whether or not epigenetics plays a
role in this development of dietary preference remains to be seen.

Figure 4.4: When you have not eaten in a while and your fat
stores are low, you will have low levels of leptin and feel hungry. After you
have eaten and your fat stores increase, your leptin levels will increase.
Leptin will then signal to your brain to make you feel full. If you are obese
and have a constant amount of large fat stores, your body will constantly
have high amounts of leptin. However, the constant high amount impairs
regulation and your brain does not receive the “fullness” signal. Thus, you
feel hungry even when you have plenty of fat stores.

4.2.2 Diabetes
Diabetes is a chronic disease that occurs either when the
pancreas does not produce enough insulin, as in type 1 diabetes, or
when the body cannot effectively use the insulin it produces, as in
type 2 diabetes mellitus or gestational diabetes mellitus (WHO,
2014b). This can lead to hyperglycemia, or raised blood sugar,
which over time leads to serious damage of many of the body’s
systems, especially the nerves and blood vessels (WHO, 2014b).
As of 2011, approximately 347 million people worldwide have
diabetes, and the World Health Organization projects it will be the
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seventh leading cause of death by 2030 (Danaei et al. 2011; WHO
2014b).
Many studies have supported the idea that epigenetic
mechanisms are involved in insulin regulation and diabetes. In
pancreatic beta cells, the insulin gene displays active epigenetic
marks including hyperacetylation of H4 and hypermethylation of
H3 at lysine 4. Importantly, these epigenetic marks are not seen
near the insulin gene in other cell types (Mutskov et al. 2007).
Furthermore, the transcriptional co-activator PPARGC1A
(peroxisome proliferator activated receptor gamma coactivator-1
alpha) gene is involved in mitochondrial oxidative metabolism,
and appears to be expressed differently in diabetics versus nondiabetics (Ling et al. 2008). DNA methylation of the PPARGC1A
promoter is elevated in pancreatic islets (groups of cells that make
the insulin) among patients with type 2 diabetes mellitus compared
with healthy subjects (Ling et al. 2008). When PPARGC1A is
methylated, its expression is reduced in diabetic islets (Ling et al.
2008).
Importantly, PPARGC1A expression is positively
correlated with glucose-stimulated insulin secretion in human
pancreatic islets, suggesting that this epigenetic axis of regulation
may ultimately have an effect on insulin levels (Ling et al. 2008).
4.2.3 Eating Disorders
Like obesity and diabetes, eating disorders also show
multivariate origins that are not based solely upon genetic or social
anomalies. Epigenetic disturbances may contribute to anorexia
nervosa and bulimia nervosa symptoms by affecting neuronal
dopamine signaling. This is crucial because the dopaminergic
system is involved in the regulation of body weight, eating
behaviour, and the reward system (Frieling et al. 2010). In one
study, patients showed an elevated expression of dopamine
transporter gene activity when compared with control patients, and
this was correlated with hypermethylation of the dopamine gene’s
promoter (Frieling et al. 2010). This means that individuals
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exhibiting anorexia nervosa or bulimia nervosa symptoms show
altered dopamine function compared with individuals without a
disorder. Although down-regulation of the dopamine receptor 2
gene was seen in both nervosa groups, it was accompanied by
hypermethylation of the gene’s promoter only in patients with
anorexia nervosa (Frieling et al. 2010).
Atrial natriuretic peptide (ANP), a hormone that has anti
anxiety effects, may also have implications in the pathophysiology
of eating disorders via epigenetic regulation (Strohle et al. 2001;
Frieling et al. 2008). Patients suffering from both anorexia nervosa
and bulimia nervosa showed decreased activity of the ANP gene,
correlated with hypermethylation of the ANP gene’s regulatory
region (Frieling et al. 2008). However, whether these epigenetic
changes are causes or effects of eating disorders are questions that
require further research (Frieling et al. 2010).
4.3 Inter-Generational Epigenetic Effects - Overfeeding
and Supplementation
In addition to intra-generational effects contributing to the
increased incidence and prevalence of multivariate diseases, intergenerational effects probably also play a role in the development of
these diseases. This first part of this section focuses on intergenerational effects that arise from overfeeding, specifically with
respect to the development of obesity and diabetes. Over the last
few decades, the prevalence of obesity and diabetes among
children and adolescents has increased dramatically (PinhasHamiel and Zeitler 2005; CDC 2014b). An explanation for these
trends suggests that both adult and childhood obesity and diabetes
rates may be due to a cyclical propagation of these diseases
through generations. This propagation could be mediated by
epigenetic modifications in utero, also known as developmental
programming (Gabory et al. 2011). Furthermore, the mechanisms
by which epigenetics plays a role in predisposing these conditions
are likely similar to those mentioned in Section 4.2.
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4.3.1 Obesity
Since inter-generational epigenetic effects are often due to
changes that are imposed during the fetal stage of life, these
environmental challenges are thus transmitted to the fetus via the
maternal environment. This means that examining the nutritional
state of the mother during pregnancy could provide insight into the
development of obesity and other diseases in the offspring.
Numerous studies have reported that maternal prepregnancy body mass index (BMI) and gestational weight gain are
positively associated with the BMI of offspring at birth as well as
during infancy, childhood and early adulthood (Gale et al. 2007;
Mamun et al. 2009; Rooney et al. 2011). At the time of birth,
infants born to obese women tend towards increased adiposity (fat
tissue), insulin resistance, and cord blood leptin levels (Battista et
al. 2011). Another study suggests that children born to obese
mothers are twice as likely to be obese by two years of age
(Whitaker 2004). Furthermore, large cohort studies point to an
increase in adolescent and adult obesity for at least 25 years if
individuals weigh more at birth (Curhan et al. 1996a; Curhan et al.
1996b). A study in rats has supported the idea that maternal obesity
is a risk factor for later obesity in offspring. First, obesity was
induced in rat dams (mothers) through an obesogenic liquid diet
before mating and throughout pregnancy (Shankar et al. 2008).
After birth, the pups were cross-fostered to lean dams. Compared
to those born from lean dams, the offspring from obese dams
exhibited increased adiposity and insulin resistance (Figure 4.5)
(Shankar et al. 2008).
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Figure 4.5: Obesity was induced in a normal weight mother
(therefore, the propensity for obesity was not due to genetics). The
pups from the obese mother were then cross-fostered - that is, raised
and fed by a normal weight mother. These pups that were crossfostered ended up with increased adiposity compared to the true
offspring of the cross-foster dam.

4.3.2 Diabetes
Similar to the development of obesity, looking at the
nutritional state of the mother may provide important clues as to
the mechanism by which diabetes is propagated. Population based
studies have demonstrated that the offspring of diabetic mothers
have an increased risk for glucose intolerance and type 2 diabetes
mellitus (Silverman et al. 1995). A study of the Pima Indians of
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Arizona, who have the world’s highest incidence and prevalence of
diabetes, showed a genetic transmission component (Knowler et al.
1978). The study also revealed that the cycle of inter-generational
diabetes can be explained by environmental factors, since the
strongest single risk factor for type 2 diabetes mellitus was
exposure to maternal diabetes in utero (Dabelea et al. 1998).
Children born to diabetic mothers showed a 10-fold increase in the
prevalence of diabetes by early adulthood compared with children
whose mothers did not develop diabetes until after delivery
(Heerwagen et al. 2010). This inheritance could be in part due to
exposure to a diabetic intrauterine environment (Dabelea et al.
2000).
In another study, individuals whose cord blood or amniotic
fluid insulin levels were elevated had a three to fourfold risk of
developing glucose intolerance and type 2 diabetes mellitus during
childhood (Pinney and Simmons 2012). This suggests that
persistent fetal exposure to hyperinsulinaemia in the uterine
environment contributes to the development of diabetes through
epigenetic mechanisms. This notion is supported by studies
showing that impaired glucose tolerance of adolescent offspring is
associated with maternal hyperglycemia and not with the specific
type of diabetes of the mother (Silverman et al. 1995). A study in
rats also showed that although an intrauterine environment that
provides normal glucose concentration cannot overcome a genetic
predisposition to diabetes, a hyperglycaemic intrauterine
environment significantly increases the risk of diabetes in the adult
life of the offspring (Gill-Randall et al. 2004).
4.3.3 Maternal Diabetes and Offspring Obesity
Obesity and type 2 diabetes mellitus are closely related;
consequently, there are many studies where maternal diabetes
seems to predispose offspring to obesity. One study showed that
newborn infants of women with gestational diabetes have 20%
more body fat than infants of women with normal glucose
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tolerance, regardless of birth weight (Catalano et al. 2003). The
aforementioned Pima Indian study also looked at the differing
BMIs of siblings born before their mother was diagnosed with
diabetes compared to those born after the diagnosis. The results
showed that the mean BMI was 2.6kg/m2 higher in offspring of
diabetic pregnancies than in offspring of non-diabetic pregnancies
(Dabelea et al. 2000). In contrast, there were no significant
differences in risk of diabetes or BMI between offspring born
before and after the father was diagnosed with diabetes (Dabelea et
al. 2000). This is similar to what was discussed in 4.3.2 and
therefore supports the idea that this difference might also be based
on exposure to a hyperglycemic uterine environment.
Researchers have also studied the effect of maternal
diabetes on offspring using a mouse model of insulin deficiency
created via injections of streptozotocin, a chemical that induces a
diabetic-like state (Steculorum and Bouret 2011b; Steculorum and
Bouret 2011a). Insulin deficient dams had offspring with
significantly higher pre and post-weaning body weight compared
to the offspring of control mice. Moreover, they had increased
fasting glucose levels, increased insulin levels, and displayed
increased food intake during their adult life (Steculorum and
Bouret 2011b; Steculorum and Bouret 2011a).
Insulin deficiency and hyperglycemia during pregnancy
might also exert inter-generational effects in offspring metabolic
regulation via leptin resistance. In the study previously mentioned,
streptozotocin injections caused the offspring to develop
abnormally organized feeding pathways in the hypothalamus. As
adults, these offspring showed increased food intake and leptin
resistance (Steculorum and Bouret 2011b; Steculorum and Bouret
2011a). This reduced ability of leptin to activate neurons within the
hypothalamic feeding pathway may contribute to the mechanism
by which uterine hyperglycemia leads to obesity. Further study is
required to discover any epigenetic mediator of this long lasting
environmental effect.
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The maternally imprinted mesoderm-specific transcript
(MEST) gene is involved in growth of the embryo and placenta,
and is also implicated in a mechanism by which a hyperglycaemic
uterine environment could predispose offspring to obesity
(Lefebvre et al. 1998). MEST showed decreased methylation levels
in the umbilical cord blood and placentas from mothers with
gestational diabetes compared to samples from mothers without the
condition (El Hajj et al. 2013). In other studies, an enlargement of
adipocytes and fat mass expansion occurs where MEST is
overexpressed (Kamei et al. 2007). Likewise, decreased blood
MEST methylation levels were observed in adults with morbid
obesity when compared with normal control animals (El Hajj et al.
2013).
In sum, these observations suggest that decreased
methylation of the MEST gene, possibly due to a diabetic in utero
environment, could cause its over-activity leading to increased fat
cell growth in the offspring later in life.
4.3.4 Maternal Supplementation
A change in gene activity due to diet-related epigenetics
changes is associated with the development of other diseases,
including schizophrenia and cardiovascular diseases, among others
(Kirkbride et al. 2012a; Kirkbride et al. 2012b). Methylation of
these gene regulatory regions can sometimes be restored to their
original state using dietary supplements administered during
pregnancy. Deficiencies with respect to methyl donors – the
metabolic substrates that provide the methyl groups for epigenetic
modifications– such as vitamin B12 and folate, are responsible for
decreased methylation within genes and regulatory regions
(Kirkbride et al. 2012a). Numerous studies have revealed that
neural tube defects can be significantly reduced by vitamin B12 or
folic acid supplementation during early pregnancy (Brown et al.
1996; Susser et al. 1996; Kirkbride et al. 2012a). In fact, studies
show that the offspring may develop increased cognitive function
and a reduced risk of autism by supplementation with these methyl
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donors (Schmidt et al, 2011; Kirkbride et al., 2012a). In addition to
vitamin B12 and folic acid, a methyl donor proven to have longterm epigenetic effects is a protein called genistein, a soy-derived
isoflavone and phytoestrogen. This nutrient has been shown to
shift coat color distribution in mice via methylation of sequences
near the agouti gene (Dolinoy et al. 2007). In addition to changing
the coat colour phenotype, genistein also protects offspring from
obesity (Dolinoy et al. 2006). Another study concluded that methyl
donors can reverse demethylation caused by the estrogen mimic
bisphenol A (BPA). BPA was identified as a common contaminant
that leached from food packaging and plastics. In the study, BPA
perturbed coat colour, obesity, and diabetes in mice (Dolinoy et al.,
2007). To conclude, these studies support the hypothesis that
maternal diet may play a role in modulating the epigenome. Thus,
not only does the type and quality of food have an effect, but also
the quantity.
4.4 Potential Inter-generational Epigenetic Effects Dietary Restrictions and Starvation
As previously explained at the beginning of this section,
inter-generational epigenetic effects arise due to maternal exposure
to an environmental event while the offspring is still in utero.
While the first half of Section 4.3 focused on the effects of
overfeeding and supplementation on the epigenome and thus
offspring development, this half will focus on the effects of dietary
restrictions and starvation. In sum, the environmental event or
challenge here is a decreased level in the quality or quantity of the
diet.
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CASE STUDY: Nutrition Supplements in
Guatemala
A nutritional supplement study was conducted
between 1969 and 1977 in El Progreso, Guatemala.
The results of this study may provide information
about the relationship between nutrition and the
epigenome (Behrman et al., 2009). This study differs
slightly from the above studies in that the supplements
were given while the mother was still in her youth,
before pregnancy and even prior to puberty. Two
villages were given a high calorie protein supplement
drink called atole while two similar villages were
given fresco, which was low in calories and did not
contain protein. Records of supplement consumption
were kept for children aged 0 – 7. Subsequently,
during a follow-up, a comparison of the offspring of
the women who received these different supplements
as children were evaluated on measures of birth
weight, height for age scores, and weight for age
scores (from ages 0-12). Children, particularly sons, of
mother’s who received atole had a significantly higher
birth weight, height, and weight (Behrman et al.,
2009). Therefore, the results of this study support the
relationship between supplements and an altered
offspring phenotype, perhaps through altered
methylation as the epigenetic mechanism.

While the first half of Section 4.3 focused on the effects of
overfeeding and supplementation on the epigenome and thus
offspring development, this half will focus on the effects of dietary
restrictions and starvation. In sum, the environmental event or
challenge here is a decreased level in the quality or quantity of the
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food consumed.
4.4.1 Dietary Restrictions
The term “dietary restrictions” may imply restricting
caloric intake to some drastic level, much like extreme dieting.
However, for the present instance, “dietary restrictions” will mean
total caloric intake, while still providing essential nutrients. In
terms of epigenetics, dieting in this sense is considered to be one of
the most effective methods of achieving a maximum lifespan
(Tollefsbol 2014). Reducing total caloric intake by 25–60% while
still providing essential nutrients led to a 50% increase in lifespan
in rhesus monkeys. This is due to DNA methylation affecting the
activity of histone deacetylases (enzymes introduced in Chapter 2)
(Tollefsbol 2014).
Another form of dietary restriction involves limiting
glucose intake. However, the epigenetic results of glucose
restriction differ depending on cell type. In most cells, glucose
restriction causes an increase in hTERT (human telomerase reverse
transcriptase) and a decrease in p16, a gene that slows cellular
replication. Both components have the potential to enhance life
expectancy. Possibly, one way that they might achieve this is via
their effects upon pre-cancer cells: hTERT and p16 can induce
apoptosis (programmed cell death) of the cells (Figure 4.6) (Li et
al. 2010). Thus, dietary restrictions can have a profound impact on
gene expression in different cell types.
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Figure 4.6: This flowchart describes the differing impact of glucose
restriction on precancerous and noncancerous cells.

Malnutrition, however, is the dietary restriction of all
foods and therefore has negative consequences for the body. There
is evidence to indicate that telomere shortening, a sign of cellular
senescence, is accelerated by malnutrition: a protein, TORC1, that
is deployed in the maintenance of telomere length in organisms as
diverse as yeast and humans mediates this effect (Ungar et al.,
2011). In humans, telomere shortening is cumulative and
irreversible: acute fetal malnutrition results in shortened telomeres
even if an adequate diet is restored (de Rooij and Roseboom,
2013). Therefore, as was concluded at the end of the Maternal
Supplementation subsection, not only does the quality of the diet
affect the epigenome, as is seen with the development of diseases
such as obesity and diabetes (discussed earlier in this chapter), but
the quantity of the diet in terms of restricting both calorie and
glucose consumption has also been proven to affect a person’s
lifespan.
4.4.2 The Dutch Famine
Near the end of World War II, German forces imposed
restrictions on the transportation of supplies to the west
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Netherlands between October 1944 and May 1945 (Lumey 1992;
Roseboom et al. 2011). It is estimated that the food intake dropped
to below 1000 calories a day per person (Burger, 1948 as cited in
Lumey, 1992; Roseboom et al., 2011). This defined time period,
location, and level of malnutrition provides a level of control not
always possible with retrospective studies, and it represents an
exceptional opportunity to examine the epigenetic effects of
nutrition in people who lived through this event. The long term
consequences of the Dutch Famine on the health of prenatally
affected individuals was marked. A broad range of adult onset
symptoms and diseases appeared in time-sensitive (exposure/onset)
(Ravelli et al. 1999; Roseboom et al. 2006) and gender-specific
ways (Ravelli et al. 1999; Tobi et al. 2009).
Timing-specific effects
Studies show that regardless of the fetus’ gender, early
gestation is the most vulnerable time, since this is the busiest
trimester in terms of establishing the body plan of an embryo.
Famine exposure was shown to increase risk of obesity and
coronary heart disease much later in life, and to raise prognostic
indicators such as lipid levels and blood clotting dynamics
(Roseboom et al. 2006). Some of the later onset metabolic and
cardiovascular diseases may be due to changes in the
hypothalamic-pituitary-adrenal response to stress, which was also
higher in these individuals.
During mid gestation, organs continue to develop and the
fetus grows in size and weight (Roseboom et al. 2006). Thus, a
fetus affected during this stage would experience organ and
growth-specific impairments. Late-onset consequences include
renal dysfunctions related to diabetes, as well as obstructive airway
diseases (Roseboom et al. 2006).
Fetuses exposed to famine during the third trimester
exhibited the common trend of decreased glucose tolerance
(Roseboom et al. 2006), independent of birth size and body
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proportions. Although fetuses exposed at this time point had the
lowest birth weights, overall they were the least affected by the
famine (Stein et al. 2004). Furthermore, an increase in
hypertension and high blood pressure was seen in both men and
women who were exposed during gestation, compared to their
same sex siblings who gestated under normal nutritional
circumstances (Stein et al. 2006).
Recent studies suggest that both men and women conceived
at the height of the famine had a two-fold increased risk of
developing schizophrenia (Susser et al. 1996). Schizophrenia can
be caused by the reduced expression of the Reelin gene. Since this
gene’s regulation is dependent upon DNA methylation, an
epigenetic mechanism may be implicated (Kirkbride et al. 2012b).
Finally, fetuses exposed to famine during any point in
gestation were more likely to have decreased glucose tolerance and
increased rates of type 2 diabetes mellitus.
Gender-specific effects

Many studies provide evidence to support the idea of
gender-specific effects due to famine exposure. One study found
modifications in methylation levels of two genes involved in
cardiovascular disease that were restricted to men (Tobi et al.
2009). In terms of obesity, both male and females who were
prenatally exposed to the famine displayed abnormal fat
distribution in adulthood (Ravelli et al. 1999). The gender
specificity of obesity is determined by the timing of fetal exposure.
Men exposed to the famine during early gestation had an increased
chance of becoming obese in adulthood, while those exposed
during late gestation had a decreased chance of obesity later on in
life. For females, there was an increase in obesity only if they were
affected by the famine in early gestation, and were properly
nourished throughout the rest of the pregnancy (Ravelli et al.
1999). The suggested mechanism is a modified central endocrine
regulatory mechanism. Table 4.1 provides a summary of the
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differences between men and women who were exposed to the
famine at different periods during gestation.

Table 4.1: Famine impacts on fetuses are specific to the timing of famine
exposure and fetal gender.

In summary, those conceived during the famine had: an
increased risk of schizophrenia and depression; a more severe
atherogenic plasma lipid profile; adverse responsiveness to stress;
and twice the rate of coronary heart disease. They also performed
worse in cognitive tasks, which is a sign of accelerated aging.
Moreover, a higher incidence of type 2 diabetes mellitus and
increased glucose intolerance were observed in both genders.
A possible mechanism by which exposure to an
environmental challenge, such as the Dutch Famine, in utero could
result in long-term health consequences for the adult offspring is
provided by the fetal origins hypothesis (Roseboom et al. 2006).
This hypothesis implies that adaptations for the survival of the
fetus occur at the potential cost of long-term consequences
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(Roseboom et al. 2006). Stress in utero may “program” changes
that enable the child to cope with an immediately challenging
environment while coincidentally leading to the development of
disease later in life, perhaps via an altered hypothalamic-pituitaryadrenal response to stress (Gluckman et al. 2005a; Gluckman et al.
2005b; Roseboom et al. 2006; Bogdarina et al. 2007). Possibly, if
the environment experienced in utero fits the actual environment
after birth, the fetus will thrive; however, if mismatched, the
individual may suffer a pre-disposition to disease later in life.
Numerous Dutch Famine studies provide mechanistic
evidence to support the fetal origins hypothesis (Painter et al. 2005;
Roseboom et al. 2006). For example, the insulin-like growth factor
2 gene (IGF2) is central to many of the results in the Dutch Famine
studies. This gene plays a crucial role in early development, and
plays a role in brain growth and development. Certain epigenetic
modifications to this gene and adjacent sequences may later result
in the development of schizophrenia (Pidsley et al., 2012:
(Kirkbride et al. 2012b). Early data supporting the idea that
prenatal exposures have long lasting epigenetic effects was based
on the methylation levels tested at the IGF2 locus. At the age of
sixty, the women who experienced the famine in utero showed
hypomethylation of the IGF2 locus compared to women who were
not exposed in utero (Heijmans et al., 2008). Although the level of
methylation on this gene was not associated with birth weight, the
level of methylation increased with age (Heijmans et al. 2008). A
separate study monitored methylation levels of the IGF2 gene in
relation to a methyl donor, namely folic acid (Hoyo et al. 2011). It
demonstrated that low methylation of these regions deregulated the
IGF2 gene, but that this could be reversed with folic acid intake.
This was also demonstrated in a rat study, where folic acid had a
permanent restorative effect upon methylation levels on the IGF2
gene, even after the nutrient was removed from the rats diet
(Waterland et al. 2006).
These studies indicate a potential for epigenetic
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intervention via dietary rectification of methylation levels. The
significance of the timing of fetal exposure in determining the
gender specificity of many of the epiphenotypes described above
suggests an interaction between sex hormones and DNA methyl
transferases (DNMTs), enzymes that play a role in methylation,
and this will be important to study in the future (Tobi et al. 2009).
4.4.3 Crohn’s and Coeliac Disease
If epigenetic changes can be induced in fetuses of starving
mothers, then it is reasonable to assume that diseases that disturb
adequate nutritional absorption could also cause epigenetic
modifications. Examples of these diseases include Crohn’s
disease and coeliac disease. In Crohn’s disease, the preponderance
of female patients may be related to the female-to-female specific
imprinting of a predisposition to the disease (Zelinkova et al.
2012). This is supported by a speculative study that showed no
sex-specific pattern for Crohn’s disease when the disease was
transmitted through the father, but showed significantly higher
rates of daughters being affected when the disease was inherited
maternally (Zelinkova et al. 2012). These gender specific effects
are reminiscent of the inter-generational effects of the Dutch
Famine, but no mechanistic evidence of epigenetic phenomena
have yet been identified in the evolution of these diseases.
The relationship between epigenetics and coeliac disease
has also been examined. Parental coeliac disease may contribute to
the etiology of non-syndromic cleft lip and palate through
epigenetic mechanisms. Unlike Crohn’s disease, both maternal and
paternal coeliac disease appears to perturb offspring equally, and
the effect is postulated to be mediated by genomic imprinting
(Arakeri et al. 2010). Again, since no mechanistic evidence is
presented that links the phenomena to epigenetics, the hypothesis
is interesting, but speculative.
4.5 Potential Trans-generational Epigenetic Effects
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An epigenetic effect cannot be said to be truly transgenerational unless an exposure in one generation produces a
measurable outcome in a following generation that was never
exposed to the altering factor (Pembrey et al. 2013). Few studies
on the trans-generational effects of nutrition have been conducted,
so retrospective studies on human cohorts have provided an
alterative approach. As was explained in Section 4.3, the defined
duration, location, and level of malnutrition during the Dutch
Famine has provided an important cohort from which to study the
effects of nutrition upon the health of future generations. There is
also another cohort, the Överkalix cohort, which has been used to
infer the effects of nutrition cycles upon the epigenome and the
predisposition to disease in future generations. Unlike the Dutch
cohort, the Overkalix data relies solely upon demographic
measures: investigators have yet to examine the epigenetic
biochemistry of potentially affected genes. Both of these cohorts
will be examined in this section in order to illustrate effects that are
good candidates for epigenetic modifications can be passed down
trans-generationally.
4.5.1 The Dutch Famine
Nutritional deficits during fetal development not only result in
intra-generational epigenetic effects, transferred from mother to
fetus, but also promote defects through subsequent generations
(Skinner and Guerrero-Bosagna 2009). Pregnant women and their
fetuses experienced this starvation. Although fetal death due to
malnutrition was high, many of those that did survive nevertheless
developed normally and went on to have children of their own
(deJong et al., 1981 as cited in Lumey, 1992). The study of these
children constitutes the bulk of the trans-generational studies done
on humans. As with the inter-generational studies, the relationship
between the timing of in utero famine exposure of fetuses that
went on to become mothers, and its effect upon the birth weight of
this generations’ firstborn offspring was examined (Figure 4.7).
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Studies conducted using these children looked at both timing- and
gender-specific effects, similar to what was described in Section
4.3.

Figure 4.7: Generational terminology as a pictogram. The term mother in
the following section refers to the female fetus grown up, and the term
offspring refers to her children (red).

Timing-specific effects
The fetuses that were exposed to famine in the first
trimester (early gestation) later as adults delivered firstborn babies
that were statistically lower in birth weight, even if the mothers’
own birth weight was not depressed (Lumey 1992). A lack of
similar results in the parents exposed during their second and third
trimester suggests that epigenetic modifications are more likely to
occur during early gestation. Contrarily, a second study of a
different cohort found that mothers exposed to the famine in the
first trimester had babies within the normal weight range, however
instead of delivering subsequent babies with progressively heavier
birth weights (the normal trend), the firstborn was the heaviest, and
subsequent offspring were progressively lighter (Lumey et al.
1995). Although the results are not consistent, they reveal that the
mother’s nutrition in the womb may have an effect on the
offspring’s birth weight. Why is this important? It is important
because low birth weight is associated with increased susceptibility
to cardiovascular disease, obesity, and type 2 diabetes during adult
life (Jimenez-Chillaron et al. 2009).
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Gender-specific effects
Subsequent studies looked at both men and women exposed
to malnutrition at an early stage of their fetal life and its effect on
their offspring (Painter et al. 2008). The children of
undernourished female fetuses were found on average to be
shorter, have a higher ponderal index (adiposity) at birth, and have
higher rates of autoimmune disease later in life (Painter et al. 2008;
Roseboom et al. 2011). The children of men exposed in utero had a
higher BMI and weight, while women’s children showed no
difference in either characteristic (Veenendaal et al. 2013). Gender
specific trans-generational effects of in utero exposure are still
being studied, as is the effect of the timing of famine exposure.
Thus far, an effect of lower overall health can be seen: there is an
association between the in utero nutrition of your mother and
father, your birth weight, and health later in life.
Supporting Mammalian Studies
Prenatal underfeeding
Experiments on rodents and other mammals also
demonstrate both timing-specific and gender-specific results,
providing support to the retrospective Dutch Famine studies. One
study revealed the effects of a parental (F0) protein restricted diet
during pregnancy and/or lactation upon the grand-offspring (F2)
generation in rats (Figure 4.8) (Zambrano et al. 2005). It should be
noted that the rodent lactation period is developmentally equivalent
to the third trimester in humans, and it is usually folded into the
accounting as such. First generation females (F1) received a low
protein diet in utero or during initial feeding. This affected the
glucose and insulin metabolism of their offspring (F2). Female F2
offspring maintained higher glucose and lower insulin
concentrations than F2 males. These results depended on the
timing of the protein restriction of their parents, whether it was
only during pregnancy, only during lactation or during both
pregnancy and lactation. Both male (if restricted during lactation)
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and female (if restricted during pregnancy) F2 showed decreased
insulin sensitivity (Zambrano et al. 2005). This indicates that
maternal protein restriction timing affects male and female
offspring differently.

Figure 4.8: Generational designations (F0, F1, F2, and F3) for rat
studies.

In another study, the female F1 generation was exposed to
either an adequate or protein-deficient diet in utero and during
early development (Benyshek et al. 2006). The F2 generation was
found to be insulin resistant and the great-grandchildren (F3)
showed altered glucose homeostasis. The F3 generation showed
gender specific effects. F3 females exhibited higher glucose levels
and F3 males exhibited lower glucose levels than controls, though
a trend towards normalization could be seen in both cases
(Benyshek et al. 2006). Even though the magnitude of the
epigenetic effects lessened, they persisted as far as the greatgrandchildren!
In Jimenez-Chillaron et al.’s (2009) study, F0 females
received either a normal diet or a calorie restricted diet (50%)
throughout pregnancy. Therefore both male and female F1
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offspring were malnourished in utero. This resulted in impaired
glucose tolerance and insulin resistance in both male and female
F2 offspring. This was found to be passed through both maternal
and paternal lines. F2 males and females had increased adiposity,
which progressed through the maternal line. However, in contrast
to retrospective human studies, low birth weight in mouse F2
offspring was affected by their fathers, the F1 malnourished males
(Jimenez-Chillaron et al. 2009). Human studies initially revealed
only a maternal effect Lumey (1992), however the Överkalix study
has since revealed the potential for transmission through both
parents. Therefore, these studies support the idea that protein
restriction has an effect on inherited glucose tolerance and insulin
resistance, but that the gender-specific effects may vary according
to species or the nature of the dietary challenge.
Prenatal Overfeeding
In contrast to studies where rats were placed on a restricted
diet, Burdge et al. (2011) put rats on a high protein diet. Three
generations of mothers (F0, F1, and F2) were given this increased
protein diet during pregnancy and lactation. It was found that the
high protein diet improved the ability of offspring to regulate
glucose and fatty acid metabolism. Here the F1, F2, and F3
generations are the analyzed offspring. The high protein diet led to
an increased ability to maintain glucose and lipid levels and to
regulate body weight by the F2 generation. Such changes were also
inherited by the F3 generation. This suggests that, with regard to
over-feeding, both the in utero environment (intergenerational
epigenetic changes) as well as the modified maternal epigenome
(trans-generational epigenetic changes) contribute to affect traits in
offspring (Burdge et al. 2011). What does this all mean for
humans? Glucose regulation and metabolic alterations can be
passed through generations. This is important, since insulin
resistance is known to be related to heart disease, high blood
pressure, obesity, and diabetes, which are all related to a poor
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health prognosis later in life.
4.5.2 Överkalix: Cycles of Overfeeding and Malnutrition
Överkalix, Sweden, experienced periods of low food
production interspersed by periods of high food availability
throughout the 1800’s. During high food availability periods,
residents overfed as compensation for the periods of malnutrition
(Kaati et al. 2007). The Överkalix cohorts provide us with distinct
periods of varying food availability and defined groups of
individuals for study, much like the Dutch Famine cohort. Before
we delve into the findings, some background information is
necessary to fully understand the studies. A male’s slow growth
period (SGP) occurs between the ages of 9-12 and a female’s
between the ages of 8-10 (Bygren et al. 2001; Pembrey et al. 2006;
Kaati et al. 2007). This slow growth period is the period just before
puberty, leading up to the pre-pubertal growth spurt (Bygren et al.
2001).
Kaati et al. (2002) looked into the effects of overfeeding
and famine exposure during the slow growth period of
grandparents and parents and tied them to health changes in the
grandchildren. They found that nutritional changes had transgenerational effects with respect to the risk of diabetes and
cardiovascular disease, mainly through the male line (see figure
4.9). If the paternal grandfather was overfed during his slow
growth period, his grandchildren were likely to have a shorter
lifespan and a four-fold risk increase of death due to type 2
diabetes mellitus (Kaati et al., 2002). By contrast, if his exposure
was to famine, he passed on a resistance to diabetic death among
his grandchildren (Kaati et al., 2002; Bygren et al., 2001).
Therefore, paternal grandfather overfeeding in his slow growth
period increases health risks in grandchildren and underfeeding
decreases them. Paradoxically, overfeeding during the slow growth
period of the father offers protection from diabetes as the cause of
death (Kaati et al., 2002). Paternal famine exposure and maternal
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overfeeding during the SGP decreased the risk of cardiovascular
disease of the offspring (Kaati et al., 2002; Pembrey et al., 2010).
The paternal grandmother’s exposure to famine also decreased the
risk of cardiovascular disease in grandchildren (Kaati et al., 2002).
These complex results demonstrate how your parents’ and
grandparents’ eating patterns may have an effect on you (Table 4.2
and Figure 4.9).
Supporting Mammalian Studies
Mammalian studies support a male-mediated pattern of
results evident in humans. In contrast to epigenetic modifications
that may result from in utero experiences that are dependent solely
upon the mother, paternal transmission must involve epigenetic
modifications before or during spermatogenesis. Ng et al. (2010)
tested whether the diet of male rats had an effect on offspring
health using males fed a high fat diet or control diet throughout
life. The paternal high fat diet was linked with decreased glucose
tolerance and insulin secretion in female offspring, which is similar
to the finding in humans that paternal obesity is linked to increased
risk of diabetes in children (Ng et al. 2010). Specifically, the
pancreatic β -cells that produce insulin were found to have altered
expression of 642 genes. These expression differences are thought
to be caused by epigenetic mechanisms.
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Table 4.2: The effects of overfeeding or famine exposure during the SGP
as found by Kaati et al. (2002). The dashed lines indicate that the results
were not mentioned for these particular conditions.

Figure 4.9: Flow chart depicting male line pattern inheritance. It is
through transmission by the grandchild’s father that grandparental effects
occur. Furthermore, gender effects were found to occur: Kaati (2007)
found overfeeding in the father’s slow growth period increased mortality
rate in sons. However, these results were not significant in Bygren et al.’s
2001 study. Only the paternal grandfather’s access to surplus food that
showed a negative effect on lifespan (Bygren et al., 2001). Furthermore
they found that both parents’ food intake affects the daughter’s mortality,
where good parental food conditions increase mortality risk and poor
conditions decrease it. They also determined that paternal grandfather’s
food supply during his slow growth period affects the mortality risk only of
grandsons (high food intake means higher risk of mortality and vice versa)
and that the paternal grandmother’s food supply in fetal, early life, and
slow growth period only affects granddaughters (Pembrey et al., 2006;
Kaati et al., 2007). This suggests that the father’s sperm may carry
information about the ancestral nutrition from either his mother or his
father (Kaati, 2007).
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For instance, hypomethylation was seen in the Ill3ra2 gene,
the gene that showed the highest difference in expression (Ng et al.
2010). In another study, male mice born to overfed mothers passed
features of metabolic syndrome (insulin resistance and impaired
glucose tolerance) onto their male offspring and grandchildren,
though there was a progressive weakening of the phenotype
(Pentinat et al. 2010). This demonstrates male-line inheritance,
supporting Kaati et al.’s (2007) human studies. In summary, these
studies support the idea that environmental effects causing obesity
in males may have long-term health implications such as obesity
and diabetes in their offspring and grandchildren, possibly
transmitted via epigenetic modifications.
Trans-generational Mechanisms
The last question you may be wondering is: “if these transgenerational effects are due to epigenetics, then how are these
epigenetic changes passed through the generations?” Epigenetic
inheritance is a strong candidate for three reasons; some epigenetic
states can be transmitted to the next generation(s); specific
nutritional exposures can alter the epigenetic state; and transgenerational methylation responses to specific exposures have
been shown in experimental animals (Kaati et al. 2007). This type
of research is barely underway, and technology has only recently
been developed to examine epigenetic modifications. So the short
answer is we do not know – but we have some ideas, and a few
hypotheses have been advanced.
1. The Feed-forward Control Loop
Similar to the fetal programming hypothesis for intergenerational epigenetic mechanisms, a feed-forward control loop
has been proposed as the link between grandparents’ nutrition and
the grandchild’s growth (Pembrey 1996; Bygren et al. 2001; Kaati
et al. 2002). The mechanism could be a specific response to the
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parents’ nutritional state, which directly modifies the setting of the
gametic (sex cell) imprint on one or more genes determining
growth in the offspring (Pembrey, 1996). For example, a change
may occur in an individual’s epigenome or the epigenetic imprint
of their gametes by starvation during their slow growth period.
This imprint may facilitate the efficient conservation of calories
and may be passed to successive generations. If starvation
conditions continue, future generations will already be
epigenetically prepared for them.
2. Sex Cell and Sex Chromosome Involvement
The involvement of the sex chromosomes in transgenerational effects was suggested by Pembrey et al. (2006). The
role of the Y chromosome might explain paternal grandfather to
grandson effects as these could be mediated by an imprint carried
on the Y chromosome. Perhaps something about the unmatched Y
and X chromosome in fathers permits a different erasure and reestablishment of an epigenetic imprint? The X chromosome, along
with any epigenetic modifications, would therefore be passed from
grandmother to granddaughter via an intermediary father only,
explaining paternal grandmother to granddaughter effects
(Pembrey et al., 2006) (Figure 4.10). Alternatively, the transgenerational transmission of imprinted states could have nothing to
do with the sex chromosome per se, but instead reflect the
differential capacity of sperm to carry miRNA that are packaged in
response to environmental challenges: these miRNAs would
presumably impart cues for subsequent epigenetic modification
(Dias et al., 2013; Marczylo et al., 2012).
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Figure 4.10: The blue pathway indicates paternal grandfather to grandson
effects. The red pathway indicated paternal grandmother to granddaughter
effects.

The sex cell hypothesis has several attractive attributes.
For example, environmental changes during specific times in
gametogenesis could modify sex chromosome epigenetic imprints
(Pembrey et al., 2006). Since trans-generational effects must
involve the germ line, this process would not be expected to have
the same timing in males and females. As was explained in the
Introduction, gametogenesis occurs later in males (Pembrey,
2013). Spermatogenesis, the formation of mature sperm cells,
occurs just before puberty, during a male’s slow growth period .
This is when trans-generational effects of starvation in males are
their most profound. Oogenesis, the formation of primary oocytes
or ovum, occurs mainly during fetal life. However, recently it has
been suggested from mice studies that oogenesis continues beyond
the fetal period, presenting a reason why a female’s slow growth
period could also be associated with multigenerational and gender
specific effects (Pembrey et al., 2006).
Research done by Anway et al. (2008) gives support to this
hypothesis. They found that the critical period to influence the
germ line epigenome through methylation is during the epigenetic
programming of the germ cells when they migrate to the gonads
during sex determination. Inducing permanent alterations in the
germ line DNA methylation pattern would therefore allow the
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phenotype to become trans-generational (Anway et al. 2008;
Anway and Skinner 2008; Burdge et al. 2011). In Anway et al.’s
(2008) study, rats were exposed to vinclozolin, a compound
previously shown to cause changes to hormonal systems during the
embryonic period (Gore and Dickerson 2012). The toxin altered
the expression of 196 genes in the testes in the F1, F2, and F3
generations. Most of these genes showed decreased expression.
Since the F2 germ line (presumptive sperm) is also exposed
directly to the vinclozolin, it is the F3 generation that manifests
trans-generational effects (Anway et al. 2008). This study also
showed that effects are mediated through the paternal line.
Pembrey et al. (2010) coined this the “Y dipstick hypothesis”: sexspecific segregation of diet influencing information transmits via
the Y chromosome. He put forward the idea that DNA sequences
within the non-recombining part of the Y chromosome may
accumulate epigenetic marks in response to early experience. Thus,
it is the Y chromosome imprint that is more significant (Pembrey
2010). Moreover, the X chromosome is inherited relatively
unmodified since in the father the X and the Y are unmatched there is no other chromosome to act as an imprinting template. The
consequence could be that the X imprint is transmitted with less
degeneration. Thus epigenetic gametic inheritance is one possible
mechanism for an environment’s ability to affect multiple
generations. The major failing, however, is that even fourth
generation offspring (F3), sometimes of both genders, have
exhibited effects in rodent diet/epigenetic studies.
To conclude, epigenetic changes may reach the F3
generation by a combination of de novo imprinting and the
retention of some epigenetic memory. Studies have subsequently
shown that metabolic syndrome effects fade by the third
generation; this reinforces the idea that trans-generational
phenotypic changes may occur through imprinting (Benyshek et al.
2006; Pentinat et al. 2010). Epigenetic modification can occur
gradually over a few generations, but genetic changes due to
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selection or genetic drift require a longer period of change. This
supports epigenetics as a potential answer to inherited effects due
to nutritional changes. Moreover, genetic defects tend to be
irreversible over the span of a couple of generations, and yet we
have seen that folic acid can reverse some of the effects discussed
in rodent studies. Thus, the role of epigenetic mechanisms in transgenerational nutritional effects is gaining more support through
these studies.
4.6 Inherent Weaknesses of Retrospective Studies
Despite the usefulness of retrospective studies, they have
their drawbacks. For example, the reliability of reported years and
the severity of starvation and overfeeding in Sweden can be
questioned. Although these challenges spanned well-defined
years, different individuals would have had varying access to
resources: the reported caloric intake values during these periods
and specific lengths of starvation may not be accurate. The fact
that these retrospective studies relied upon telephone interviews,
data based on participant responses, and food estimates based on
municipal boundaries adds variability by the distancing effects of
time and memory. This in turn leads to the over- or
underestimation of trans-generational effects. Furthermore, both
the Dutch Famine cohort and the Överkalix cohorts resided in
specific geographical regions. There could be confounding
environmental effects experienced by these cohorts that would not
occur in a randomized sample. Moreover, although both cohorts
are relatively homogenous Northern European populations, given
the historical patterns of settlement, marriage, and propagation,
they might have represented a narrow genetic background, and
have responded idiosyncratically to potential epigenetic
modifications. One must then ask, how generalizable are these
results?
Despite possible drawbacks, these historical alterations to
human nutrition offer unique opportunities to study trans113

generational nutritional effects in humans. It is neither possible nor
ethical to collect a randomized group of individuals, place them in
an environment without confounding variables, and starve or
overfeed them to observe the epigenetic effects.
4.7 Implications for Society
Epigenetics allows us to understand the ways in which
environmental cues, such as diet, impact the expression of our
genes and our prospective descendants. However, the knowledge
of this relationship also raises new medical, legal, and ethical
concerns that have implications for both political leaders and the
average citizen alike.
4.7.1 Obesity as a Disease
Discovering more about the uncontrollable factors in
disease development could lead to patients refusing individual
responsibility for their condition. For example, as of June 2013, the
American Medical Association has labeled obesity as a ‘disease’
(AMA 2013), although it can be combatted through diet and
lifestyle changes.
Although framing obesity in this way could promote
greater social acceptance of this condition, researchers say that this
could also perpetuate the perception that weight is unchangeable or
fated and thereby render self-regulatory efforts seem futile (Hoyt et
al. 2014). In this latter study, an online survey revealed that
participants who read articles about obesity being a disease placed
less importance on healthy eating and weight loss, and expressed
less concern over weight when compared to obese people who read
control articles. These findings suggest that the messages people
hear about the nature of obesity - like conceptualizing it as a
disease, passed on by ancestors through genetics or epigenetics –
could take the onus off individuals and lead them to point an
accusing finger at their genome or epigenome (Hoyt et al. 2014).
This would not only have consequences for the way certain
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diseases are perceived, but it would also have consequences for
healthcare costs and resources as a whole.
CASE STUDY: The Chinese Famine
The 1959-1961 Chinese Great Leap Forward
famine will likely provide a new cohort that can help to
test the generalizability of the previous human studies, and
whether or not these effects are solely specific to Northern
European populations. In the 1959-1961 famine cohort,
both intra- and inter-generational impacts have been
reported. Preliminary inter-generational studies reveal that
children born to mothers who had experienced the famine
in utero have a higher risk of mortality in infancy (Song
2013). Gender effects are also seen, with maternal
exposure more significantly affecting the sons and paternal
exposure more significantly affecting the daughters (Fung
and Ha 2010). Surviving offspring only just reaching the
age at which adult diabetes or cardiovascular disease risk
usually emerges. Will this cohort, which is genetically
different from the Dutch famine or Överkalix cohorts, and
which also presents a much larger demographic, exhibit
similar health risk factors and predispositions? And what
kind of trans-generational effects might be seen?

4.7.2 Obesity in Children: A Case for Child Abuse?
If a parent makes poor choices before, during or after
pregnancy, could the negative epigenetic impact upon the
prospective child be considered child abuse? Child neglect is
typically defined as placing a child at risk for serious harm through
the failure of caregivers to seek or provide necessary care, medical
or otherwise (Varness et al. 2009). Thus, childhood obesity could
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be considered neglect by contributing to the development of
conditions such as severe obstructive sleep apnea, uncontrolled
type 2 diabetes mellitus, and advanced fatty liver disease. Not only
does childhood obesity increase the risk for serious harm during
childhood, it also increases the risk for the development of diseases
as an adult (Varness et al. 2009). While the law states that parents
have a duty to protect their children from harm, the law also
supports parents raising their children according to their own
values and beliefs (CYH.COM 2012). Hence, this issue can be
approached from numerous perspectives, making it difficult to
discern whether or not childhood obesity is, in fact, child abuse.
It is clear that parents are responsible for their children,
however, parental responsibility to unborn children in terms of
inherited epigenetic propensities to certain diseases is not as clear.
First and foremost, Canadian law does not grant person status to a
fetus. Similar debates have met with mixed results in the United
States. Where a pregnant woman has the right to refuse medical
treatment that is in the best interest of the fetus and abortion is
legal, maternal autonomy often rules (ACOG 2005). However, in
the past, criminal charges have been brought against women for
their abuse of alcohol during pregnancy (Lisko 2006). Could it
then be argued that a mother who abuses food during pregnancy,
and therefore exposes her unborn child to epigenetic consequences,
should also be charged? The extent of maternal responsibility is a
grey area in many jurisdictions. Opponents of criminalization of
certain maternal behaviors during pregnancy argue that it violates
the mother’s constitutional rights, and that this type of regulation is
a slippery slope (Lisko 2006). Thus, the dissemination and
deployment of epigenetic knowledge may add fuel to these
arguments.
Epigenetic risks incurred during pregnancy could place an
unjust burden of responsibility on women (Chadwick and
O'Connor 2013). While the majority of human fetal effects
discussed were effects of in utero exposure, recent evidence also
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points to epigenetic paternal contributions to obesity and diabetes.
Responsibility of the parents could then extend to regulating their
activities to prevent epigenetic harm to the gametes that may create
children in the future – where does the line get drawn?
Preconception? Chadwick and O’Connor (2013), argue that “transgenerational justice demands not that those alive today live their
lives slavishly devoted to the yet- to-be-born, rather, that the
interests of current and future generations be balanced”.
4.7.3 Governmental Control of Nutrition
Ideally, a government enacts laws in order to protect the
citizens of that country. A current topic of discussion is how to
regulate the kinds of foods that are available to the public,
potentially providing them with better nutritional choices: but how
will this be accomplished without infringing upon the rights and
freedoms of the public? For example, from 2002 to 2013 the mayor
of New York City, Michael Bloomberg, proposed a ban on large
sugary drinks. This policy would have prohibited restaurants and
other eateries from serving soda pop or other sugary beverages
larger than 16 ounces. This was thought to be an important first
step in fighting rising obesity rates. It was unlikely that the
proponents of the move were conscious of the potential for
epigenetic harms - these arguments were not advanced. Opponents,
however, argued about government encroachment upon freedom in
decision-making. The New York City’s board of health
unanimously passed this law, but it was invalidated by a New York
Supreme Court Judge six months later (Grynbaum 2014).
Although policies such as these may have the potential to increase
public health and decrease health care spending, will personal
freedom be the cost? How willing are we to live in a country where
the government has control over our nutritional, exercise, and
health choices? Should the needs and health of the prospective
many trump the freedoms of those currently living their lives?
Given the demographics of obesity, diabetes, and health, how are
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future health costs to be controlled?
4.7.4 Correlational Conclusions
Links between the nutritional intake of one generation and
its effects on subsequent generations are correlational in nature.
Since the multiple mechanisms of action and influence upon the
epigenome cannot be definitively separated, quantified, and
defined, causation cannot be explicitly characterized. This affects
the ability of government and institutions to enact laws or policies
regulating environmental conditions that may exert adverse
epigenetic effects. It also reduces the ability to assign
responsibility to current generations for the negative consequences
that they may impose upon their descendants.
4.7.5 Privacy
The epigenome and epigenetic effects will eventually
embody a substantial dataset that patients will want to keep safeguarded. Privacy, as we will see in Chapter 9, is important with
respect to any type of health information. Equipped with the
knowledge of trans-generational effects, we now know that your
parents’ and even grandparents’ health can have far reaching
effects on your current and future health. Therefore, your parents’
and grandparents’ information could become a privacy issue for
you, as it could affect job prospects or insurance coverage if
information is leaked. In sum, how can protective policies be
created in a non-discriminatory way? Conversely, descendants
might have a legitimate claim upon the health records of their
antecedents – how do we balance their respective interests?
4.8 Conclusion
The food we eat can affect us long after our meal has
ended. Furthermore, our dietary and lifestyle choices can impact
our children and grandchildren, through acquired and inherited
118

Dietary Epigenetics

epigenetic modifications that give rise to intra-, inter-, and transgenerational effects.
All of these factors and modes of
transmission can affect our future society’s health, productivity,
and economy. Understanding how the epigenome is modified and
how diet can lead to epigenetic changes will allow for more
effective medical strategies to deal with this category of health
effects. For example, knowing that obese and diabetic mothers
transmit epigenetic modifications to their child in utero, thereby
contributing to disease predisposition, could facilitate strategies,
education, and interventions to reduce the prevalence of obesity,
diabetes, and related disorders both in the mother and her offspring
via epigenetic-based medicine (Lehnen et al. 2013). It is crucial to
understand the effects and mechanisms that overfeeding and
malnutrition have on the transmission of generational diseases, and
retrospective studies have been an important part of the discovery
process. Could 21st century North America be the newest cohort
for the study of overfeeding, and trans-generational effects, the
likes of which have yet to be seen? If we do not change our path,
the answer may be grim.
Provocative Questions
• Retrospective studies
Is the information researchers receive from patients about
reported years and the severity of periods of starvation or
overfeeding reliable? Are we over- or under-estimating intergenerational or trans-generational effects?
• “Not my fault”
Could deeming multivariate conditions, such as obesity, a
“disease” induce patients to minimize their sense of individual
responsibility for their condition?
• Epigenetics and disease in children- child abuse?
Mothers who abuse alcohol during pregnancy have been
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convicted. Could a mother who abuses food causing lasting
epigenetic harm to her child, also be tried?
• Governmental control of nutrition
Should governments enact laws and dietary regulations? Where
should the line between public good and personal freedoms be
drawn? Since studies have indicated gender and cultural
differences in epigenetic effects and disease risk, how can
protective policies be made non-discriminatory?
• Correlational conclusions
Current retrospective studies and experiments on model
organisms provide a strong case for the link between nutrition
and epigenetics. However, the evidence still remains
correlational. Should governments enact nutritional policies
based strictly on correlational data?
 Privacy
How can we protect privileged information, such as where your
parents and grandparents grew up and what they ate, so that it
does not affect job prospects or insurance coverage? Should we
all have the right of access to the health records of our parents
and grandparents?

Possible Solutions




Education is currently our only tool to mitigate epigenetic
harms and diseases that are due to diet and nutrition.
Perhaps people might change their behaviours if they knew
that their actions would affect their children and
grandchildren as well.
Education could be specially targeted to expectant-mothers
to help improve the epigenetic prospects in utero.
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Feeding, nutrition, and educational food preparation
programs could be implemented to teach schoolchildren the
importance of nutrition with respect to the epigenome.
Starting younger is better.
Finally, the possibility of government-imposed restrictions
or taxation regimens on dietary choices could prove to be
beneficial for the public, depending on their willingness to
accept the intervention.
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Chapter 5
Chemical Epigenetics: Prescriptions,
Pollutants, and Picking your Poison
Aaron Hegazi, Jake Pfaff, Kaela Scott
Abstract
We interact with chemicals every day – they arrive in the
form of recreational drugs, prescriptions or by environmental
exposure. All can have an effect on our epigenome. They are
externally derived substances that we ingest, and we call them
xenobiotics. The xenobiotic chemicals discussed are thought to
have a basis in epigenetic modification and may cause changes
over both the near and long term. Pharmaceutical drugs can
both negatively (DES) and positively (valproic acid and ritalin)
affect the epigenome; alterations caused by alcohol,
amphetamines, cocaine, nicotine and morphine have been
linked to addiction. Cautionary measures as well as the legal
and ethical responsibilities of pharmaceutical companies are
also discussed. Environmental factors show variable effects
upon the epigenome: environmental toxicants are most often
associated with human diseases, but chemo-preventative
receptors are involved in preventing and correcting harmful
epigenetic variations. For the most part though, air pollutants
and dietary xenobiotics have been correlated with disease and
adverse health effects. Liability, insurance, governmental
action, chemical safety protocols, and personal awareness are
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needed to deal with drugs, environmental toxins, and their
population-wide epigenetic effects.

5.1

Introduction
When most people hear the word “chemical”, they think of
strange liquids bubbling in vats or test tubes. In fact, everything
you can see or touch is some kind of chemical, and life itself can
be reduced to a series of chemical reactions. Humans are quite
good at harnessing chemical properties to manipulate the complex
reactions in our body with drugs to produce desired effects or to
suppress disease. Understanding chemical reactions allows us to
protect crops, build homes, and create everyday objects. Just as
drugs can exert powerful effects on pathogens, environmental
chemicals can also invade and interfere with processes of the body,
and some of these effects are now known to be epigenetic in
nature. They can be elicited both intentionally and incidentally.
Chemicals not normally manufactured within our bodies, but that
find their way there by one means or another are called
xenobiotics, and they will be the focus of this chapter.
Recreational and medicinal drugs, as well as chemicals in our
environment can leave marks and alterations upon our epigenome
that science is only recently revealing. We will examine these
interactions, beginning with drugs and followed by the
environmental chemical context within which we live.
5.2

Epigenetics and Drugs
In 2003, the Human Genome Project reached completion,
affording us the information and tools to study our own biological
blueprint. While the Human Genome Project will doubtless lead to
advances in research practices and safer drugs, the promise of easy
and safe genetic manipulation remains largely unfulfilled (Wrobel
et al. 2009; Verma et al. 2011; Brunschweiger and Hall 2012). This
is because of the unexpected complexity of the genes themselves,
and in part, because the technology is still too blunt to finesse
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without causing collateral damage. Epigenetics is an example of
unexpected complexity, but it may also offer a tool to manipulate
gene activity. Epigenetics is now understood to play a role in
regulating gene activity in most animals and plants
Gene therapy has delivered promising results in clinical
trials, but is showing limited success in practice (Tani et al. 2011).
There is another way to alter gene expression without physically
changing the genetic code. As outlined in Chapter 2, in the case of
certain genes, epigenetic changes can provide a regulatory
function. By modulating the intimacy of interaction between
histones and DNA, problematic genes that cause certain diseases
can be “turned off” without having to alter a single nucleotide.
While drugs that change epigenetic factors circumvent the
challenges of traditional gene therapy, they come with their own
risks and problems. Research is revealing that many of the adverse
effects of addictive drugs can be attributed to epigenetic factors
and pharmaceutical drugs previously considered safe may have
extensive epigenetic consequences, including cancers and birth
defects. In this section, we will discuss the unintended epigenetic
side effects of pharmaceutical drugs that are presently in
widespread use, the beneficial effects of marketed drugs and the
epigenetic changes that contribute to making drug addiction
heritable.
5.2.1

Epigenetic Side Effects of Prescribed Drugs
Clinical and/or experimental evidence has demonstrated
that a number of drugs already on the market have persistent
epigenetic side effects that need to be addressed. While the extent
or severity of these risks is unclear, it might be prudent to assume
that any one of the drugs presently on the market has the potential
to affect the epigenome.

Negative Drug Effects
137

On September 19th, 1941, diethylstillbestrol (DES) was
approved by the United States Food and Drug Administration. The
drug was prescribed to pregnant women to prevent the risk of
pregnancy complications and miscarriage. Not only was the drug
ineffective at preventing pregnancy complications, but we now
know that it had epigenetic consequences for the children exposed
to the drug in utero. Women born to mothers who had taken DES
experience impaired fertility and are predisposed to cervical
cancer, breast cancer, and clear cell adenocarcinoma (Palmer et
al. 2001; Troisi et al. 2007; Hoover et al. 2011). Men who had
been exposed prenatally to DES suffer a higher incidence of
genital malformations, most commonly epididymal cysts and
hypoplastic testes (Wilcox et al. 1995). It is now known that DES
causes measurable epigenetic changes: the methylation patterns in
genes of the estrogen pathway are altered (Li et al., 2003). It is
unknown how these changes affect development – do they alter
cell responsiveness and behaviour, or do some cell types form
abnormally or die out altogether?
There are concerns that the effects of the drug could propagate
even further to subsequent generations. For example, preliminary
reports suggest that DES causes increased risk of ovarian cancer in
the granddaughters of woman who had taken DES while pregnant
(Titus-Ernstoff et al. 2008). There are not enough third generation
DES victims old enough to mount a comprehensive study, so
understanding the multi-generational effects of DES will take some
time. However, the emerging appearance of these symptoms is
consistent with the knowledge that epigenetic alterations can
persist through multiple generations. For more information on DES
and the associated legal debate, see Chapter 8.
While the case of DES highlights how ignorance of
epigenetic consequences can lead to disasterous health issues,
epigenetic knowledge can be utilized to discover novel treatments
for disease. By regulating the genome, it is possible to choose
which genes are expressed and which are inhibited, creating a new
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strategy that can be used for medical applications. Drugs that act
directly on the epigenome, for example valproic acid, can
functionally accomplish the goal of changing how the genome is
expressed without the technical challenges and risks inherent in
gene therapy.
Positive Drug Effects
Valproic acid is a short branched fatty acid currently used
in the treatment of epilepsy, although the mechanism of how it
mitigates seizures is unknown. Recent research shows that valproic
acid acts on the epigenome by up-regulating 726 genes and downregulating 577 others in rat cortical neurons, including a gene that
is implicated in epilepsy (Fukuchi et al. 2009). The drug works as a
histone deacetylase (HDAC) inhibitor, which means that it acts
on the epigenome directly to regulate DNA – histone interactions.
Valproic acid’s epigenetic effects have become the focus of many
research studies since it is a relatively cheap and safe compound
and has a myriad of unexpected benefits. The drug has been shown
to render multiple types of cancer cells more susceptible to
radiation therapy: it arrests their cell cycle. Valproate affects
multiple cancers from human erythroleukemic cells to breast
cancer cells - this diversity of effect, despite the varied and
heterogeneous nature of cancer, is impressive (Karagiannis et al.
2006; Travaglini et al. 2009). Valproic acid also has the benefit of
targeting cancer cells specifically - it affects normal cells much
less (Travaglini et al. 2009). The benefits of valproic acid do not
stop at cancer and epilepsy; it has neuroprotective properties that
promise possibilities for treating multiple neurodegenerative
diseases (Monti et al. 2009). One study even showed that valproic
acid’s epigenetic effects facilitate the development of perfect pitch
learning in humans and mice – a skill which is normally
impossible to acquire after early development (Gervain et al.
2013).
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We Need to Employ Caution
Valproic has been approved safe by the FDA, but DES
shows that caution must be exercised with any drug that affects the
epigenome, especially one like valproic acid that acts directly upon
epigenetic machinery. Valproic acid was found to increase neural
tube defects in mice by 1-2% because of its epigenetic effects,
although it is still prescribed as an anti-epileptic medicine (Tung
and Winn 2011).
In fact, many currently prescribed drugs are thought to
display epigenetic side effects. Methylphenidate (MPH) is often
prescribed to children with attention deficit hyperactivity disorder,
and is most commonly known by the trade name Ritalin.
Methylphenidate alters the population of lncRNA present in the
brain (Wu et al., 2015). Rats treated with MPH through
adolescence exhibit different responses to emotional stimuli at
adulthood than untreated rats. The MPH treated rats displayed
decreased responsiveness to rewarding stimuli such as sugar and
sex, but increased sensitivity to aversive stimuli such as swim
stress (Bolanos et al. 2003). MPH causes up-regulation of 5
neurotransmitter genes, including the genes Grik2 and Htr7, which
can remain up-regulated even into adulthood (Adriani et al. 2006).
Grik2 is linked to changes in reward perceptions, and Htr7 may
play a role in depression (Tang et al. 2004; Guscott et al. 2005).
This suggests that the epigenetic regulation of these genes could
underlie the permanent effects of MPH exposure.
Antidepressants, contraceptives, chemotherapeutics, and
general anaesthetics are just a few more of the currently available
pharmaceuticals that show signs of epigenetic side effects (Csoka
and Szyf 2009). For example, fluoxetine, found in antidepressants
like Prozac, alters DNA methylation and chromatin structure
leading to altered cerebral gene expression and hormone levels,
and this can result in sexual dysfunction and infertility. Oral
contraceptive pills affect gene expression immediately and longterm, and are linked to an increased incidence of breast cancer in
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women who took the pills prior to their first pregnancy. General
anaesthetics, may cause neuronal injuries, brain protein misfolding,
as well as postoperative cognitive dysfunction that persists, via
epigenetic changes, long after the surgery (Csoka and Szyf 2009).
These side effects in some cases sound minor; a 1-2% increase in
neural tube defects caused by valproic acid could be judged as
inconsequential when compared to its positive effects. However,
epigenetic side effects are distinct from most other side effects
because they may be heritable. Heritability adds a new dimension
when judging the cost and benefit ratio of medications: the
patient’s long term epigenetic health and prospective descendants
should be considered.
5.2.2
Addictive substances
Alcohol
Alcoholism is a serious addiction that can lead to cirrhosis
and increased risk of throat, mouth, and liver cancer (Thun et al.
1997). There are two types of alcoholism: Type I and Type II.
Alcoholism Type I is acquired in adulthood; Type 1 alcoholics
often feel guilt associated with their addiction. In contrast,
Alcoholism Type II begins as early as adolescence, and is more
likely to cause violent behaviour (McGue 1999). An analysis of
577 Swedish men found that Type I alcoholism is associated with
genetic and environmental factors in males, but Type II alcoholism
is associated with a family history of abuse, where the postnatal
environment plays little if any role. In reference to this latter
etiology, men whose biological mothers were alcoholics had
higher incidence of Type II alcoholism, even if they were raised by
non-alcoholic foster mothers (McGue 1999). Not only does
alcoholism appear to be heritable, but the negative effects of
alcoholism upon cognitive function can be inherited as well. Both
prenatal alcohol exposure and maternal alcoholism history play a
significant role in the propagation of alcohol related disorders
(Cottencin et al. 2009). The reason for heritability of alcoholism is
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a mystery, but the interplay between environmental and genetic
effects in the development of alcoholism suggests that addictions
operate through epigenetic mechanisms. Indeed, the questions of
how fetal alcohol exposure leads to alcoholism, and how
alcoholism can be passed down through family histories, may only
have their answers in epigenetic behaviour.
Rat fathers that had been exposed to alcohol sire offspring
with problems including congenital malformations and cancers,
and these effects last for generations (Stockard 1913). This effect
isn’t genetic in the classical sense - alcohol is not a mutagen that
can install mutations inherited via the germ cells (Phillips and
Jenkinson 2001). The offspring were never directly exposed to
alcohol, and yet paternal exposure to alcohol had lasting
consequences. This study adds to a growing, somewhat
controversial body of evidence suggesting that paternal exposure to
drugs may affect children for generations, even when the drugs do
not mutate genes (Friedler 1996). To investigate the possibility that
addiction heritability is epigenetic, investigators looked to see
whether alcohol has effects on the epigenome.
The gene TLR4 encodes a lipid sensory receptor called tolllike receptor 4. TLR4 activation contributes to binge drinking and
epigenetic mechanisms are suggested to be involved (Liu et al.
2011). A surplus of product from this gene was shown to cause
damage to the liver and brain in mice (Pascual et al. 2011). TLR4 is
normally important for recognizing microbes in the body and for
signaling an immune response. Alcohol decreases the acetylation
of the H4 histone and the activity of histone acetyltransferases
(HATs) in the frontal cortex, hippocampus, and striatum of mice
that carry a normal TLR4 gene. In mice with TLR4 receptors,
ethanol exposure normally causes inflammatory damage to the
brain, memory loss, liver damage and behavioural disorders, while
mice engineered to be mutant deficient for this receptor gene are
protected from such damage (Pascual et al. 2011).
The
biochemical basis for this difference was tested: mice lacking
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TLR4 receptors could absorb alcohol, but would not experience
any decrease in the net acetylation of H4 histone measured in
biopsied material. Other genes now known to be epigenetically
affected in human alcoholics include: alpha synuclein which is
hypermethylated in alcoholic patients and that is important for
neuronal synapse function (Bonsch et al., 2005); monoamine
oxidase A, a neurotransmission modulator that is methylated in
female alcoholics who are co-dependent upon nicotine (Philibert et
al., 2008); vasopressin and atrial naturetic peptide are hyper- and
hypomethylated respectively, and this correlates with degree of
craving (Hillemacher et al., 2009); the H19 and insulin like growth
factor regulatory domain is abnormally methylated in the sperm of
alcoholic males, suggesting a possible route for transmission to
offspring (Ouko et al., 2009). Finally, alcohol appears to alter the
epigenetic status of a gene important for neuronal function in mice,
brain derived neurotrophic factor (Bdnf; Stragier et al, 2015).
Whether or not these changes are of trans-generational importance
remains to be seen.
What could alcohol change via epigenetic modification of
histone H4 that would result in an increased chance of alcoholism?
Evidence suggests that alcohol affects chemosensory systems in
the brain to make the substance taste more palatable (Youngentob
& Glendinning, 2008). In this latter study, rats were inferred to
have inherited epigenetically altered gene expression in the taste
and olfactory systems - changes that predisposed them to develop a
preference for ethanol compared to their non-exposed peers. This
conclusion must be regarded with caution, however, as no genes
were examined directly. Fetal alcohol exposure could increase the
chance of alcoholism by simply making it taste less bitter.
Nevertheless, olfaction and taste provide a plausible epigenetic
mechanism that would help explain the heritability of alcoholism
(Youngentob and Glendinning 2009).
Other Addictive Substances
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The epigenetic activity of addictive drugs doesn’t stop at
alcohol. Amphetamines can, through epigenetic pathways, subvert
their stimulation pathway to become less effective over time. For
example, amphetamines change the imprint status of a gene called
DeltaFosB in brain – this a gene has carry-on effects in the
regulation of other genes such as c-Fos, histone H3
methyltransferase, and KMT1A , a lysine methytransferase. Note
that these last two genes are likely to alter the epigenetic status of
additional genes. The end result is an addict needing more
amphetamines to achieve the same high (Renthal et al. 2008).
Zhou et al. (2011) measured the epigenetic effects of alcohol and
cocaine in the post-mortem brains of human cocaine abusers and
alcoholics. Cocaine has some of the same epigenetic effects as
alcohol in the hippocampus, the area of the brain affecting
memory, which suggests a common mechanism that both links and
escalates addictions (Zhou et al. 2011). Although these substances
cause several adverse effects, the following study describes a
resistance to addictive behaviour across generations. Male rat
offspring of sires that had self-administered cocaine showed a
resistance to cocaine abuse behaviours (Vassoler et al. 2013). This
difference in behaviour was not observed in female offspring or in
male offspring of sires who self-administered saline (i.e. controls).
Neither was it observed in the male offspring’s self administration
of sucrose and, therefore, cannot be attributed to operant learning
deficits. Thus a decreased reinforcing effectiveness is seen among
the male sire offspring (Vassoler et al. 2013). Can this be deemed a
‘positive effect’?
Nicotine is argued to be a gateway drug. Levine et al.
(2011) developed an animal model using mice to determine if
previous exposure to nicotine primed their response to cocaine. By
measuring addiction-related behaviours and the synaptic plasticity
of the striatum, an increase in cocaine-associated responses was
seen only when nicotine was administered first. Cocaine had no
influence on nicotine effects when the order was reversed.
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Nicotine was found to inhibit HDAC (histone deacetylase) in the
striatum, thereby enhancing cocaine’s ability to induce expression
of the FosB gene, a key player in cocaine addiction (Levine et al.
2011).
Addiction is not only caused by ancestral and prenatal
factors: how one is raised in early childhood also has an epigenetic
effect on the predisposition to addiction (Schwarz et al. 2011).
When rats are introduced to morphine, their glia increase the
expression of a subset of cytokines. These particular cytokines are
predictive of whether the rats will become addicted to morphine.
Rats that were raised by nurturing and loving mothers had
significantly more of a competitor cytokine, IL-10, which inhibits
the activation of addiction-related ones in the offspring. Well
nurtured mouse pups are less likely to become addicted to
morphine upon exposure. Presumably, poor parenting decreases
IL-10 expression, and this renders offspring more vulnerable to
additive behaviour. It was found that the IL-10 gene expression is
modulated by differential methylation patterns, where nurtured rats
show nearly a 5-fold decrease in methylation compared to rats that
were poorly nurtured (Schwarz et al. 2011). This explains, in part,
some of the social influences upon epigenetics and substance
abuse. A greater understanding of these mechanisms could
facilitate cures and countermeasures to combat addictive drugs.
5.2.3
Future of Pharmacology in an Epigenetic World
Epigenetic pharmacology is an emerging field that should be
treated with equal measures of caution and enthusiasm. Since it is
now obvious that epigenetics constitute an inextricable part of the
blueprint of life, epigenetic treatments present challenges,
especially when it comes to safety testing and ensuring the health
of future generations. The ability to fully understand complex
conditions like addiction, and the prospect of creating drugs that
present novel solutions to medical conundrums should be weighed
against those challenges.
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Epigenetic testing is imperfect. Pharmaceutical companies,
armed with epigenetic knowledge, should be responsible to test
their drugs for epigenetic changes. The tragic case of DES stands
as an example of the consequences of ignorance when it comes to
epigenetic side effects; however, the cost of epigenetic testing is
unclear. Should the epigenetic effects of every drug taken to
market be studied, including those already being sold? How many
post-patient generations should be analyzed? Much of the time,
rodents reveal epigenetic effects that are similar to those found in
humans: we share a near-identical assembly of genes, regulatory
pathways, and activities. But the gene regulatory pathways are
complex and can vary in subtle but important ways between
species. Moreover, no single epigenome map exists since, unlike
DNA, an epigenetic map would need to take into consideration
each and every tissue and cell type, parental legacy, sociological,
and environmental factor in order to provide a useful reference
point. Some steps are being taken to assemble this information
(The Encyclopedia of DNA Elements, called the ENCODE project
for short), but given the combinations and variables that will need
to be considered, the project will be mammoth indeed.. Moreover,
given the interplay of all of the aforementioned factors, cause and
effect relationships would be difficult to determine. Finally,
methylation patterns change naturally with age, so longitudinal
studies showing changes in methylation, acetylation, miRNA,
lncRNA etc., will need very strong controls to establish causation.
For true confidence, multiple generations of humans would have to
be monitored, and this is impractical since it would effectively
slow drug development to a halt, and raise development costs to
prohibitive levels. The current program of epigenetic testing
undertaken by pharmaceutical companies has been examined and
deemed reasonable, given the current understanding of epigenetics
(Alyea et al. 2012). As understanding grows, though, will current
testing methods continue to be adequate? It is clear that some
responsibility must be taken by drug developers and purveyors for
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the epigenetic effects of their products. The trick will be to balance
the expense of testing before it risks becoming burdensome both to
developer as well as to society at large. Look at the stalled
pipeline of antibiotic development: similar cost disincentives have
dangerously impaired our ability to control infection. Clearly, care
will have to be exercised when introducing policies, because both
economic as well as epigenetics effects can last for generations.
The pharmaceutical industry is no stranger to regulation,
and for good reason. Modulating the chemical balance of any
system as complex as a body is a dangerous and difficult task.
Epigenetic research will not only change how companies approach
drug safety and testing, but also how they consider waste
management and their consideration of patient metabolites. By
extension, patients will also have to assume some responsibility for
safe and compliant practices. For example, it is not uncommon on
Canadian television to see public service announcements
encouraging safe disposal practices for expired pharmaceuticals:
patients have to acknowledge that they are also consumers with a
responsibility for proper disposal. The reason for this is clear: our
water supply is becoming measurably contaminated. If substances
that affect epigenetics are released into the environment, they
expose humans and other animals to potentially harmful transgenerational effects. In fact, as you’ll read in the next section, such
toxicants already have polluted the ecosystem, due largely to
ignorance.
5.3

Environmental Epigenetics
According to the World Health Organization, more than
13 million deaths occur annually due to environmental causes. As
much as 24% of disease is caused by exposures that can be
averted: pollutants are among the list of environmental threats to
human health (Prüss-Ustü and Corvalán 2006). Compounds that
are of natural and artificial origin, chemicals that can have harmful,
positive, or neutral effects, and molecules that contaminate the
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environment for numerous years, all encompass our everyday
exposure. Increasingly, scientific evidence is shedding light on the
changes that environmental chemicals exert upon the epigenome.
5.3.1

Toxicants & Chemopreventative Reversers
The environmental chemicals we are exposed to can be
grouped broadly into two categories: environmental toxicants or
chemopreventative reversers (Kim et al., 2012). These variations
induce opposite effects on the epigenome in relation to their
primary effects upon methylation (Kim et al., 2012).
Environmental toxicants are strongly emphasized throughout the
literature since they present the most obvious impact on human
disease. Various human diseases have been attributed to
environmental toxicant effects on the epigenome, a prime example
being cancer (Goodman & Watson, 2002; Chapter 3). Current
evidence suggests a second category of epigenetic alteration
effects: the “chemopreventative reversers.” These potentially
prevent and correct harmful epigenetic perturbations.
Environmental
epigenetics
encompasses
how
environmental exposure to nutritional, dietary, physical, and
chemical factors can alter gene expression and modify individual
genetic susceptibility through changes in the epigenome (Kim et al.
2012). In this field of study, DNA methylation is investigated as a
product as well as a diagnostic signpost of exposure to
environmental toxicants. (Yang and Park 2012). Mixed exposure to
environmental toxicants and chemopreventative reversers
simultaneously makes interpretation and understanding of the
etiology of environmental effects complicated. However, given the
complexity of environments, it is perhaps inevitable that many
studies have focused upon mixed exposures of multiple
environmental toxicants, the combinatorial nature of which leads
to outcomes that are more deleterious than the additive effects of
separate chemicals individually (Christiansen et al. 2009). By
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exposing multiple environmental toxicants simultaneously a
“1+1=3” effect occurs: the synergisms are complex.
5.3.2
Pathways of Exposure & Health Implications
Air Pollution
Respiratory diseases and epigenetic imprinting imparted
by environmental exposure appear to be linked. Animal studies
have shown that chronic exposure to air pollutants can lead to
noticeable changes to the methylation patterns of inflammatory
genes, in addition to changes in miRNA expression patterns
(Jardim 2011). Recall, miRNA may act as an upstream epigenetic
modifier that causes later biochemical alterations to genome
packaging and the behaviour (Bartel 2004; Sevignani et al. 2006)
(Chapter 2). Even a 2 hour exposure to diesel fumes is sufficient to
induce measurable epigenetic change (Jiang et al. 2014).
Epidemiological studies suggest that exposure of a mother
to tobacco smoke may transmit the risk of asthma to her children
(Alati et al. 2006) or even grandchildren (Li et al. 2005).
Therefore, it is important to consider air pollution as an issue not
just of environmental but also of generational justice. Other
common air pollutants with epigenetic implications include:
ground-level ozone, diisocyanate, endotoxins, allergens, and
pesticides (Miller and Ho 2008) (Table 5.1).
Many individuals are exposed to workplace air pollution.
For example, gas station attendants and traffic police experience
low-dose benzene exposure that is measurable in blood samples
(Bollati et al. 2007). This exposure is linked to global DNA
hypomethylation and the specific hypermethylation of p15, a
tumour suppressor gene. p15 is important because of its role in cell
cycle regulation. These characteristics are often seen individuals
with acute myelogenous leukemia (Bollati et al. 2007). Highlevel benzene exposure has also been associated with an increased
risk of this disease (Snyder 2002). Working conditions vary quite
broadly; some individuals are much more likely to be exposed to
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hazardous substances than others (see case study on Heavy
Metals).
Dietary considerations can work synergistically with air
CASE STUDY: Heavy Metals in and Around the Workplace
A significant concern relates to the exposure of workers and
individuals to heavy metals in and around the workplace.
Factories may use heavy metals during production; both the
workers and people living in the area surrounding the factory
become exposed to heavy metals by air, but also by contact.
Numerous papers have outlined the effects of heavy metal
exposure on the epigenome. These heavy metals include arsenic,
cadmium, chromium, lead, mercury, tungsten, and nickel. They
all exhibit an epigenetic component, resulting in various cancers,
cardiovascular disease, and trans- generational effects (MartinezZamudio and Ha 2011). One can only speculate at the long term
effects upon people who garden, play, or inhabit structures built
on land that is reclaimed from industrial use.
Steel plant workers are exposed to inhalable particulate
matter which is associated with an increased risk of lung cancer
(Cantone et al. 2011). Particulate matter contains carcinogenic
and toxic metals such as arsenic and nickel. It was found that
human exposure is associated with an increased amount of
histone 3, lysine 4 methylation and histone 3, lysine 9 acetylation
in blood leukocyte samples, especially in individuals with more
years of employment. These regional changes are associated with
open chromatin states also present in lung carcinoma cells
(Cantone et al. 2011).
Animal models have been used to show that the DNA of
sperm in mice exposed to air from a steel plant exhibit
hypermethylation compared with control animals. The change
persists even after the environmental stimulus is removed. This
raises flags regarding trans-generational effects (Yauk et al.
2008).
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pollution to lead to diseased phenotypes. Dietary supplements to
provide methyl donors during pregnancy can increase the risk of
respiratory disease and these effects are compounded with air
pollution exposure (Hollingsworth et al. 2008). Table 5.1 outlines
various research which associates the epigenetic changes of asthma
and atopy (allergic hypersensitivity) linked genes with
environmental stimuli.

Table 5.1 Representative Research on Gene-By-Environment Interactions
In Asthma or Atopy (Adapted from Miller & Ho, 2008)

Dietary Exposures
Pesticides
The typical North American diet is contaminated with various
xenobiotic chemicals. Extensive research has been done on the
epigenetic effects of vinclozolin, a commonly used agricultural
fungicide, which is also an endocrine disrupting chemical.
Vinclozolin is very difficult to wash off with water. Increasingly,
this chemical is shown to lead to specific and adverse epigenetic
effects such as altered methylation patterns of genes encoding a
protein phosphatase, and another encoding a serine threonine
kinase (Anway et al., 2005). It is anti-androgenic and induces
spermatogenic defects, male infertility, breast cancer, kidney
disease, prostate disease, and immune abnormalities (Anway et al.
2006).
An additional pesticide, methoxychlor, is estrogeneic and
also has been found to exert trans-generational effects including
changes to sperm number and motility. These chemicals, among
others, produce measurable epigenetic methylation changes within
the germline that have been linked to impaired embryonic testis
cord formation and increased spermatogenic cell apoptosis in the
adult testis (Skinner and Anway 2005). These changes are also
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correlated with adult onset male infertility (Guerrero-Bosagna et
al. 2013).
Vinclozolin and methoxychlor are just a couple of the
many pesticides of concern. Other examples include: DDT,
paraquat, dieldrin, and propoxur (Collotta et al. 2013). A common
feature of many of these contaminants is that they are endocrine
disruptors. Herbicides, pesticides, fungicides, and heavy metals, all
have been shown in various models to have adverse health effects
and further research is being done to elucidate the epigenetic
effects (Collotta et al. 2013).
Plastics
Food and beverage products are often packaged in plastics
that leach chemicals with harmful effects. Bisphenol-A (BPA) is
one of these chemicals. BPA acts as an estrogen mimic and is used
in conjunction with polycarbonate plastics. The classical example
of BPA contamination is via disposable water bottles. Studies have
revealed that BPA induces hypomethylation of various genes and
is associated with higher body weight and higher risks of breast
and prostate cancer (Dolinoy et al. 2007). Early stem cell
development is sensitive to BPA. However, it has been shown that
maternal supplementation of diet with methyl donors, such as folic
acid or the phytoestrogen genistein, can reverse the effects of such
hypomethylation in early development (Dolinoy et al. 2007). This
is an example of an environmental toxicant and a
chemopreventative reverser, this time a normal component of diet,
working antagonistically.
It is crucial that we are aware and understand where our
food sources come from and what chemicals they contain.
Chemopreventative Reversers
A few supplements have been identified with the potential to
reverse changes caused by chemicals like alcohol, BPA or even
heavy metals (Kim et al. 2012). Methyl donors, such as folate,
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methionine, betaine, choline and vitamin B12, affect methylation.
Downing et al. (2011) compared the Igf2 gene methylation patterns
in the embryos of dams given alcohol during pregnancy. They
found that the embryos of mice not given methyl donors were
hypomethylated at the Igf2 locus while those receiving
supplementation had increased methylation of the Igf2 gene. Thus
the effect of alcohol hypomethylation was reversed (Downing et al.
2011). Evidence also suggests methyl donors can reverse metal and
BPA effects (Kim et al. 2012). Unfortunately, in contradistinction
to these remediating effects, research also indicates that in utero
exposure to a diet rich in methyl donors may enhance the severity
of allergic airway disease in mice and that this predisposition has
trans-generational effects (Hollingsworth et al. 2008). Dietary
polyphenols, such as genistein derived from soy, are among other
things, inhibitors of
DNMTs (the genes encoding DNA
methyltransferases – epigenome modifiers) and are implicated in
reversing methylation of tumour suppressor genes involved in
multiple types of cancers (Kim et al. 2012). Other
chemopreventative reversers include vitamin D3, the tomato
carotenoid lycopene, and selenium (Kim et al. 2012).
5.3.3

Environmental Justice
As research progresses in this burgeoning field, more
health effects will undoubtedly be revealed. It is important to
evaluate environmental conditions consistently, to perform
chemical and biological risk analyses to prevent subsequent health
complications, and to fulfill our obligations to future generations
who will inherit both our physical environment as well as our
epigenome. Some epigenetically associated disease examples are
listed in Table 5.2. Research continues to reveal a growing list of
diseases that can be attributed to epigenetic modifications.
The environmental domain requires regulation and
legislation to keep individuals safe from exposure and subsequent
health effects, but responsibility should be a two way street.
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Personal chemoprevention as well as government regulation of
environmental toxicants has been recently emphasized for
individual and societal protection from environmental toxicants
including cancer (Kim et al., 2012).
5.4
Considerations
5.4.1
Regulation and Liability
Insurance
Currently in the U.S., laws exist to protect individuals
from insurance discrimination under the Genetic Information
Nondiscrimination Act (GINA) (Hudson et al. 2008). By contrast,
in Canada, a person who has their DNA tested and does not
disclose a defect to their insurer could lose coverage. There is no
legislation in either jurisdiction that explicitly covers epigenetic
features. Medication and residential histories may indicate
increased risk of epigenetic changes and consequently also
predisposition to diseases. Should this permit insurance companies
to charge more for health insurance based upon your geographical
proximity to pollutants? This is an important question as there are
economic and social inequalities that affect levels of environmental
exposure, the affordability of health care, and access to insurance
coverage. Who will protect economically disadvantaged
individuals from under-representation or discrimination on the
basis of parental legacy, upbringing, or other socio-economic
factors that they could not reasonably be expected to control? What
if effects are not manifest for a generation or more? Will the
burden of proof to establish causal links be too onerous to permit
successful remedy? How short or long should statutory limits be?

Toxicant

Biomarker

Related Disease
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Alcohol
Benzene
BPA

MTHFR
PARP-1
Hoxa10

DES
Dioxins
Vinclozolin

Lactoferrin
Foxp3
H19, Gtl2

Arsenic
Cadmium
Chromium

p53
LINE-1
45s rRNA

Lead
Mercury
UV-B

COL1A2
Rnd2
p16,
RASSF1A

Lung Cancer
Leukemia
Abnormal uteri
development
Uterine cancer
Colitis
Abnormal male
reproductive system
Various cancers
Various cancers
Trans-generational
cancer
Preterm birth
Neurotoxicity
Skin cancer

Vaissiere, 2009
Gao, 2010
Bromer, 2010
Li, 2003
Singh, 2011
Stouder, 2010
Hou, 2012
Hossain, 2012
Cheng, 2004
Hanna, 2012
Arai, 2011
Nandakumar, 2011

Table 5.2 A Selection of Epigenetically Associated Diseases. (Adapted from Kim
et al. 2012)

Liability
Corporate and personal liability already presents a
problem that needs attention as epidemiological studies reveal
associations between epigenetic signatures and disease states
(Chapter 8). If epigenetically induced diseases arise as a
consequence of pharmaceutical or environmental exposures,
questions will arise regarding who is liable, especially since many
of the effects might not become perceivable within normal
statutory limits. If reparative actions are pursued, there will need
to be a framework for enforcement and determination of the extent
of the damages. For example, if workers who are employed in
factories that utilize hazardous chemicals later show
epigenetically-based diseases, should the company be held liable if
all possible precautions were not taken to limit exposure? What if
exposure risks were unknown at the time? The same questions
might also be asked in cases pertaining to prescription drugs.
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Government
Taxation models could be developed to reserve funds and
provide reparations when pharmaceutical or environmental
toxicant harms are later identified. Such reserves could ensure that
affected citizens will have recourse to aid in future generations
when the offending company might no longer exist. Models of
similar funding approaches to facilitate public health solutions
already exist, such as vaccination development programs. In the
United Kingdom, the government has allocated money to
incentivize vaccine development by manufacturers. This allows for
vaccines to be more affordable because they have established a
competitive context and market that may otherwise have been nonexistent. This is referred to as a “pull” approach (Surowiecki
2004). Perhaps similar approaches can be taken when considering
corporations and the health of citizens – models could be
developed to reward positive epigenomic maintenance throughout
the corporate world, without placing inordinately heavy
encumbrances upon businesses.
As previously mentioned, some people, - those in certain
workplaces and socioeconomic classes - are likely to be
disproportionately affected. The government must represent all
stakeholders. This includes those most severely affected and those
who are most impoverished and lacking a voice (Mansfield 2012).
It also includes those that are most likely inflicting harmful
epigenetic modifications such as heavy polluting corporations and
producers of various xenobiotic chemicals. Clearly, the
government has an important role to play when in mediating and
developing policies and practices that will promote and ensure
both a healthy and productive population, as well as a vibrant and
sustainable economy.
Chemical Safety Analysis Protocols
It is of utmost importance to have standardized procedures
to effectively measure the epigenetic implications of new and
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existing chemical compounds. Techniques must be perfected to
measure changes and to publish the epigenetic effects of toxicants
so that risks can be understood by all (LeBaron et al. 2010).
Government agencies, industrial stakeholders, and researchers
could compile information as well as generate new and centralized
databases concerning the chemical hazards in relation to
epigenetics. Testing agencies such as the American Food and Drug
Administration, the Canadian Health Agency, and other bodies
should implement requirements for manufacturers to test, to
examine potential effects, as well as to mandate policies for
corporations to follow when performing clinical trials. As recent
experience demonstrates, the present model for cataloguing,
reporting, and making information from trials accessible could
benefit from greater transparency: even negative results could be
useful to future development and safety. When balanced against
the potential risks of liability and litigation, corporations might
find it cheaper to make data public.
5.5

Conclusion
Chemical exposure, whether by intention via drug use or
inadvertently via environmental exposure, is an important field of
study because of the complex mix and high volume we are
exposed to each and every day. There are various questions and
concerns that have arisen from epigenetic studies: for example,
which commonly used but heretofore untested chemicals and drugs
are harmful? What effects might their use have upon my children’s
children? Research may lead to better prevention and treatment
options even if currently employed but unsustainable practices are
upset. This moves us into the frame of thinking of the environment
and our place in it as a larger and more complex interactome
(Guthman and Mansfield 2012).
How do we create healthy environments to promote
positive epigenomic reinforcement and to limit human disease?
This remains a question of importance that will be addressed
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through policy initiatives, government intervention, corporate
accountability and transparency, changing societal dynamics, and
education. It is important that all stakeholders are aware of the
potential consequences of chemical exposure both at a genetic and
an epigenetic level. This means that personal education is likely to
be as important as actions by larger bodies.
Many chemicals that we take for granted may suddenly be
revealed as environmental toxicants upon further inquiry.
Exposures can have adverse health effects, whether they are from
pharmaceutical drugs, addictive substances, air pollution, dietary
components, or by any other route that xenobiotics can invade our
everyday lives. Often, if a substance is not immediately or visibly
harmful, we do not think of the effects of long term exposure to
these chemicals. Epigenetics is increasingly likely to indicate that
it is no longer enough to understand how our genetic code is
written; we must understand how it is read, stored, and accessed by
the body. In a practical sense, in terms of immediate effect, any
chemical that affects how our DNA is expressed deserves the same
respect and caution that we reserve for mutagens.
Provocative Questions
Chemical and pharmaceutical development.
 How should we balance the benefits of development
against potential long term and inherently unknown
epigenetic risks and costs?
 How much can developers be encumbered before
development ceases? Is there a middle ground between
responsible testing and advancement?
How will new products be tested? How will liability be
assessed?
 Different tissue and cell types can have different epigenetic
marks - how would one determine which tissues to test?
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Can comprehensive yet simple tests be developed? Will
they be cost-accessible?
How could one determine causation – how do we
distinguish between the single compound being tested
versus the other myriad of factors (inheritance,
socioeconomic status, diet, aging, drugs etc.)
How many generations should be tested? Will this slow
development, increase liability?
Who should determine the procedures and policies that
pertain to epigenetics-oriented interventions in medicine
law, ethics, or society?
Where should we draw the line between corporate and
personal liability?

Remediation
 If a process or treatment has generational consequences,
how will a fair cost-benefit analysis weigh competing
interests?
 Environmental toxicants are often distributed within
geographically finite boundaries. Who’s responsible to
clean up the environment? What onus falls to society,
business, and individuals to mitigate geographical risks?
 What is to prevent agencies and companies from
discriminating against individuals on the basis of their
geographical and employment histories (ie; their possible
exposure, epigenetic status, and possible health predispositions)?
Possible Solutions
Chemical and pharmaceutical development will be determined
with time and experience.
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●

Laws and regulations mandating the testing for epigenetic
effects should not only be in place, but should be reviewed and
refined often.
● At the very least, if testing every drug for epigenetic sideeffects is found to be impractical, the fact that the drug has not
been tested should be included in the list of side effects: this
creates awareness and a market preference for drugs that are
tested.
Genetic testing was imprecise in its infancy, so it is likely that
epigenetic testing methods will improve with time.
● Tissues that are the target of, say, a drug, may be a testing
priority; subsequently, tissues often involved in high risk
diseases, like stem cells in which changes are often linked to
rapidly developing diseases, are important to test.
● All drugs containing substances that are known to have
epigenetic effects should be subjected to multi-generational
testing or monitoring, even drugs that have no previously
discovered mechanism.
● Privacy policies/non-discrimination laws need to be expanded
to cover epigenetic risks and histories.
Remediation is a difficult problem to solve; past and current
issues with known negative consequences, such as industrial
pollution, highlight this point.
● It will take time and effort by researchers and agencies to push
companies and government to solve these issues –
communication, education, and consultation among all
stakeholders will be critical.
5.6
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Chapter 6
Developmental Epigenetics and
Reproductive Medicine:
Apparently Always a Parent!
Marisa Market and Jessica Hebert
Abstract
If diet during pregnancy can epigenetically affect the
fetus, then it follows that those environmental and social
experiences that have the potential to alter maternal physiology
might also produce fetal modifications. It is also likely that such
changes might be mediated by the placenta. A common theme in
epigenetic studies revolves around the role of hormones in
effecting long term changes to patterns of DNA packaging and
behaviour. It is not surprising then, that hormonally assisted
deliveries, birth control, patterns of nursing, as well as the
manipulations that underlie ART (Assisted Reproductive
Technology), especially IVF, are linked to imprinting changes.
In vitro fertilization (IVF) involves both hormonal priming of the
mother, as well as direct manipulation of gametes under highly
artificial conditions. The demonstration of specific DNA
methylation changes outlined in the previous chapters, as well as
the generational persistence of imprinting defects in other studies
(such as diet-induced changes), make careful assessment of such
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procedures all the more compelling. Medical interventions (such
as Caesarean section or the administration of epidural analgesia
and hormonal labour-inducing agent Pitocin) that have been
trademarks of assisted labour and delivery are being questioned
again in the light of their potential to modify the epigenome, as
are some of the practices that follow immediately after birth,
such as breast or bottle feeding. Epigeneomics might also give us
pause to interrogate the surprising ways in which surrogate or
adoptive mothers might influence the development of an
individual despite their different genetics.

6.1 Introduction
Your autobiography might often start with the date you were
born. That is the beginning of your story. However, the epigenetic
mechanisms that influence the construction of who you are and
who you will become begin much earlier. As we have learned in
previous chapters, it is possible to inherit epigenetic traits that span
at least two generations. Apparently you cannot be too careful in
your choice of parents: all joking aside, the epigenetic bonuses or
deficits that come packaged along with your inheritance of DNA
matter. In this chapter, we will discuss epigenetic mechanisms
associated with: pregnancy environment, Assisted Reproduction
Technologies (ART), oral contraception, birth, and parental
behaviours.
6.2 Epigenetic Interactions of Maternal Environment and
Fetus
Maternal taste preference for high-energy foods consumed
during gestation can be transmitted to offspring, thus reproducing
an affinity for this diet in future generations (Gicquel et al. 2003;
Delport and Pollard 2010). In this way, attributes of the broader
social environment can be transmitted via the intimate molecular
connection of the mother to the fetus, and via parental social
interactions with the delivered child. The mechanics of this
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relationship remain somewhat hazy, however a picture is emerging
in which epigenetics plays a prominent role. If one’s choice of
food can be attributed to influences such as epigenetics, prenatal
programming, and learned cultural norms, it becomes clear that
culture and biology work in an interactive and reinforcing fashion:
diet culminates in biological alterations, and it is these changes that
further influence dietary choices and culture. As we saw in Chapter
4, under-eating, over-eating, or certain nutrients can all elicit
epigenetic changes, sometimes even pre-conception, and such
changes are heritable. If dietary experience can affect the fetus,
then it stands to reason that social exposures and psychological
experiences that alter a mother’s physiology during pregnancy
could also affect the fetus and newborn (Bale et al. 2010).
6.2.1 Depression during Pregnancy
Women who were depressed during pregnancy bore infants
of lower than average birth weights (Gicquel et al. 2003; Laprise
2009; Liu et al. 2012). These latter authors contend that depression
disrupts the proper functioning of the hypothalamic/pituitary
hormonal axis (consisting of interactions between the
hypothalamus, pituitary, and adrenal glands), but only in the
African American women within the study cohort. Results
indicated a 2.4% higher methylation level compared to those
women that identified as non-depressed. Moreover, in samples of
umbilical cord blood, DNA methylation patterns differed for 10
genes compared to infants born to unstressed mothers within the
cohort. This increased methylation could contribute to an increased
vulnerability to neurodevelopmental disorders (Liu et al. 2012).
Additionally, African Americans exhibit lower levels of DNA
methylation in umbilical cord blood samples compared to
Caucasian participants (Adkins et al. 2011). Finally, African
American women experience a higher rate of pre-term delivery,
and lower birth weights, compared to Caucasians, even when
financial incomes are comparable (Collins et al., 2007). What these
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studies may truly indicate is that the maternal environment affects
offspring (as has been asserted before). However, these studies
neglect to account for the possibility that correlations made with
race will be confounded by external cultural and economic features
that are unrelated to genetics (see Chapter 7).
6.2.2 Smoking during Pregnancy
Maternal habits of cigarette smoking harm the fetus. Head
circumference and low birth weight (LBW) are common side
effects in babies born to mothers who smoke cigarettes throughout
pregnancy. The consequences of cigarette smoke inhalation during
gestation is at least somewhat mediated by methylation (Breton et
al. 2009). In samples of umbilical cord blood, tests reveal
methylation shifts in response to smoking, potentially explaining
part of the correlation of smoking and LBW (Murphy et al. 2012).
A major challenge of this study is that changes detected in the
methylation of umbilical cord blood samples might not reflect
changes in the body of the delivered baby, however, the results
certainly raise cause for concern. Women who quit smoking for the
duration of pregnancy were compared to a smoking and a nonsmoking group: their newborns compared favorably to nonsmokers relative to those who smoked. Another study of smokers
showed down-regulation of four different micro RNAs in the
placenta (miRNAs, Chapter 2). Recall that miRNAs are assistants
that control essential cell activity (Maccani et al. 2010; Maccani et
al. 2013). Since the placenta mediates the transfer of nutrients to a
fetus, it seems likely that these changes could indicate a significant
mechanism by which maternal smoking alters fetal health. If a
specific miRNA is down-regulated, whatever target it is supposed
to interact with is up-regulated. The researchers suggested that the
down-regulation of these four miRNAs miR-16, -21, -146, and 182), and corresponding up-regulation of their target genes
disturbed processes of cell cycle regulation, development, immune
system adjustment, and growth in the placenta. These alterations
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could also confer changes in fetal metabolic programming,
including development of neurological strucutres (Maccani et al.
2010; Maccani et al. 2013).
6.2.3 The Placenta
During the first trimester, the placenta develops from
trophoblastic tissue and serves to nurture the fetus until birth. The
human placenta is the first embryonic organ to develop, and it
provides the resource for the mother and fetus to exchange gas,
nutrients, waste, and metabolites. It is structured to permit this
exchange between maternal and fetal blood without direct mixing.
Nevertheless, potentially harmful substances and pathogens can
pass across the placental barrier. Some examples include medical
drugs (the morning sickness medication thalidomide), illicit drugs
(heroin), alcohol, chemicals from cigarette smoke, and even certain
pathogens (HIV) can cross the placental barrier.
Changes in the epigenome of placental tissue might result
in low birth weight and pre-term birth. Changes in placental
imprinting, however, may be responsible for many more diseases.
This is due to the fact that aberrant epigenetic changes that are
readily repaired in embryonic tissue appear to persist in placental
tissue (Mann et al. 2004). This is not to say that imprinting
modifications in embryonic tissue do not result in imprinting
diseases, it highlights the major role that placenta plays in fetal
development through epigenetic regulation. Diseases caused by
changes in the placental epigenome include gestational diseases,
such as Gestational Trophoblastic Disease (GTD) and preeclampsia (CASE STUDY 6.1, 6.2), as well as diseases that
impact the rest of the child’s life. Pre-eclampsia is an umbrella
term used describe a variety of deficiencies that result in
dangerously high maternal blood pressure. There are likely
multiple different causes, some of which might be epigenetic in
origin.
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CASE STUDY 6.1: Gestational Trophoblastic Disease
Gestational trophoblastic disease describes a group of
rare tumors that are caused by derailed trophoblast growth in a
woman’s uterus. The cells that make up the trophoblast layer
that should eventually become the placenta begin to grow
abnormally and can cause various tumors. The most common
type of tumor is a hydatidiform mole, which has the potential
to develop into a carcinoma. Studies have found that the cause
of this abnormal growth is improper epigenetic marks within
embryonic stem cells (such as aberrant tumor suppressor gene
methylation and the hypermethylation of transcription factors
that play an important role in maintaining embryonic stem cell
pluripotency) (Nelissen et al. 2011).
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CASE STUDY 6.2: Pre-eclampsia
Pre-eclampsia is characterized by high blood pressure
and excessive amounts of protein in urine. From this,
eclampsia can develop, which is characterized by the onset of
seizures, usually in the last half of pregnancy.
There are many factors that can lead to pre-eclampsia,
but an important mechanism involves the fetal
hypoxia/reoxygenation response pathway. The reduced
methylation of genes encoding hypoxia-inducible factors leads
to increased transcription of proteins that prevent proper
trophoblast differentiation. This then leads to a failure of
placental trophoblast cells to effectively invade and remodel
maternal spiral arteries, ultimately leading to abnormal
placental blood circulation. Due to hypoxia and re-oxygenation
stress, pre-eclampsia can develop. The mechanism that senses
maternal vascular pressure is disrupted and this leads to a
generally broadcast cue to constrict arteries - high blood
pressure ensues. This can then lead to eclampsia. Preeclampsia is a common cause of fetal growth retardation in
developed countries, causing both pre-term birth (PTB) and
low body weight (LBW). Intrauterine growth retardation
(IUGR) and LBW are negative health predictors for newborns
and children, as they are associated with the development of
chronic diseases expressed later in life (such as cardiovascular
disease, hypertension and type 2 diabetes). Finally, improper
placental development due to aberrant methylation can also
cause harm to the mother where poor placental development is
associated with maternal hypertension. Therefore, aberrant
DNA methylation in the placenta impacts fetal growth, the
development of diseases later in life, and could affect maternal
morbidity (Blair et al. 2013).
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Figure 6.1 Factors affecting placental development. (Nelissen et al.
2011) Placental development is determined by many factors
including DNA methylation and histone modifications that regulate
gene expression, as well as environmental factors such as medical
procedures (ART), and exposure to toxic substances (chemicals,
alcohol, smoke), among others. Abnormal placental development can
result in consequences for both the fetus and the mother. The fetus
may be born pre-term, have low birth weight or could be more at
risk of developing diseases later in life. Maternal risks include
morbidity and death.

Epigenetic changes arise in both the embryo and the placenta:
aberrant DNA methylation and histone modification of many genes
have been observed under the circumstances discussed in CASE
STUDY 6.2 Such genes include H19 and IGF-2 (Li et al. 2005).
However, epigenetic alterations in the placenta appear to be more
common, especially in the placentas of babies that were conceived
using assisted reproduction technologies (ART). While the precise
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cause of this is unknown, some theories suggest that the placenta is
more affected since it derives from outer trophectoderm cells,
which by virtue of being the most external cells of the early stage
embryo, are in closer contact with the Petri dish culture medium in
which maternal and paternal contributions are combined. They are
also the first cells to differentiate and therefore undergo slightly
longer exposure as differentiated cells. They might simply also be
more strongly affected by the in vitro environment. The
trophectoderm cells have different DNA replication patterns and
might consequently have less capacity to maintain imprints (Mann
et al. 2004). Furthermore, increased prevalence of diseases
resulting from placental imprinting modifications could reflect the
diminished capacity of presumptive placental cells to deal with
epigenetic challenges (for example hypoxia, nutrition, disease, or
drugs) compared to cells that go on to form the body of the fetus
itself (Mann et al. 2004). Aberrant epigenetic marks in placental
tissue could lead to altered placental function, which may in turn
lead to diseases such as pre-eclampsia or placental previa. Either
outcome results in disrupted growth and development of the fetus,
ultimately leading to LBW or PTB (de Waal et al. 2014).
It is important to note that aberrant methylation and histone
modification can arise in non-ART children as well. Studies have
shown that the environment under which the placenta develops
(maternal diet, smoke, alcohol, chemicals, etc.) can also alter
epigenetic marks (Nelissen et al. 2011). A disturbance in placental
development or function through changes to the epigenome could
alter fetal development and increase in disease susceptibility later
in life. Not to be forgotten are the effects that anomalous fetal
growth could have upon maternal health: difficult pregnancies and
births can have long lasting effects. However, more research still
needs to be done in order to fully understand the relationship
between the placenta and long term epigenetic sequelae.
6.3 Assisted Reproductive Technologies
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The causes of male or female infertility are numerous and
broad. There are many genes and mechanisms involved in the
fertilization of an egg by sperm and the progression from a singlecelled zygote through to a human baby; the cause of any one
person’s infertility is complex and unique. Assisted reproductive
technology (ART) has revolutionized the field of reproductive
medicine and solved the problem of infertility for millions of
people around the world. The first “test tube baby”, Louise
Brown, was born in 1978 (Laprise 2009), and by 2008, an
estimated five million babies were born that were conceived
through in vitro fertilization (IVF) and other reproductive
techniques (ESHRE 2012).
ART is considered to be any medical technique or procedure
that aids in the conception of a child. The extent to which
reproductive assistance is required depends on the cause of
infertility and can vary from helping with the production of eggs to
injecting sperm nuclei directly into an egg. Some examples of
ART include:
 Ovulation induction/ Superovulation stimulation:
Gonadotropin releasing hormone analogues are used to
control the timing of ovulation and the number of
mature eggs released from the ovary (Elder and Dale
2000).
 Egg retrieval: Eggs are harvested from the ovary to be
used for fertilization. They are then: cultured in an
incubator; fertilized; cultured some more; and then
transferred back to the female reproductive tract or to
cryopreservation vessels.
 Fertilization: Fertilization is the process of sperm and
egg fusing to form a zygote and can occur in vitro or in
vivo via artificial insemination.
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Embryo transfer: Following in vitro fertilization and
culture, the embryo is inserted into the uterus to grow
and develop further.
Cryopreservation: Extra eggs and sperm can be frozen
in order to preserve them for future use, avoiding the
need for multiple egg and sperm retrievals. Embryos
can also be cryopreserved if too many were fertilized in
vitro (Kaariainen et al. 2005; Iliadou et al. 2011).
Artificial/ Intrauterine insemination: The process of
inserting sperm into a woman’s uterus in order to
facilitate in vivo fertilization.
Third-party reproduction: This form of ART includes
egg donation, sperm donation, and the use of a
surrogate or a gestational carrier. A gestational carrier
is a woman who carries and delivers a baby that is not
biologically hers, while a surrogate donates her eggs for
fertilization and gestation. In a recent innovation, a
donated egg can be stripped of its own chromosomal
DNA to be replaced by DNA from the prospective
mother. Since the mitochondrial genes come from the
donor egg, and the genomic chromosomes from the
father and mother, these embryos have three genetic
parents.

6.3.1 In Vitro Fertilization
In vitro fertilization (IVF) is the process that involves
removing mature eggs from the uterus, fertilizing them outside of
the body, and implanting one or more embryos back into the
uterus. This is done in order to facilitate fertilization and early
embryonic development for people who would otherwise be unable
to conceive. A typical IVF cycle includes:
1. Ovarian stimulation/ Superovulation
2. Egg retrieval
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3. Fertilization: This step may vary depending upon the ability
of the sperm to fertilize the egg. If the sperm are unhealthy
or lack the ability to fuse with the egg, intracytoplasmic
sperm injection (ICSI) may be used. ICSI involves
injecting a single sperm nucleus into a single egg using a
micropipette in order to increase the odds of successful
fertilization (Iliadou et al. 2011).
4. Culturing.
5. Fertilization.
6. Culturing again for a while to assess embryo viability and
health.
7. Embryo transfer to a receptive womb.
ART, especially IVF, has been linked to the development
of imprinting disorders in children. These disorders are
generally thought to be caused by aberrant DNA methylation
and/or histone modifications that lead to the improper
expression of certain genes, and the consequent development
of a disease. The imprinting disorders that have been most
strongly correlated with ART include Beckwith-Wiedemann
syndrome (Gicquel et al. 2003; Maher et al. 2003; Laprise
2009; Vermeiden and Bernardus 2013), Angelman syndrome
(Gicquel et al. 2003; Maher et al. 2003; Laprise 2009) and
Silver-Russell syndrome (Kagami et al. 2007; Laprise 2009;
Vermeiden and Bernardus 2013) (CASE STUDY 6.3). It is
important to note, however, that some studies refute a link
between these imprinting diseases and ART. It is an ongoing
and controversial topic of research (Zheng et al. 2011;
Vermeiden and Bernardus 2013).
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1. Hormone therapy stimulates egg production

2. Eggs harvested from ovary

3. Eggs fertilized in vitro with sperm

5. Embryos transferred to uterus

4. Embryos undergo multiple cell divisions

Figure 6.2 Summary of the IVF procedures.
IVF consists of numerous procedures. The exact procedures may
vary, and this is based on the person(s) undergoing IVF.
Generally, hormones are used to induce superovulation, eggs
are harvested from the woman’s ovaries, these eggs are fertilized
by sperm in vitro, the embryos are cultured on media and
allowed to undergo multiple cell divisions before finally being
transferred back to either the mother’s or donor’s uterus.

In order to understand the reasons why ART might cause
imprinting disorders, it is necessary to understand the process by
which the epigenome is established during gametogenesis
(production of the egg or sperm) and embryo development. Prior to
implantation of an embryo into the uterine wall, there are two
major phases of epigenetic reprogramming that occur: 1) at
gametogenesis, when the sperm and egg develop, and 2) shortly
after fertilization.
1) During gametogenesis, the epigenetic marks that were
present in the pre-gamete cells are largely, though not completely,
erased. Then, new sex-specific imprints are established; a
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paternally directed pattern is imposed in sperm, and a maternally
directed pattern is imposed in eggs. This erasure and re-imprint is
necessary because the chromosomes in the gametes will have
derived from and carry a partial imprint from a mixture inherited
from each gender of grandparent. This is known as genomic
imprinting (Johnson 2005; Iliadou et al. 2011; Market Velker et al.
2012).
2) During fertilization and early embryo development,
generalized DNA methylation patterns and histone modifications
take place along with specialized epigenetic processes that include
the maintenance of genomic imprints, silencing of retroviral
elements, and X chromosome inactivation.
Genomic imprinting allows for the expression or silencing of
each copy of the alleles (pairs of genes) inherited from each parent
via sperm and egg. The imprint is dependent upon whether the
mother or the father provided that allele. These imprints remain
intact, despite other DNA modifications that occur in early
development, in order to protect the regulated expression of
specific alleles from each parental chromosome.
Retroviral elements are ancestral remnants of viral genes that
are present in our genome (Market Velker et al. 2012). They can be
mobile and pose a disruptive threat to genome integrity. In order to
protect against the deleterious effects of these elements, they are
silenced during this period by epigenetic modification.
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CASE STUDY 6.3: Imprinting Disorders
Beckwith-Wiedemann
syndrome
(BWS)
BeckwithWiedemann syndrome is an overgrowth syndrome causing
macrosomia (excessive birth weight). Half of BWS cases are caused
by epigenetic changes at one of two genes on chromosome 11:
H19/IGF-2 and KCNQ1OT1 (Gicquel et al. 2003; Laprise 2009).
Normally, H19 is expressed only from the maternal alleles while
IGF-2 is expressed only from the paternal alleles. The KCNQ1OT1
gene is normally methylated on the maternal alleles, therefore being
expressed solely by the paternal alleles (Gicquel et al. 2003). Loss of
imprinting at the imprinting centers of these genes leads to aberrant
transcriptional regulation, resulting in BWS (Laprise 2009).
Angelman syndrome (AS) / Prader-Willi syndrome (PW)
Angelman syndrome primarily affects the nervous system and can
lead to delayed development. Normally, AS is caused by the loss of
function of certain genes on the maternal chromosome 15, due to
gene deletions through paternal uniparental disomy (Laprise 2009)
(inheriting two alleles from the father and none from the mother).
Less than 5% of AS/PW cases are due to imprinting errors in the
gene SNRPN DMR, however, all cases associated with ART are due
to loss of methylation on the maternal allele of this gene (Laprise
2009). This suggests that there is something about ART procedures
that is increasing the incidence of AS/PW caused by epigenetic
alterations.
Silver-Russell syndrome (SRS) Silver-Russell syndrome is
a slow growth disease characterized by intra-uterine and postnatal
growth retardation (Rossignol et al. 2008), resulting in low birth
weight and failure to thrive (Laprise 2009). SRS is a “sister” disease
to BWS, as it is also due to epigenetic errors in genes on
chromosome 11. Two-thirds of cases are due to hypomethylation of
H19/IGF-2, while the remaining cases are due to epigenetic
mutations on other chromosomes (Laprise 2009).

Finally, X chromosome inactivation is crucial during
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development of females in order to compensate for the second set
of genes that they receive through their XX pair. This adjustment
of gene dosage is necessary because a male’s Y chromosome is
smaller and carries fewer genes compared to the X chromosome.
X chromosome inactivation is carried out by condensing it 90%
into inactive, tightly packaged heterochromatin. Epigenetic marks
aid in the process of DNA condensation that mediates Xinactivation (Market Velker et al. 2012).
Given the timing of in vitro fertilization procedures relative to
epigenetic remodeling, there is a possibility that procedures will
disrupt imprinting erasure/re-imprinting and alter the epigenome
(Laprise 2009; Feng et al. 2011).
6.3.2 Contributing to the Development of Imprinting Diseases:
The In Vitro Environment
Despite efforts to simulate the female reproductive
environment, a Petri dish cannot replace a uterus and fallopian
tubes. The natural environment is extremely complex and cannot
be completely recapitulated by the type of media and incubators
used for embryo culture. Variables introduced by this artificial
culture environment include composition of the medium, the
addition of serum albumin, temperature, and the oxygen/CO2
concentration at which the gametes and embryos are incubated.
Studies on in vitro culture media have concluded that embryo
culture affects global DNA methylation patterns, chromatin
remodeling and gene expression (Market Velker et al. 2012; Feng
et al. 2011). Early embryo development is programed to be flexible
enough to respond adaptively to the environmental changes that
occur as the embryo moves from the fallopian tubes to the uterus,
and then implants (Johnson 2005). However, when subjected to the
vaguaries of artificial culture conditions, researchers suspect this
adaptive quality is subverted. Studies have also examined the
effects of adding serum albumin to culture media (Bavister 1995).
Serum albumen is an additive that is frequently used to supplement
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cultures and to enhance cell viability and growth. Mouse studies
showed that the addition of serum resulted in changes in the
methylation and expression of numerous imprinted genes,
including H19 and IGF-2 (Khosla et al. 2001; Market Velker et al.
2012). It is hard to predict the epigenetic consequences of media
supplementation upon human embryos, however the addition of
both serum and serum substitutes has been used for several years
to improve human embryo viability and implantation success (and
we are not even discussing the subtle and proprietary changes that
for-profit clinics might deploy).
The temperature at which embryo culture occurs is not as
homeostatic as the temperature an embryo would experience in
vivo, and this may also introduce epigenetic effects. The
eggs/embryos in their Petri dishes are removed from the incubator
for observation under microscopes. The transition from one venue
to another, or from the incubator to the transfer pipette, and then
into a womb introduces temperature swings and physical stress.
Finally, oxygen/CO2 levels in the female reproductive
environment are dynamic from pre-implantation through to postimplantation and are crucial to the development of the embryo.
However, embryos are often cultured in vitro at a static
concentration of 20% or 5% oxygen, and removal from the culture
chamber to the microscope introduces new variability. Therefore, it
is possible that inappropriate gas concentrations (and attendant
shifts in pH) could impair the development of the embryo,
genetically or epigenetically (Rinaudo et al. 2006; Nelissen et al.
2011; de Waal et al. 2014). In summary, the abnormal environment
in which gametes are stored and fertilized, and where early embryo
development takes place could affect the embryonic epigenome
(Laprise 2009).
Additional factors could also impinge upon success and the
epigenetic health of the embryo. First, the physical and chemical
manipulations that gametes and embryos undergo during the in
vitro process could not only introduce DNA damage, but could
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also have an effect on the epigenome. Second, superovulation and
use of immature sperm could alter the genomic imprints that are
formed during gametogenesis or introduce incompletely imprinted
sperm to the egg. Imprint marks are still being established in
oocytes during meiosis. Therefore, the use of gonadotropins during
superovulation procedures may have an epigenetic impact, perhaps
by restricting the amount of time available for imprint acquisition.
Although imprint marks are established before meiosis in sperm,
immature sperm might not be fully developed or the use of
immature sperm may cause imprint changes in the resulting
embryo (Laprise 2009).
Finally, the Intra-Cytoplasmic Sperm Injection (ICSI)
procedure could lead to media or acrosome pieces (pieces lost
during normal fertilization) being introduced into the egg, or to a
physical disruption in the egg via the micropipette (Maher et al.
2003; Kalra et al. 2011). Both of these situations could affect the
embryo’s epigenome.
6.3.3 In Vitro Fertilization and Low Birth Weight
Low birth weight and pre-term birth have been associated with
assisted conception and reproduction (Schieve et al. 2002;
MacDonald et al. 2009; Kalra et al. 2011). It is hypothesized that
low birth weight and pre-term birth could be due to epigenetic
alterations that arise during IVF procedures. Potential factors that
could induce low birth weight or pre-term birth include ovarian
stimulation, oxygen tension, culture media type, serum addition,
and multiple embryo implantation.
There may be a link between the use of exogenous hormones to
induce superovulation, and birth weight. By comparing live births
from fresh embryo transfers (where the maternal environment had
just experienced ovarian stimulation) with cryopreserved or
frozen-thawed embryo transfers, researchers were able to compare
the effects of these stimulatory hormones (Kalra et al. 2011).
Interestingly, there was a higher incidence of low birth weight in
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children conceived after fresh embryo transfer. Might freezing
have mitigated otherwise damaging hormone concentrations and
effects? Could subtle damage induced by freezing have elicited
impromptu repairs? While the mechanism by which low birth
weight occurs is currently unknown, one possibility is that the
reproductive environment (altered by exogenous hormones) affects
epigenetic marks either withing the placenta or the embryo that
acquired during early development (Kalra et al. 2011).
As previously discussed, oxygen tension during embryo culture
has been found to affect epigenetics: these changes could lead to
low birth weight or pre-term birth (de Waal et al. 2014). As
previously mentioned, the type of culture media used during IVF
has epigenetic consequences (Johnson and Krasnow 1990; Market
Velker et al. 2012). Some studies have also concluded that embryo
culture can affect the birth weight, suggesting that this is the reason
behind the higher risk for low birth weigh in IVF singletons
(Dumoulin et al. 2010). Other studies, however, suggest that there
is no significant relationship (Carrasco et al. 2013; Lin et al. 2013).
Could these disparities be due to undisclosed and proprietary
differences in embryo culture and transfer practices? Changes in
the methylation and expression of imprinted genes such as H19
and IGF-2 have been reported (Market Velker et al. 2012). This is
important because these genes are involved in growth development
and the development of imprinting disorders. In fact, the use of
serum for in procedures used to propagate domestic livestock has
been associated with Large Offspring Syndrome (Walker et al.
1996; Market Velker et al. 2012) and Beckwith-Wiedemann
syndrome in humans.
During embryo transfer, often more than one embryo is
implanted into a woman’s uterus in order to maximize the chance
of pregnancy. Sometimes multiple embryos implant and begin to
grow, with some terminating over the course of gestation –
generally between 5 and 10 weeks; this is known as a “vanishing
twin” (De Sutter et al. 2006). Singletons that result from a double
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embryo transfer (due to a vanishing twin) imply a suboptimal
implantation environment. This environment could contribute to a
higher miscarriage rate and less-than-ideal placental development
and fetal growth leading to lower birth weight (De Sutter et al.
2006). It is not known if this environment affects the epigenetic
health of the remaining fetus. Alternatively, another simple
explanation might be that in the first place, procedures are being
deployed to aid embryos that are in some way already sub-optimal
(see section 6.3.4 below). In summary, the loss of embryos over
the course of harvest, culture, transfer, and implantation may be
the result of technical deficits, procedural insults to the embryos, or
merely to poor egg or embryo quality. and Distinguishing between
the possibilities will not be trivial.
Assisted reproductive technologies have provided many people
with the welcome option to reproduce. Given the potential for
imprinting diseases, low birth weight, pre-term birth and intrauterine diseases, it is crucial to confirm or refute the relationship
between ART and disease development. Moreover, studies based
on animal models must be extrapolated with caution to the human
reproductive process since significant difference exist between
species with regard to both fertilization and development (Iliadou
et al. 2011). Furthermore, there are no long term studies that track
the development of IVF babies into late adulthood: IVF is a
relatively recent procedure, so ART children are not old enough to
reveal late-onset diseases (Johnson 2005). Moreover, they are only
just beginning to have children of their own, and trans/multigenerational effects need to be assessed. Finally, the epigenetic
effects of superovulation upon the mother or egg donor are still not
clear. So, in reality, many of the epigenetic consequences of ART
and IVF remain unknown and some people have suggested that a
discussion is required regarding whether it is ethical to continue
ART under these circumstances (Amor & Halliday, 2008;
Rothstein et al., 2009; von Wolf et al., 2015).
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6.3.4 The Condition of Infertility
An alternative hypothesis as to why IVF may result in
imprinting disorders is that the condition of infertility or
subfertility is what is responsible for the epigenetic alterations, not
ART procedures. If a reproductive system is not able to: produce
gametes; undergo sperm-egg fusion; permit the embryo hatch from
blastocyst stage or to implant properly, there must be a nutritional
or physiological deficit, or one or more mutations that are
inhibiting these processes. Therefore, by artificially aiding the
reproductive process, these traits are being passed along to the next
generation despite the fact that they are suboptimal. These genetic
mutations and/or epigenetic alterations may be inherited by the
next generation and may unfortunately manifest as imprinting
disorders.
An example of one IVF procedure where this might be the
case is ICSI (Intra-Cellular Sperm Injection), which was originally
thought to be the direct cause of ART-related imprinting diseases.
ICSI compensates for unhealthy or weak sperm that are not able to
travel to the egg or to fertilize it without assistance. Therefore,
ICSI circumvents fertilization barriers that have been imposed by
evolutionary pressures (Laprise 2009). Ergo, it is possible that
these suboptimal sperm carry DNA damage that affects the
epigenetic imprinting process, and that these deficits are being
passed onto the offspring (Maher et al. 2003; Laprise 2009).
Numerous studies have looked into this hypothesis and found that
children were more likely to have imprinting disorders related to
subfertility rather than ART (Vermeiden and Bernardus 2013).
Thus, the quality of the gametes used should be taken into
consideration and perhaps gametes with DNA damage or genomic
imprinting defects should be avoided if possible (although it is by
no means clear how this would be assessed – the ability to detect
and exclude these gametes is not yet feasible). Also, in extreme
cases, we knowingly use immature eggs or sperm if the male or
female cannot produce fully matured gametes: this raises both
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practical and ethical issues (Laprise 2009). Likely, it is a
combination of both the condition of infertility and ART that play
a role in the disruption of epigenetic marks and the development of
relevant diseases.
Continued studies on ART- conceived children and adults,
especially long-term studies, are necessary in order to better
understand the relationship between epigenetics, ART, and disease.
ART-conceived adults are beginning to have their own children
now, and this could provide the opportunity to investigate the
trans-generational effects (genetic or epigenetic) of these
procedures.
We have learned that the pre-conception and conception
conditions, intrauterine environment, and external experiences of
mothers during pregnancy can alter methylation patterns in a fetus.
From this arises the important ethical issue of responsibility.
When a drug, environment, or personal decision has deleterious
epigenetic effects for descendants two generations down the line,
who bears responsibility for the pain and suffering that they
endure? When a wrong has been done by people who actually
abided by the laws of their time, can blame fairly be placed from
the perspective and situation of more recent technological and
ethical standards? It easy to say that it is a pregnant woman’s
ethical obligation to create a healthy environment for her fetus, and
that this should include avoiding drugs and dangerous work
environments. How practical is this though, when there are social,
economic, and cultural influences that might subvert such care?
So, given that epigenetic harms can be absorbed even
before conception, where should lines of obligation and
responsibility be drawn? Methylation or histone acetylation
modifications incurred before conception or during gestation can
alter gene expression in life outside the womb, and in this sense,
biological science could be used to further question the “starting
point” of life. Currently in Canada for example, criminal law does
not limit abortion, nor are fetuses deemed to be persons (section
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223 of the Criminal Code of Canada), thus it can be inferred that
women have no legal obligation to their fetuses. In the process of
determining legal responsibility, epigenetic studies could reopen
the legal “when-does-life-begin” debate. This will be tricky legal,
ethical, and social terrain indeed.
6.4 Oral Contraceptives
Oral contraceptives can be used for a variety of reasons, but
are generally used to treat menopausal disorders, or to control a
woman’s menstrual cycle, and prevent pregnancy (Hilakivi-Clarke
et al. 2013). Oral contraceptives may also be referred to as
“synthetic estrogens” despite the fact that they contain a mixture of
steroid hormones including estrogens and progesterones.
Oral contraceptives prevent pregnancy by preventing the
pituitary gland from producing the hormones (LH and FSH)
necessary for the ovaries to release a mature egg. Furthermore, oral
contraceptives thicken cervical mucus making it more difficult for
sperm to travel toward the fallopian tubes. Finally, oral
contraceptives thin the lining of the uterus so that implantation of a
fertilized egg cannot occur. Despite the fact that combined
hormone oral contraceptives work by preventing fertilization,
many of the ethical questions surrounding the use of oral
contraceptives stem from what some critics define as an essentially
abortive function. This stance questions a woman’s right to control
her bodily and reproductive functions,. Tangentially, even though
there may be medically pertinent reasons to prescribe the
hormones to teenagers in order to regulate the menstrual cycle,
some critics have voiced concerns that this will encourage early
sexual behaviour.
6.4.1 Oral Contraceptives and Cancer Risk
Since oral contraceptives disrupt certain endocrine axes, their
potential for epigenetic effects on various cells and tissues has
been the focus of recent studies. Many epigenetic effects are being
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investigated including an increased risk of developing breast
cancer, disruption of macrophage function, and changes in mRNA
expression patterns of a wide variety of genes.
The link between estrogens and breast cancer appears
controversial: some studies have confirmed a causative
relationship, while others not (Lodha et al.). An association
between methylation on the estrogen receptor alpha CpG island
(ERα) and breast tumor subtypes with bleak prognoses has recently
been identified (Izadi et al. 2012). Izadi et al. (2014) suggest that
never experiencing a full term pregnancy or waiting until after 30
years of age to do so could possibly present higher chances for
circling estrogens, natural or synthetic, and/or environmental
carcinogens to induce aberrant methylation in the breast tissue
before it undergoes pregnancy-triggered differentiation.
Furthermore, some results go so far as to suggest that exposure to
synthetic estrogens may increase the risk of developing breast
cancer not only in the women who used these pills, but in their
daughters as well (Collaborative Group on hormonal factors in
breast cancer, 1996; Hilakivi-Clarke et al. 2013). The potential
epigenetic mechanisms of these trans-generational effects include
epigenetic modifications in mammary glands and germ cells,
thereby causing a heritable susceptibility to breast cancer
development.
Although it has been well known and generally accepted
for years now that oral contraceptives reduce the risk of ovarian
cancer in women (Collaborative Group on Epidemiological Studies
of Ovarian et al. 2008), only a few studies have examined the
differences between high and low hormone dose regimens on
cancer risk. For example, one study found associations between
high-dose progesterone and reduced risk, leading the authors to
postulate that progesterone is the central component in the
protective effect of oral contraceptives against ovarian cancer
(Rodriguez 2003). Another found that low-dose progesterone
offers the stronger protection (Lurie et al. 2007). Clearly, studies
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on the exact causes of the reduced risk of ovarian cancer in women
with prolonged exposure to oral contraceptives have been
ambiguous. However, one more recent study yielded interesting
results that could possibly explain the ambiguous findings. Faber et
al. (2013) illustrated that the estrogen potency in the oral
contraceptive did not affect the level of reduced ovarian cancer
risk. Progesterone alone also did not reduce risk. The authors
suggest that the protective effect may be due to anovulation (an
egg-free menstrual cycle), finding a 6% risk reduction for each
year a woman took oral contraceptives, and this may be
independent of estrogen and progesterone intake altogether (Faber
et al. 2013).
6.4.2 Other Epigenetic Side Effects
Since oral contraceptives are ingested systemically, they
disrupt the hormonal environment throughout a woman’s body and
this has the potential to affect many biological functions, including
the disruption of phagocytic macrophage functions. Macrophages
in the bloodstream rely heavily on cues provided by the “milieu” in
which they function. A decrease in global methylation was
observed in the white blood cells of women that were exposed to
synthetic estrogens. This hypomethylation is in turn associated
with a predisposition to atherosclerosis and other age-related
chronic diseases. Furthermore, aberrant methylation of genes in
white blood cells could impact immune function, potentially
leading to very serious autoimmune diseases or failures to remove
abnormal, pre-cancerous cells (Campesi et al. 2012).
Abnormal methylation of DNA could have a plethora of
consequences depending on the gene that is affected. A specific
example of this is the altered expression of DNMT3a (DNA
cytosine-5-methyltransferase 3a; a methyltransferase responsible
for controlling gene methylation and the epigenetic imprint) within
the developing rat amygdala following exposure to estradiol and
dihydrotestosterone (Kolodkin and Auger 2011). The DNMT3a
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changes in turn affect multiple other genes, thereby perturbing
amygdala function. As we will see in the chapter discussing the
estrogen mimic diethylstilbestrol (DES, Chapter 8), there is a
possibility that oral contraceptives may have many more lasting
and subtle epigenetic effects than presently appreciated.
6.4.3 Oral Contraceptives and Risk to Progeny
From 1960 to today, the number of women using oral
contraceptives in the United States has grown from about one to
eleven million (Jones et al. 2012). In 1990, the annual FDA
Consumer Report declared a general opinion (taken from
government, medical, and public sources) in support of the safety
and effectiveness of oral contraceptives. More recently, Strifert
(2014) noted that the increased prevalence of autism spectrum
disorder coincides with the increased use of oral contraceptives.
He invokes the Knudson hypothesis that was developed to explain
the development of cancer (Knudson 1971): an accumulation of
“multiple hits” to the genome contributes to the mutations leading
to cancer. In the case of autism spectrum disorder, oral
contraceptive install the epigenetic changes necessary for Autism
Spectrum Disorder to develop. The first “hit” is the damage done
to the egg from continued use of the pill. The second “hit” could be
epigenetic, environmental, or genetic and this compounding of
damage is what yields an autistic phenotype in the progeny (Stifert
2014). There is no direct evidence to establish a causal link
between hormonal contraceptives and the disorder, so the
relationship could just be coincidence.
6.4.4 Estrogenicity of Drinking Water: Are Oral Contraceptives
Part of the Problem?
In vivo fish experiments have demonstrated the potency of
EE2 (Ethinyl Estradiol- an artificial estrogen found in oral
contraceptives) to be much higher than that of natural estrogens
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(E1, E2, E3) and the documented environmental effects of oral
contraceptives are a growing concern (Thorpe et al. 2003).
Estrogen contamination of drinking water is a rising concern: the
increase in intersex fish and human reproductive issues raises some
alarms (Massart et al. 2006; Wise et al. 2011a). Natural estrogens
(E1, E2, and E3) as well as synthetic estrogens (EE2) enter the
water supply from many different sources (Table 6.1) (Velicu and
Suri 2009). EE2 is such a huge concern because of its higher
potency compared to E1, -2, and -3. However, the compiled data
depicted EE2 as playing a relatively small role in the total
estrogenicity of drinking water. In The Netherlands, EE2 was
found to account for about 1% of total human estrogen excretion,
which is just one source of estrogens - in the United States, it is
likely that the proportion of EE2 is less than 1% (Wise et al.
2011a).
Other noteworthy sources of estrogen include mimics in
pesticides like: vinclozolin; organochlorine pesticides, a prime
example being DDT; and atrazine, which is known to be extremely
mobile in the environment (Thurman and Cromwell 2000;
Solomon et al. 2008). Runoff of these pesticides are less potent
than E2, however the quantities detected in surface waters are
much higher and can produce deleterious effects on aquatic life at
levels as low as 0.1 ppb (parts per billion) (Hayes et al. 2010).
Although it has been roughly estimated that approximately 40% of
the EE2 ingested reaches sewage as active EE2 (Johnson and
Williams 2004), the amount of EE2 in relation to all the other
estrogens contributing to the estrogenicity of drinking water poses
a minimal risk to human health (Wise et al. 2011a).
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Source

Waste
Where does it
Management
go?

Homes

Treated

Surface water

Escapes
Drinking
water
treatment?
YES

Measured
in
drinking
water?
YES

Livestock

Untreated

Surface water

YES

YES

Industry

Treated

Surface water

YES

YES

Agriculture

Untreated

Ground water

YES

YES

Landfills

Untreated

Ground water

YES

YES

Table 6.1 Sources from which estrogen has the means to enter our
water supply. Adapted from Velicu et al., 2009.

Only water waste from homes and industrial sources is treated
twice. If our goal is to reduce the estrogenicity of drinking water,
then we are going to have to look at all of the different estrogen
sources and act on them. Wise et al., (2010) propose some general
ideas of ways to address each identified source: improvements to
waste water treatment, detection methods/monitoring, and
estrogenicity tests; frequent chemical policy reform, since testing
protocols and chemical information need updating; reduction in
overall use of EE2; and further research in this area.
Critics have strongly disagreed with the characterization that
EE2 posed minimal health risk to humans (Grzybowski 2011).
Performing his own calculations based on the Dutch population
statistics that Wise et al., (2010) presented, he concluded that EE2
likely contributes 93% of estrogenicity in German drinking water.
He appears to have factored in a value for potency that enormously
increases results. Without a more detailed explanation of his
methods, one must read with a critical eye.
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Figure 6.3 Estimation of percentage of EE2 from oral contraceptives
before water treatment. EE2 is a clear contributor to increased water
estrogenicity. The amount of active EE2 excreted and available in the
system, even considering this is only an estimate, is astonishing.
However, taking into account the detection rates of between 0 and 1
per cent of EE2 in drinking water, we should have confidence in our
water filtration and treatment plants and focus our attention on what
we can do about other sources of estrogen coming into our drinking
water. (Adapted from Johnson and Williams, 2004.)

Wise and colleagues respond with a reiteration of two main
points that perhaps they did not make clear in their original paper.
The first point is that water treatment systems have become
increasingly effective, so the amount of EE2 actually in the water
that reaches our taps falls to virtually nothing (Wise et al. 2011b).
But are the discussants talking about the same geographical areas,
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the same populations, etc.? Perhaps not all water treatment
facilities are equally sophisticated. Depending on the population
and its practices, the amount of natural and synthetic estrogens
coming into the system could differ. The second rebuttal point
stressed by the authors is that there are many other overlooked
sources of estrogenenic compounds that can be just as harmful as
EE2 from oral contraceptives (Wise et al. 2011b). There are still
natural estrogens from human waste and untreated agricultural
runoff, estrogenic plant compounds, and even other synthetic
estrogens from industrial waste. EE2 from oral contraceptives
likely plays a role in the estrogenicity of drinking water, but it is
not a big enough role to be solely responsible for this growing
concern. We must look to all estrogen sources if we want to
address the issue.
6.5 Birthing Method
Dahlen et al. (2014) invites those who argue for medical
intervention during labour and delivery to take a moment and
consider what is being given up. Physiological birth, normal
vaginal delivery without medical intervention, could be the key to
the health and stability of not only the baby, but the future children
of that baby. Our birthing day could be a much more significant
event in our epigenetic construction than we have given it credit
(Dahlen et al. 2013; Dahlen et al. 2014). EPIIC (Epigenetic Impact
of Childbirth) is a group that specifically studies the epigenetic
effects of childbirth. The EPIIC hypothesis posits that the
physiological birth process, from labour to delivery, is in place to
exercise purposeful and positive stress on the fetus in preparation
for life outside the uterus. The argument is advanced that birth
epigenetically programs specific genes involved in calibrating
immune response, controlling weight regulation, as well as
suppressing tumors. These changes to the epigenome are heritable
and could conceivably lead to lifelong, perhaps trans-generational,
consequences to health (Dahlen et al. 2013)
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During a vaginal delivery, contractions of the uterus and
fetal hypoxia stimulate a significant perinatal stress response.
There is an increase in stress hormones like cortisol and
catecholamines, which serve to: mobilize fuel for the journey
through the birth canal; trigger lung-liquid reabsorption to facilitate
air-breathing after birth; and to activate the hypothalamic-pituitaryadrenal axis. These processes contribute to the maturation of
certain organs, the nervous system, and the immune system
(Schlinzig et al. 2009; Cho and Norman 2013). This increase in
stress hormones is different in babies delivered by elective
Cesarean section: concentrations rise rapidly and suddenly as
opposed to the gradual increase that is experienced during vaginal
birth. This altered perinatal stress pathway might have epigenetic
consequences via modification of gene methylation (Schlinzig et
al. 2009). Altered DNA methylation has been observed in
glucocorticoid receptors in the hippocampus, which leads to
higher stress sensitivity, and in genes involved in the pathway that
regulates T-helper cell type populations, possibly contributing to
the development of immune diseases (Cho and Norman 2013).
6.5.1 Medical Intervention During Birth - The Caesarean
Section
During an elective Cesarean section, an incision is made in
the lower abdomen in order to remove the baby without having it
pass through the birth canal. Since Cesarean sections are surgical
procedures, there are potential issues and complications that do not
arise during a vaginal birth. This could cause the mother or baby
more harm if the procedure is carried out inappropriately. On one
hand, a physician must respect their patients’ decisions, but also
must not expose the mother or baby to unnecessary harm (Muula
2007).
Hematopoietic stem cells were extracted from the
umbilical cord and analyzed for differential methylation between
infants born by Caesarean section and infants born by vaginal
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delivery (Almgren et al. 2014). Cesarean newborns showed more
methylation than vaginally delivered newborns and these results
were independent of maternal and infant characteristics such as
age, weight, gender, and parity. Just over half of the differentially
methylated positions were linked to known genes. Surprisingly,
about three quarters of the differentially methylated positions in
the Cesarean newborns were hypomethylated when compared to
the vaginally delivered newborns. Affected genes were mainly
those with responsibilities in the metabolism of sugar, and in
regulating cell apoptosis. At least one gene related to the immune
system was differently methylated, and this particular gene has
strong associations with a genetic predisposition to type I diabetes
(Lie et al. 1999; Almgren et al. 2014).
The clear evidence that the epigenetic profile of the
hematopoietic stem cells in umbilical cord blood is altered by
mode of delivery could become an issue for umbilical cord blood
banks. Can this blood be used for transplants if it is not
epigenetically altered? Almgren et al. (2014) theorize that these
differentially methylated positions do not take immediate effect,
but rather require a successive “hit” or “hits” to trigger disease.
The next logical step is to compare adolescent and adult
hematopoietic stem cells of Cesarean versus vaginally delivered
individuals to see whether or not the differentially methylated
positions retain their epigenetic marks over a lifespan. Cesarean
sections lead to a higher incidence of certain diseases including:
asthma, allergies, lower respiratory infections, type 1 diabetes,
celiac disease, peripheral and central adiposy, obesity, and
inflammatory bowel disease (Magnus et al. 2011; Azad and
Kozyrskyj 2012; Bager et al. 2012; Cho and Norman 2013;
Flemming et al. 2013; Mesquita et al. 2013). So, not only is our
birth day a critical life event, but perhaps more importantly our
birth way makes all the difference: unquestionably, emergency
Caesarian sections can save lives, but how should physicians
weigh the cost/benefits of the procedure, and how much should we
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worry about elective procedures?
6.5.2 The Cesarean Section and the Microbiome
The human body is covered in mutualistic and commensal
microorganisms that constitute our normal microbiota (Penders et
al. 2006). In utero, however, humans are generally considered to be
microbe-free (although this has recently come under scrutiny – see
Aagaard et al., 2014; Romano-Keeler et al., 2015). It is during
birth that normal microbial populations are established in the
infant. These microbes are acquired primarily during the journey
through the birth canal, and then later from the environment when
breathing, breastfeeding, and contact with the parents begins.
Babies delivered vaginally are colonized by bacteria from the
mother’s birth canal and perianal region, while those delivered via
Cesarean section are colonized by bacteria from maternal and nonmaternal skin, and from the hospital environment (Penders et al.
2006; Cho and Norman 2013). The “hygiene hypothesis” suggests
that an altered neonatal gut microbiome leads to changes in the
neonatal immune system, potentially predisposing babies to
develop certain diseases such as asthma and allergies (Schlinzig et
al. 2009). Gut bacteria prime the immune system (Penders et al.
2006) and change the proportion of T-helper cell types so that the
immune system can mature. A disrupted balance of microbes in a
neonate’s gut could prolong this maturation period and impair
functional efficiency. This in turn increases the risk for immune
diseases later in life (Schlinzig et al. 2009). Moreover, it is also
important to note that babies delivered by Cesarean section are
more likely to receive antibiotics: the composition of the neonate’s
microbiota can be changed for years. An altered microbiome
would result in unusual metabolite production. These metabolic
products could alter the environment for developing cells,
influence epigenetic marks and change the expression of certain
genes. These are confounding factors when discussing the
differences in the microbial flora of babies that were delivered
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vaginally as opposed to by Cesarean (Schlinzig et al. 2009).
Hence, the establishing human microbiome can both alter and be
influenced by numerous factors and is an important aspect of many
biological processes, including epigenetic regulation.
6.5.3 Medical Intervention During Birth - Epidural Analgesia
and Pitocin
Epidural analgesia, more commonly referred to simply as an
epidural, is a common and effective pain reliever during labour. An
epidural injection contains a combination of low doses of local
anaesthetic and opioid. Epidural analgesia desensitizes the mother
and blocks the pain of uterine contractions. Another effect of an
epidural is paralysis in the lower body. What does this mean for
the physiological birth process if the woman is disconnected from
sensation of her body? Data taken from a large cohort of women in
Australia showed that one of these effects is a higher risk of
Caesarean section after administration of an epidural (BannisterTyrrell et al. 2014). Fetal distress is listed as the reason for
intervention in a small fraction of cases, so, the epidural seems to
be putting more than just a block on the pain, it appears to be quite
effectively slowing down labour to the point of having to perform
a C-section (Bannister-Tyrrell et al. 2014). One tool to jump start a
slow or stalled delivery is to administer oxytocin to the mother.
Pitocin, or synthetic oxytocin (synOT), is also a usual
intrapartum (period of time between pregnancy and delivery)
intervention. It is used to increase the frequency and intensity of
contractions with and without epidurals (Bell et al. 2013). If
Pitocin is administered before an epidural, the contraction pain
becomes too intense to bear without anesthetic aid. Thus, most of
the time, Pitocin and epidural analgesia go hand-in-hand. It
culminates in an increased chance of ending by Caesarean section.
As with research on effects of epidural analgesia, studies on
Pitocin outcomes are just beginning to surface. One of the first
discovered effects that synthetic oxytocin can have on a
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developing neonate brain is higher risk for Autism Spectrum
Disorder (ASD). Studies have shown a solid predictive correlation
between synthetic oxytocin administration and development of
ASD later in childhood (Kurth and Haussmann 2011). Oxytocin
administration correlates with childhood onset of ASD almost 2:1
compared to controls. Additionally, male infants exposed to
Pitocin appeared to have higher risk of developing ASD, although
the authors admit this could simply be because of the fact that ASD
is generally more frequent in males (Kurth and Haussman, 2014).
Another consequence of synthetic oxytocin for the baby is
less optimal levels of pre-feeding cues and breastfeeding behaviour
(Olza Fernandez et al. 2012; Bell et al. 2013). This latter group
saw medium-low levels of pre-feeding cues and organization in
75% of infants with mothers who had intrapartum oxytocin. In
contrast, 100% of the infants with mothers who had no oxytocin
had medium-high levels of pre-feeding cues and organization.
Education is the key in creating an informed birth plan and
in helping to make tough choices during labour and delivery.

6.6 Breastfeeding
Whether or not to breastfeed is an important decision that
must be made by every new mother. It is also the topic of an
ongoing ethical debate. Breast feeding has been associated with
many benefits, including the provision of antibodies and vital
enzymes to protect the baby and aid in immune system
development (Jackson and Nazar 2006), as well as providing an
overall increase in neurocognitive function (Quinn et al. 2001).
Breast milk contains secretory IgA antibodies that can protect the
baby from harmful pathogens, and leukocytes, that are thought to
influence immune system development. Furthermore, breast milk
contains lysozyme (which destroys bacterial cell walls), lactoferrin
(which removes excess iron to stop microbial growth), as well as
nucleotides and complex sugars (which help fight off pathogens
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and aid in immune system development) (Jackson and Nazar
2006). Breastfeeding has also been shown to: increase the size of
the thymus gland, whose function is T lymphocyte development
and maturation; cause an increased immune response to childhood
vaccines; protect individuals from allergies and the development of
autoimmune disorders (Azad and Kozyrskyj 2012); and to prevent
the development of diabetes mellitus (Jackson and Nazar 2006).
Breast milk also appears to aid in neurocognitive function,
resulting in babies with higher IQ’s (Quinn et al. 2001). Moreover,
breast milk is free, does not allow for extreme over-feeding, and
can help mothers to lose weight. However, noxious substances like
polychlorinated biphenyls (PCBs), polycyclic aromatic
hydrocarbons (PAHs) and infectious diseases (HIV/AIDS) can also
be passed from mother to baby via breast milk. Furthermore,
breastfeeding may be painful and some people still consider it
inappropriate or unacceptable to breastfeed in public.
6.6.1 Breast Milk and the Epigenome
Breast milk is a biologically active substance that includes
genetic materials, such as microRNAs, stem cells, and organic
substances that affect epigenetic marks and gene expression
(Ozkan et al. 2012). Studies have also indicated a relationship
between post-natal nutrition, the microbiome, and epigenetic
regulations that influence development and the predisposition to
certain diseases. MicroRNAs have been implicated in controlling
the expression of epigenetic regulators like DNA
methyltransferase and histone deacetylase (Chapter 2).
Therefore, if transmitted through breast milk to a baby, this genetic
material has the potential to alter epigenetic marks (Ozkan et al.
2012).
The presence of stem cells that are harbored in the baby,
but that are derived from the mother or prior siblings in the birth
order is known as microchimerism. These “foreign” stem cells
might also play a role in development, particularly of the immune
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system (Miech 2010; Chan et al. 2012). Breast milk is a significant
source of maternal-fetal microchimerism (Dutta and Burlingham
2010), and the maternally derived cells may persist in the offspring
for years: they could perform unknown epigenetic effects.
Furthermore, it has also been hypothesized that early postnatal nutrition (breast or formula feeding) epigenetically programs
certain organs via the gut microbiome (Mischke and Plosch 2013).
The epigenome of intestinal cells and first line immune cells would
be most susceptible to these changes, but so would other tissues
that come into contact with microbial metabolites, such as fat and
liver cells. This is because foods cause adjustments to the
composition of gut microbiota: changing the type microbes present
alters the cocktail of metabolites released. Studies indicate that
breast milk stimulates the development of a microbiome dominated
by carbohydrate-fermenting bacteria like bifidobacteria and
ruminococci, which produce large amounts of the secondary
metabolite folate. Folate is an essential compound in one-carbon
metabolism that provides methyl groups to regenerate S-adenosyl
methionine (SAM). SAM in turn provides the methyl groups for
DNA methylation. These bacteria may also affect epigenetic marks
via increased histone modification since areas of DNA methylation
act to attract histone-modifying enzymes. Thus, these bacteria play
a role in DNA methylation (and subsequently histone
modification), potentially altering epigenetic marks in certain
tissues (Mischke and Plosch 2013). On the other hand, formula
contains more proteins in order to compensate for low protein
quality. More protein therefore travels to the colon and causes an
increase in the growth of proteolytic bacteria such as the firmicutes
lactobacilli, clostridia, and streptococci that produce butyrate.
Butyrate is the product of microbial fermentation of
undigested carbohydrates and proteins. It serves as an energy
substrate and therefore contributes to fat accumulation, but it also
inhibits the actions of histone deacetylases. This means that in the
presence of high levels of butyrate, histones could remain
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hyperacetylated, resulting in the epigenetic changes that lead to upregulation of certain genes. This mechanism of hyperacetylation
has been implicated in various cancers, sickle cell anemia, as well
as cholesterol, lipid metabolism and storage disorders (Mischke
and Plosch 2013). Studies have linked these microbial mechanisms
to the incidence of obesity in breast fed versus formula fed

Figure 6.4 Epigenetic pathways initiated by the reception of breast
milk or formula respectively. Adapted from Mischke, 2013. The
type of nutrients a baby receives is able to cause life-long metabolic
changes. Breast milk has been shown to nourish bacteria that
promote DNA methylation. This leads to a decrease in gene
transcription and is associated with the development of certain
characteristics (tend of be leaner as an adult, increased levels of
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intelligence, and increased immune response to vaccines). Formulafed infants tend to have different gut bacteria that promote histone
acetylation, which in turn promotes gene transcription. This leads to
the development of other characteristics (predisposition to obesity,
cancers, and cholesterol and lipid metabolism and storage
disorders).

children: breastfed children are generally leaner well into
adulthood (Mischke and Plosch 2013). None of the aforementioned
precludes a role for the bacteria that are transferred from mother to
child by the intimate contact of breastfeeding. More research is
required to understand the role of epigenetics as a link between
breast milk and offspring characteristics/ disease development.
6.7 Maternal Programming
We still struggle with questions of nature versus nurture:
how much of who we are is genetic and how much is influenced by
our experiences? Studies of twins, for example, provide a way of
exposing those differences that are derived solely from
environmental variables (Haque et al. 2009). Now, mechanisms of
methylation and histone modifications offer an entrée to solving
this puzzle: environment, genetics, epigenetics, and psychology
have never been more entwined. Any infant’s environment
includes a caretaking individual(s) who shape(s) the infant’s
immediate world. Early nurturing or rearing deficits now appear to
lead to epigenetically encoded mental stability or disorders
respectively in later years (Sullivan and Lasley 2010).
One such disorder is chronic physical aggression (CPA).
This behavior constitutes an aggression that usually diminishes
before kindergarten but that instead persists through to adulthood
with predictable consequences for criminality and family stress.
Provencal et al. (2013) studied a group of males diagnosed with
childhood physical aggression on a CPA trajectory and found they
showed lowered cytokine activity, associated with epigenetic
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modification, compared to the control group. The underpinning
causes of the association between CPA trajectory and methylation
remains a prominent question (Provencal et al. 2014; Provencal et
al. 2015): which came first: the methylation or the childhood
physical aggression? What events during fetal development or
extremely early infant life could be contributing factors? For a
more on this study, refer to Chapter 7.
6.7.1 Imprinted Maternal Care Behaviour
In rats, mothering behaviours can be inherited and some of
this character may be transferred across generations when the
mother fails to nurture sufficiently, and the pup is stressed. This
has an impact upon its epigenetic imprint: if a female pup was
cared for by a good mother, the pup grew up to be a good mother
herself and treat her pups to the same high standard of
licking/grooming behaviour to which she had been treated
(Sapolsky 2004; Weaver 2007; Weaver 2009). Other studies
corroborated these results, and demonstrated the epigenetic
mechanisms that underpinned the perpetuation of this behaviour: a
gene in the stress response pathway, glucocorticoid receptor, is
marked by post-natal experience. Pups absorbed not only maternal
caregiving attributes, but differential sensitivity to stress. The
imprint is reversible by fostering. Subsequently, another gene in
the stress response pathway, brain-derived neurotrophic factor
(BDNF) was found to be affected by maternal care patterns (Blaze
et al. 2013). Pups that were maltreated by their caregivers and pups
that were pulled away from their biological mothers, even though
they were well-nurtured by their foster caregivers, all had
significant methylation on their BDNF gene. Finally, the effects of
fear and stress upon the epigenome, during early and adult life, can
be passed on to progeny (Sullivan and Lasley 2010; Dietz et al.
2011). These features are discussed in more fulsome manner in
Chapter 7, but they raise concerns for the effects of parental care
and skills upon epigenetic health in humans.
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6.7.2 Depression and Suicidal Behaviour
Unfortunately, depression is a common mental condition
that can open the gateway to even more serious conditions such as
Major Depressive Disorder (MDD), otherwise known as clinical or
unipolar depression. This condition is usually a crucial casual
element of suicidal behaviour (Dwivedi 2009). We know that
epigenetics is a factor in susceptibility to depression, MDD,
suicidal behaviours, as well as other psychological disorders.
Programmed cell death, or apoptosis, can be caused by pan75
neurotrophin receptor impairment. Neurotrophins, are proteins that
help to maintain the function, growth and survival of neurons. The
methylation status of BDNF and pan75 is linked: low activity of
the BDNF gene impairs the availability of the pan75 receptor.
Suicidal behaviour is also associated with lower expression of the
BDNF gene and the TrkB receptor. The reduced expression of both
of the genes is partly due to methylation changes that are
detectable in autopsy specimens of suicide victims. Clearly,
suicidal behaviour may have a more complex etiology than
formerly supposed (Dwivedi 2009). The experience of depression
and its consequent effects upon the epigenome are not tied solely
to the individual who experiences them. Recall in the beginning of
the chapter we explored the epigenetic effects of depressed
mothers on fetuses during gestation. This kind of cyclical
epigenetics is part of what makes causative relationships so
extremely difficult to define.
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CASE STUDY 6.4 – Post Traumatic Stress Disorder (PTSD)
Adverse social environments, in utero challenges to infant biology,
a history of familial PTSD, and traumatic childhood experiences such as
sexual or physical abuse are all ways in which epigenetic mechanisms play
a role when it comes to vulnerability to PTSD (Yehuda and Bierer 2009).
We, like rats, are all born with a pre-programed attachment system
allowing us to identify, remember, and bond with our primary caregivers.
In a healthy environment, the caregiver is strongly associated with safety,
effectively turning off fear. On the other hand, in an abusive environment,
a child can become desensitized to the difference between safety and fear.
Instead of turning off fear, the attachment system turns off the ability to
fear, because no matter what we always seek out attachment in early life
(Sullivan and Lasley 2010). In rats, Sullivan and Lasley (2010) found that
once the rats became older and started to venture from the nest, their
ability to learn fear from outside the nest functioned properly and they
demonstrated behaviour comparable to repressing and possibly snuffing
out previous fear, avoidance, maybe even memories, associated with the
nest. The same could be thought to occur in adults who experienced abuse
as children (Sullivan and Lasley 2010). The likelihood of an underlying
epigenetic connection is a topic for further research.

6.8 Conclusions
Evidently, some conditions might not necessarily be the
consequences solely of our life choices – we may inherit
predilections from our progenitors and environment. This raises
the question of whether epigenetic mechanisms will be used as a
scapegoat. Will we take responsibility for what we can control, or
will we evade it claiming that ultimately our health and behaviour
is the fault of various external drivers of our methylation status?
Because methylation can change over a lifetime and generations, it
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is extremely difficult to know which epigenetic markers are
inherited, which are acquired through our own life choices, nor
which are combinations of both and to what degree.
Remediation is not necessarily impossible: when two
Agouti mice homozygous for the Agouti mutation mate and
conceive pups, the pups will inherit the Agouti coat colour and
obesity traits. However, if during pregnancy, the mother is fed a
methyl-rich diet, it changes the activity of the Agouti gene. In this
case, too, methylation patterns can be improved (Waterland and
Jirtle, 2003). Epigenetic alterations can be large or small. They can
affect any chromosomal region, and thereby alter patterns of gene
expression. We have only begun exploring all of the epigenetic
pathways connecting environment, gene expression, and
behaviour.
So what is a responsible strategy to pursue if we want to be
healthy and to provide the best for our prospective descendants?
We should live in a way that promotes our own epigenetic health
and be considerate of the epigenetic health of prospective future
children. Unfortunately, the epigenetic disadvantages that we
inherit, we must live with, however, if we are proactive with regard
to diet, behaviour, and environment, then perhaps these
disadvantages will not affect us as severely, or perhaps they can be
reversed. The field of epigenetics provides a deeper understanding
of human biology and psychology and it poses both difficult
questions as well as promising possibilities.
Provocative Questions
 Who is at fault when it comes to epigenetic disadvantages,
especially ones resulting in major deficiencies? Should
there be a law outlining legal epigenetic responsibility?
 Infertility treatments – Are they worth the risk and cost?
 Birth control – do formulations of the pill cause cancer via
epigenetic means? What are the long term effects of the
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pill, both for the individual, her offspring, and the
environment?
How much should we worry about estrogen and mimics in
the environment – how severe will their effects be upon our
epigenetic health, reproduction, and development?
There seems to be a strong case for breastfeeding and birth
free of medical intervention. Will epigenetic research push
women to decide against epidurals and scheduled Csections? Who gets to decide?
How do we deal with pre-conception damage and liability?
Should we?
Could targeted treatment reverse methylation changes and
therefore cure psychological disorders like PTSD and
MDD (massive depressive disorder)?
Allocating legal epigenetic responsibility could potentially
necessitate extremely intrusive laws and policies that
overwrite parental freedoms to varying degrees. How far
should we go?

Possible Solutions
 Many
consequences
of
Assisted
Reproductive
Technologies are still unknown. A focus must be turned to
educating parents on all potential deleterious effects of
fertility treatment options so informed decisions can be
made. Long term studies spanning generations should
follow-up IVF/ART progeny.
 Birth control may provide the conditions in the body where
vulnerability to breast cancer is higher and susceptibility to
ovarian cancer is lower. However, we do not know exactly
what effects birth control has on eggs in the ovary – more
study is needed.
 A mother always has the right to have an epidural, or refuse
it. Her right to her own birth experience, and her own
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assessment of pain she can or cannot handle, should not be
compromised. Pain is scary, and this makes birth scary. The
more women learn about physiological birth and the
disruption of natural epigenetic processes, the better. With
the proper care and intrapartum support, women will be
endowed with better tools to make informed decisions.
Novel treatments for psychological ailments such as
depression and PTSD as well as physical disorders will be a
future avenue for epigenetic study. Ethical concerns will
inevitably surround epigenetic treatment since behavioural
modification has a history fraught with baggage. As in the
case of human fetal subjects, determining the effectiveness
of epigenetic treatment in humans will inevitably begin in
animal models and move to human clinical trials.
Education needs to be pursued in a comprehensive,
continuous, and evolving way to enable all stakeholders to
make informed decisions, and help to construct fair
regulatory, social, and legal frameworks.
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Chapter 7
The Epigenetics of Opportunity: Culture
and Socialization
Nadia Timperio, Kaylyn Tobin, Jessica Hebert, and
Aaron Hegazi

Abstract
This chapter will explore the effects that culture can have on an
individual’s epigenome, as well as how an individual’s epigenome
may affect her place in society. For example, obesity, addiction, and
depression plague traditionally marginalized demographics, but their
persistence throughout generations may have epigenetic roots. We
have known for a long time that mothers who smoke or suffer from
depression tend to give birth to babies with lower birth weights, but
we now know that this effect is correlated with measureable
epigenetic changes in the infant. Additionally, maternal care during
early childhood can cause demethylation: poorly nurtured rats display
poor parental care themselves and treat their own pups badly, thereby
perpetuating the cycle. Moreover, stress, fear, and drug addiction can
have trans-generational effects on the epigenome, at least some of
which might be reversed through diet. Finally, surveys are now
demonstrating that socioeconomic status and exposure to aggression
exerts effects upon the epigenome. Given that the human genome is
now known to hold lineage-dependent differences, some investigators
have interrogated the role of race in epigenetic modification. We
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discuss how these studies lack a fulsome analysis of non-biological
differences: components of culture such as diet, geographic location,
and social/religious practices are likely to be playing a confounding
role. We conclude with a discussion of culture’s place in the study of
epigenetics, and outline some of the challenges that society will have
to face when epigenetics is integrated into how we understand culture.

7.1 Introduction
Humans exist and act both within a biological sphere as
well as within a well-established social arena. Humans shape and
guide society to fit their needs, but epigenetics now provides a tool
that permits us to see how the societies we build can in turn affect
us on a biological level. Conceptually, this is not new: genetically
similar links have been long understood – for example lactose
tolerance. Lactose tolerance is the result of genetic mutations that
arose and conferred an advantage as humans developed agrarian
societies (Laland et al. 2001). This genetic change was the result
of a random mutation that became fixed by a cultural shift towards
the domestication of livestock. The use of milk as a food source,
where lactose tolerance could accommodate it, provided a reliable
dietary supplement that rendered populations more likely to
survive and propagate the genetic trait (Laland et al. 2001). Natural
selection usually takes centuries to change the sequence of DNA
and to produce a beneficial phenotype, however, culture can move
much more quickly, and, as it transpires, so does epigenetics. The
epigenome can change within a single generation (Szyf 2007;
Dupras et al. 2012). Moreover, it is sometimes reversible and
provides a flexible framework that can keep up with frequent
cultural or ecological shifts. In sum, the epigenome provides a
direct biochemical mechanism that links the influence of
constructed environmental attributes, both physical and social,
with the long-term packaging and behavioural patterns of our
genes.
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Among the most significant components of existing social
frameworks is culture. Culture informs patterns of child nurturing
and rearing, as well as patterns of organized behaviour, diets,
socioeconomic stratification, and education. Culture refuses simple
definition, but at its simplest, it can be considered to be a
constructed framework of interacting elements that include world
views, beliefs, traditions, artifacts and behaviours. These concepts
are transmitted between generations and other cultural groups
through social learning (Laland et al. 2001). Thus, culture can be
simplified as a fluid collection of learned traits, artifacts, and
practices that help to express, and at times codify, an individual’s
behaviour.
Considering that enculturation is achieved
predominantly through social means, culture can be considered to
be among the most potent mediums for addressing the effect of the
social environment on the epigenome.
In order to facilitate research, the sometimes nebulous
concept of culture is often broken into discrete components to
permit quantitative measurement (Laland et al. 2001). Cultural
focal points for investigation may include dietary choices, social
and physical activities (examples include drinking, smoking,
exercise), religious denomination, and even the geographical
spread of migrating populations (Braam et al. 1998; Laland et al.
2001; Toyooka et al. 2003; Delport and Pollard 2010). The
evidence of socioeconomic impact upon an epigenetic profile
contributes to the larger conversation regarding the role that
socioeconomic status can have upon human health: it adds an
additional layer of complexity upon the interactions that are
manifest in our experience of geographical location, food sources,
disease, climates, and social interactions.
No robust discussion of culture and geography can ignore
issues of race, so the question arises, to what degree are the hardwired genetic underpinnings (haplotypes) that differentiate race
separable from the effects promulgated by cultural practices? This
is understandably one of the more controversial and technically
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challenging elements to distinguish. Indeed, we might even ask if it
is even possible to identify a biologically sensible notion of race in
the context of epigenetic studies? Race and links to epigenetic
health factors have been addressed in the literature, however we
will argue that some researchers have been too quick to claim that
the minute biological differences between races have can explain
epigenetic differences between populations.
The influence that maternal care, cultural practices,
socioeconomic status, geographic location, and race have in
facilitating changes to the epigenome will be addressed
sequentially while we will also highlight the intricacy of their
interactions. We will discuss potential avenues through which
continued research and greater education concerning cultural
effects upon the epigenome could be broadcast to benefit the larger
community.
7.2 Socioeconomic Status and the Epigenome
7.2.1 Introduction to SES-methylation patterns and research
methods
Socioeconomic status (SES) is a term that attempts to
quantify level of opportunity/life chances that an individual or
family enjoys, and it takes into account their hierarchical position
in society, occupation, education level, and affluence. Not
surprisingly, SES is tied to health, with individuals in less
privileged socioeconomic positions more likely to be afflicted with
multiple chronic health disorders up to 15 years earlier than
individuals who occupy higher socioeconomic strata. (Barnett et al.
2012). Certain illnesses, such as heart disease, diabetes, and mental
illness, are known to affect those with low SES at greater
frequency compared to the more advantaged members of society
(Adkins et al. 2011). Recently, research has examined the
epigenetic mechanisms by which socioeconomic factors influence
human gene expression, and ultimately, health and morbidity.
SES is an important determinant of the quality of one’s life –
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it impinges on life opportunities: access to health care, to healthy
food, to education, to security as well as to opportunity. Low SES
is associated with lower educational attainments, and lowered
educational achievements are a predictor of employment status and
income – a self fulfilling cycle. Health will likely suffer if one is
born into a poorer family with a history of lower educational
success. Consider the following scenario. As far back as 1999, in
an isured household in the U.S., if one was diagnosed with a
serious health problem, the individual, on average, will lose about
$17,000 in out-of-pocket healthcare expenses and employment
over the next year, not to mention the years following (Smith,
1999). A decrease in the individual’s ability to work, in
combination with medical costs, results in the reduction of SES.
Evidence of direct inheritance of poor health and opportunity is
sparse, but social epidemiology at the statistical level provides
support to these claims (Loi et al. 2013).
Factors that affect patterns of DNA methylation include
diet, lifestyle, cigarette smoking, and insufficient maternal care or
diet. Other epigenetic modifiers, such as exposures to harmful
substances such as water pollutants, pesticides, and other
environmental toxins, are linked to poor SES and related suboptimal geographical location and substandard living conditions
(Rothstein et al. 2009). It is becoming clear that these factors can
have adverse effects on populations via stable epigenetic changes,
increasing risk in individuals and to specific strata of socioeconomic cohorts (Rothstein et al. 2009). To better understand the
influence that epigenetics can have on socioeconomic status, and
how researchers can correlate methylation and socioeconomic
status, consider the case study of the pSoBid cohort in the Case
Study below.
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CASE STUDY: Epigenetics in the pSoBid Cohort
Glasgow experiences high levels and distribution of
population morbidity and mortality that cannot be explained by
conventional risk factors. McGuinness et al. (2012) found an
association between the SES of an individual and global DNA
methylation patterns. The test subjects were a subset of the
pSoBid cohort, a cross-sectional population-based study
established in 2005 by the Glasgow Centre for Population
Health (GCPH). The study was designed to track and
investigate the psychological, behavioural, and biological
determinants of ill health. Researchers hypothesized that social
deprivation would be associated with a reduced methylation in
the genome (i.e. hypomethylation) and that this would
consequently account for enhanced inflammation and increased
risk for disease, specifically cardiovascular disease (CVD).
Participants in the study comprised a subset of 239
participants (from a cohort of 666) that provided DNA for
analysis. Participants were ranked using multiple deprivation
indicators to define most and least deprived areas in Glasgow.
The criteria were based on the Scottish Index for Multiple
Deprivation (SIMD). Participants were then stratified so as to
maintain a comparable distribution as in the original cohort.
Other lifestyle factors such as diet, cigarette smoking status, and
alcohol consumption were added to the base model, which
already consisted of age, gender, and deprivation group.
Following the extraction of DNA from peripheral blood
leukocytes, a qualitative and quantitative analysis of DNA was
performed. Researchers measured total DNA methylation level
in blood samples as a percentage of the total DNA present. This
method of analysis, therefore, did not reveal specific patterns of
methylation that are associated with particular traits, but served
as a general indicator of methylation extent and of epigenetic
health.
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Researchers applied linear regression models to reveal
associations between global DNA methylation and SES lifestyle
factors. Results showed that the middle age group, aged 45-54
years were the least methylated of the three age categories, and
16% less methylated than the youngest age group, 35-44 years
old, and 10% less methylated than the 55-64 year old age group.
The most socioeconomically deprived group was found to be
17% hypomethylated relative to the more privileged. Manual
workers showed 24% more hypomethylation than non-manual
working counterparts. Each year of education attained resulted
in as much as 2.4% more methylation relative to less-educated
participants.
Researchers analyzed sixteen biomarkers in hopes of
finding a particular biomarker to help link socioeconomic status
to risk of cardiovascular disease (CVD). Interleukin-6 (IL-6)
and fibrinogen were studied in depth because they showed
inverse relationships with respect to an increase in methylation.
IL-6 had its greatest decrease by 20% in the oldest age group,
whereas fibrinogen had its largest decrease by 7% in the
youngest age group. Neither IL-6 nor fibrinogens were affected
by any of the other lifestyle factors; therefore, any variable
besides the base model, consisting of age, gender, and
deprivation, had no effect on the amount of IL-6 and fibrinogen
present. Since IL-6 is a biomarker of heart disease, its
expression suggests a relationship between global DNA
methylation and systemic inflammation (McGuinness et al.
2012).

In summary, global DNA hypo-methylation was associated
with the most deprived participants. DNA hypo-methylation found
in the most deprived could be the result of diet over a lifetime, or
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during in utero development, environmental exposures, or any
combination of factors (McGuinness et al. 2012). Although these
are important findings, global methylation levels help little when it
comes to pinpointing causal chains between the factors measured –
effects could be indirect or coincidental (Landecker and Panofsky
2013). Another challenge the study presents is the limitations
presented by the sample size; participants used for the study only
represented the bottom 5% and top 20% of Scottish Index for
Multiple Deprivation score. Ethnicity was not accounted for, the
only related criteria deployed was to select for English speakers.
The assumption was that the Glasgow cohort was ethnically mixed
to an extent comparable to Liverpool and Manchester, where
morbidity was not as severe. This could probably not be argued to
represent the full population spectrum. Precisely why Glasgow
citizens experience such a prevalence of cardiovascular disease
remains uncertain, however, further studies concerning the
relationship between hypo-methylation and increased expression of
biomarkers should contribute to this conversation.
Similar studies corroborate these findings. Borghol et al.
(2012) chose to focus on the regulatory sequences of specific genes
to see if associations between childhood socioeconomic status and
DNA methylation in adults could be identified (Borghol et al.
2012). Participants for the study came from the British Birth
Cohort Study, an ongoing, longitudinal study, tracking males born
in the same week during 1958. Researchers collected samples
from forty males, aged forty-five years old at the time, and
analyzed data based on participants’ SESs in both childhood and
adulthood. They were able to identify 1252 gene promoters whose
methylation levels are associated with childhood SES (666 in high
SES and 586 in low SES) and 545 associated with adult SES.
Intriguingly, there was little overlap in the differentially
methylated promoters associated with childhood versus adult SES
(Borghol et al. 2012). Moreover, they also found clustering in
specific regions of the genome linked to specific functions; in low
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SES individuals, there was evidence of higher methylation, and
thus repression, of sensory perception of smell and taste. Since
DNA was only available in adulthood, it is unknown whether the
methylation occurred in childhood, or if findings reflect
experiences delivered in the prenatal environment. Further
investigations exploring the relationship between pre-natal,
childhood, and adult socioeconomic status health warrants future
attention.
7.2.2 Socioeconomic Status and Diet
In the United States, being socioeconomically disadvantaged
correlates with a higher likelihood of obesity: a lack of healthy
food stores, safety, and places to exercise were the main factors
holding back the disadvantaged (Lovasi et al. 2009; Rundle et al.
2009). Dietary choices are guided by many factors: economics,
geography and cultural practices to name a few. In recent history,
changes to the human diet (particularly in North America) have
corresponded with a cultural shift from a nomadic lifestyle towards
extreme sedentarism. This transition was facilitated largely by
agricultural surplus and high carbohydrate/sugar diets (Chapter 4).
Delport et al. (2010) specifically identify obesity as a product of
both biological and cultural forces. Obesity can perpetuate itself
trans-generationally through epigenetics, which can in turn make it
even harder to escape the socioeconomic factors that can
contribute to obesity: a Swedish study of 700,000 found that obese
males performed significantly worse in school even when adjusting
for intelligence and socioeconomic position. This discrepancy is
attributed to discrimination in the educational system and general
society (Delport and Pollard 2010).
The trans-generational effect of maternal food choices is
associated with circulating levels of the hormone leptin, a protein
that originates from adipocytes (fat cells) and plays a vital role in
determining an individual’s appetite via the hypothalamus.
Energy-dense and highly processed diets during the third trimester
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of pregnancy can cause the up-regulation of lipid transport across
placental membrane. This will cause the fetus to develop more fat
cells within its adipose tissue. As a consequence of the high fat
intake and the increased leptin levels, the child will likely be born
heavier and with an increased appetite during post-natal
development. In adulthood, the expression of numerous genes
within adipose tissue has been implicated in an individual’s body
mass index (BMI) calculations (including the methylation of leptin
promoters), so it appears that epigenetically-driven phenotypic
changes may account for body weight changes (Stoger 2008).
Socioeconomic status and culture not only affect diet
content, but also meal frequency. The reality for many of the
socioeconomically disadvantaged is not lack of food but
inconsistent access and poor quality (Oldewage-Theron et al.
2006). Could there be an epigenetic consequence to consistent
short term fasting, even if an individual does not starve? Funato et
al. (2011) conducted research on the effects of fasting on the
expression of histone deacetylase (HDAC) within mice. You will
recall from Chapter 2 that HDACs are responsible for histone
acetylation at specific genomic sequences to either repress or
enhance gene activity, a function that has been previously linked to
behavioural changes (Funato et al. 2011). The latter results
showed that dietary alterations have an impact on the expression of
different HDAC transcripts (numbered 1-11) in the medial
hypothalamus, an area of the brain responsible for regulating
eating and body-weight (Funato et al., 2011). After 16 hours of
fasting, there was an increase in HDAC3 and HDAC4 expression
and a decrease in the normally high hypothalamic levels of
HDAC10 and HDAC11.
Other effects of fasting include the decrease in HDAC8
expression in a portion of the hypothalamus previously shown by
other studies to exhibit changes in the expression of proteins
associated with feeding behaviour (such as TRH: thyrotropinereleasing hormone). Another area of the hypothalamus involved in
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aggression and reproductive activity was shown in this study to
exhibit lower histone acetylation levels. Cumulatively, these
effects indicate the extensive impact that fasting can have on
expression levels in the brain, with meal time influencing a variety
of potential functions ranging from eating patterns and homeostasis
to aggressive and reproductive behaviour (Funato et al. 2011).
Xu et al. (2012) addressed the impact of fasting on 3-day old
chicks at both 6 and 24 hour fasting lengths. Like Funato et al.
(2011), Xu et al.’s (2012) research showed changes in expression
levels within the hypothalamus. The study focused on the
methylation of histone 3 at a specific amino acid: lysine 27, here
referred to as H3K27. Fasting resulted in the significant increase
in di- and tri-methylation of H3K27. EZH2, the H3K27-specific
histone methyltransferase (HMT) responsible for the transfer of
methyl groups to lysine, showed an increase in concert with the
increased methylation (Xu et al., 2012). This alteration occurs
within the pre-optic/anterior region of the hypothalamus, an area
associated with maintenance of body temperature and feeding.
This is similar to the functions of the hypothalamic locations
addressed in Funato et al.’s (2011) research (Xu et al. 2012).
Alongside these methylation events, a significant increase in
thyrotropin-releasing hormone, an integral component to the
metabolism-regulating
hypothalamic-pituitary-thyroid
axis,
occurred after 24 hours of fasting (Xu et al. 2012). Fasting
appears, therefore, to have an influence on metabolic regulation,
particularly during early chick development.
Although these mechanisms and results cannot necessarily be
directly applied to humans, they still serve to display the profound
effect of diet on the epigenome and indicate the potential for
human fasting practices to likewise produce epigenetic effects.
Short-term fasting as a religious activity, however, is common; it is
a component to belief systems such as Christianity, Islam, Judaism,
and others. Since Funato et al. (2011) and Xu et al. (2012)
discovered alterations to the epigenome in mice and chicks after
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fasting durations of less than twenty-four hours, there is potential
for short-term and culturally motivated fasting in religiously
observant humans to also impinge on the epigenome.
7.3 Epigenetic Factors, Culture and the Mental State
7.3.1 Early childhood, stress, depression, and anxiety
There is a strong, consistent correlation between mental
illness and low socioeconomic status, and while this link is not
necessarily causative, nevertheless the relationship suggests a
connection (Hudson 2005). Certainly, those who are mentally ill
and have a low SES will have worse health than people who have
the same mental illness but have a higher SES (Barnett et al. 2012).
Mental illness also presents a vicious cycle, since by its nature it
can limit opportunities for social mobility, not to mention adding
to burdens by attaching a cultural stigma. The study of mental
health stands to benefit greatly from ongoing research into
epigenetics. While personality and mental disorders have clear
roots in genetics, there are still many environmental factors that
shape who we are.
Maternal behaviour can be inherited by female offspring.
Sapolsky et al. (2004) found that rat pups that experienced high
levels of licking and grooming from their mothers grew up to be
mothers who licked, groomed, and cared for their own pups well.
Demethylation and acetylation responses were a direct
consequence of maternal care and caused permanent and heritable
changes to the epigenetic packaging of specific gene loci that
influenced behaviour later in life (Sapolsky 2004). Specifically,
pups that experience high quality grooming have increased
serotonin levels and demethylation of the glucocorticoid receptor
gene. This in turn results in more glucocorticoid receptors being
expressed in the brain, and
lower levels of circulating
glucocorticoid, a stress-related hormone (see figure 7.1).
Ultimately, high quality maternal grooming behaviour and a
greater resilience to stress emerged (Sapolsky 2004). Weaver et al.
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(2008) discovered that reciprocal fostering of pups by good and
bad mothers reversed the imprints inherited by the pups. So, if they
had a mother who maltreated them, despite whether she was a
biological or foster mother, the rat grew up to be a bad mother and
to have a lower capacity to cope with stress. If the infant had a
mother who licked, groomed, and cared for them properly, despite
whether she was a biological or foster mother, the rat grew up to be
a good mother, and in turn passed this trait onto her young
(Weaver et al. 2005).
Increased serotonin
in pup
Mother rat exhibits
high licking/grooming
behaviour

Increased expression of
NGF1-A in
hippocampus of pup

Happy pup
NGF1-A

Demethylation of and
acetylation of histones
around glucocorticoid
receptor gene

GR

Pup as an adult =
High licking/grooming
behaviour

Figure 7.1 Epigenetic mechanisms associated with imprinting of
high licking/grooming behaviour. Adapted from Sapolsky, 2004.
Rat pups who experienced high levels of licking/grooming from
their caregivers demonstrated increased expression of NGF1-A
in the hippocampus as well as a demethylation of and acetylation
of the histones around the glucocorticoid receptor gene. These
two conditions combined result in adult (previous pups)
expression high hippocampal glucocorticoid receptors, low
glucocorticoid levels, and ultimately high licking/grooming
behaviour toward their own pups. Epigenetic imprints due to
maternal care behaviour remain throughout the rats’ lives and
impact their own mothering style.

In another study, investigators studied infant rats reared by
either a good or a negligent mother (Blaze et al. 2013). Like
Weaver et al. (2008), they discovered that depending upon whether
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the rats were reared by a biological parent or fostered, the female
pups would be imprinted as good or bad mothers by the context of
their conditions, and grow up to perpetuate that legacy (Figure
7.1). These behaviour differences, as well a sensitivity to stress,
were linked to epigenetic imprinting of the stress-related
glucocorticoid receptor gene (Weaver et al., 2008). Interestingly,
Blaze et al. (2013) also found increases in methylation of the
regulatory region of the gene for brain-derived neurotrophic
factor (BDNF) in both males and females of the foster groups
despite the nurturing environment. Finding increased methylation
in the maltreated groups was expected. The BDNF gene encodes
brain-derived neurotrophic factor, a member of the neurotrophin
family of proteins that assist in nerve growth and maintenance.
BDNF regulates patterns of neuronal sprouting and connectivity.
Changes in methylation of BDNF are associated with high levels
of stress-induced release of glucocorticoid. In this case, even the
stress of being pulled away from their biological mother was
enough to induce methylation of the BDNF gene (Blaze et al.,
2013).
Abnormal packaging of the BDNF gene is a significant but
small piece of evidence showing that early life trauma can have
long-term consequences for brain wiring, and consequently also
for behaviour (Roth and Sweatt 2011). Mice that are reared in a
communal nest and that enjoy surplus maternal attention and care
grow up to enjoy a predilection for adult social interactions,
specifically ones that coincide with higher hippocampal BDNF
protein levels (Branchi 2009; Branchi et al. 2009). By contrast,
stress induces hippocampal atrophy, thought to be mediated by
BDNF, and depression is the result (Warner-Schmidt and Duman
2006). The hippocampus is the brain region that forms and stores
cue and context stimuli learned from fear conditioning, and that
processes information from short-term to long-term memory.
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Figure 7.2 Maternal care behaviours exhibited in the three study
group mothers.
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A – caregiver was a good biological mother B – caregiver was a
good foster mother to a pup from a poor one, and C – environment
imposes maltreatment conditions. Adapted from Blaze et al., 2013.
Biological relation to pups made no significant difference in caring
behaviour in a normal environment. It could be hypothesized that
the cross-foster rat pups still received the imprint of good mothering
despite the stress-induced methylation from being pulled away from
their biological mother.

In mice, both male and female offspring of socially
defeated fathers exhibit depression and anxiety-like behavior.
Interestingly, these results were not usually observed when the
offspring were created via IVF (Dietz et al. 2011). This could
suggest that the epigenetic modification inherited by the offspring
to induce the depressive or anxious behaviour is inherited when
fertilization occurs in the fallopian tube and the natural process of
implantation ensues. Alternatively, it could be hypothesized that
the IVF process sometimes reverses or overwrites the epigenetic
change inherited from the father.
Chronic and unpredictable maternal separation experienced
by infant mice induces depressive-like behavior, and the male pups
that experience maternal separation pass this behavior onto their
offspring (Franklin et al. 2010). This is related to a phenomenon
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called learned fear. If something repeatedly results in a negative or
harmful outcome, an association is made between the event and the
outcome, usually resulting in fear of that particular event.
Normally, remembering danger is absolutely necessary for
survival, so early memories based on fear cannot be overwritten
and therefore will persist over the lifespan (Sullivan and Lasley
2010). Should this learning by fear give rise to any epigenetic
modifications, they could be inherited by future offspring.
For example, the regulation of chromatin structure and
DNA methylation is an important manager of gene transcription in
the central nervous system: Zovkic and Sweatt (2013) found
methylation changes in factors affecting the transcription of genes
in the hippocampus. These changes also have the potential to be
inherited. Therefore, if a parent learns a fear trigger and this causes
alterations in chromatin structure and DNA methylation, the
offspring could inherit these modifications and his or her
hippocampus could develop so that it is more or less sensitive to
the same stimulus as the parent (Zovkic and Sweatt 2013). This
learned fear is also correlated with post traumatic stress disorder
(PTSD) (Takei et al. 2011).
Early experiences are not the only way for epigenetic
modifications to occur around DNA. Traumatic stress that occurs
in adult rats can induce central nervous system gene methylation
(Branchi 2009; Branchi et al. 2009; Roth et al. 2011).
Hippocampal dysfunction in adults is also a response to traumatic
stress that may be caused by epigenetic changes to the BDNF gene
(Roth et al. 2011). It is reasonable to hypothesize that these brain
and nervous system gene methylation patterns also happen in
humans not only during childhood, but also in adulthood (Roth et
al. 2011). Interestingly, susceptibility to PTSD in children of
traumatized parents appears to reveal an epigenetic dimension that
is trans-generational. For example adults whose parents survived
the Holocaust were more susceptible to PTSD and recovered more
quickly than their control counterparts (Yehuda et al., 2015; also
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see chapter 6, specifically Case Study 6.4)
After Roth et al. (2011) found increased methylation in
stressed rats compared to non-stressed rats, Roth and Sweatt
(2010) hypothesized that a drug with the ability to reverse
methylation may also reverse the abnormally low BDNF
expression. After administration of a demethylating drug, BDNF
was restored to normal in the stressed rats (Roth and Sweatt 2011).
There is potential to reverse the behavioural consequence of this
methylation, thus opening up novel treatment options for PTSD
and other psychological conditions linked with epigenetic
mechanisms. Weaver et al. (2005) also saw some success in
methylation treatment in adult rats. In this case, they added dietary
methyl donors to restore normal maternal parenting skills and
stress responsiveness, thereby reversing the epigenetic effect of
maternal behaviour on offspring DNA (Weaver et al. 2005).
Further research needs to be done to determine if the reversion of
normal expression in the adult brain directly results in reversion to
normal maternal care behaviour as well.
These experiments all find epigenetic causes of traits linked
with depression, anxiety and PTSD, providing scientific context
for the common wisdom that early childhood nurturing is
important for proper growth. Should these mechanisms prove
persistent in the human epigenome, they would have implications
for family structure decisions. This information would place more
pressure on parents to stay home with their children, which for
many is not an economically viable choice. The trans-generational
effect of early nurturing would also help to contribute to a poverty
loop. The solutions seem simple however (albeit difficult to
implement depending on the political climate): either increased
paid parental leave or increased access to high quality preschool.
7.3.2 Aggression
Another element of stress is the experience of aggression.
Recent evidence suggests that DNA methylation of both cytokine
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gene regulatory regions, and the transcription factor genes that
regulate them, operate in response to environmental factors, such
as social signals and parental behaviour (Provencal et al. 2013a).
Cytokines are important signaling molecules for the immune
system. Boys who maintain high levels of aggressive behaviour
from kindergarten, through to adolescence, tend to be “impulsive,
hyperactive, oppositional and rejected by their peers”. Oftentimes,
the domestic environment and familial relations of these
individuals fail to encourage emotional regulation (Provencal et al.
2013a). The hypothesis was that stressful early life experiences
are associated with methylation changes that could contribute to a
chronic physical aggressive (CPA) trajectory. Recognizing the
prevalence of physical aggression in this cohort of young boys,
Provençal et al. (2013a) set out to test levels of cytokines in the
blood with long-term regulation of physical aggression in them as
young male adults (Provencal et al. 2013b).
Two groups were part of the study: one group of seven males
on a CPA trajectory and one control group of twenty-five males on
a normal trajectory. Aggressive behaviour was monitored by
schoolteachers each year from ages six to fifteen. Provençal et al.
(2013a) analyzed DNA methylation profiles of five cytokine genes
that were known to show lower plasma levels in aggressive males.
The methylation study employed blood samples taken from the
males after they reached adulthood (Provencal et al. 2013b).
Teacher-assessed hyperactivity and opposition disorder during
childhood and adolescence predisposed the males in the CPA
group to aggressive behaviour into early adulthood. 71% of the
CPA group had a criminal record by age twenty-one, compared to
20% of the control group, and 57% of the CPA group reported acts
of physical violence by the age of twenty-one, compared to 10% of
the control group (Provencal et al. 2013a). Clearly early patterns of
behaviour tend to predispose to similar patterns in adult life.
Tests for associations between DNA methylation and
cytokine levels revealed 48 differentially methylated regions
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associated with aggression (Provencal et al. 2013b; Provencal et al.
2014). Measured twice, at ages 26 and 28, for both the CPA and
control group, the CPA group showed higher methylation and
significantly lower concentrations of inflammatory cytokines when
compared to the control group. The study found agreement with
literature suggesting that associations exist between cytokines and
CPA, suggesting that there was an inflammatory immune response
elicited by conditions of aggression behavior and oppositional
environments (Provencal et al. 2014) Their results also
demonstrate the value of conducting gene-wide analysis of DNA
methylation; restricting their observations solely to gene regulatory
regions would not have allowed them to identify many of the
differentially methylated areas implicated (Provençal et al.,
2013b). This suggests that future research in the field should not
limit analyses to known promoter regions.
Provençal et al. (2013a) only tested adult blood samples and
therefore had no way of determining when aggressive behaviour
becomes associated with methylation and cytokine levels in
humans. It should also be noted that the methylation tests were
made using blood samples, and are correlational – no assay could
be made of brain tissues that would be more directly indicative of
gene function in cells of the brain.
This study and others
highlighted within this chapter suggest that early experiences can
have lifelong effects on individuals, but it is still unknown when
methylation and demethylation begins and how patterns of
methylation change throughout developmental growth, through
infancy to adulthood. Finally, given that these studies were
performed using a cohort that lived within a particular sub-district
of Montreal, in the future it might be interesting to examine the
role of habitat quality and physical environment as a contributing
factor.

7.3.3 Addiction
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Even when mental illnesses are not caused by epigenetics,
epigenetic changes to the mental state can make life significantly
harder for some people, especially those disadvantaged. Consider
that increased aggression is one of the most significant mental
factors in delinquency (Nagin and Tremblay 1999). Addiction to
illegal substances physically compels people to commit illegal
acts. Status as a criminal severely impacts one’s position within
their culture and social sphere, and can prevent already
disadvantaged people from being able to find jobs or education
opportunities. Many current prisons do not place an emphasis on
rehabilitation, but how much blame can be placed on someone
with the deck stacked against them biologically?
Misuse of drugs and alcohol is a common factor in criminal
behaviour, especially since most “recreational” drugs are illegal.
Now, studies demonstrate that drug and alcohol misuse could have
an epigenetic dimension that provides a mechanism for
transmission of addiction behavior across generations. Repeated
abuse of drugs results in persistent epigenetic changes that could
play a role in long-lasting alterations in behaviour. Byrnes et al.
(2013) exposed rats to morphine during adolescence, before they
began reproducing. Their eventual offspring had no fetal exposure
to the drug, but nevertheless inherited weakened locomotor
sensitization even after being treated with a drug to increase
locomotion. The grandchildren of the original morphine-exposed
rats, also inherited weakened locomotor sensitization. In humans,
this could imply greater vulnerability to addiction (Byrnes et al.
2013).
Epigenetic changes might also provide targets for new
treatment plans including reversal of addiction (McQuown and
Wood 2010; Wong et al. 2011). There is potential for epigenetic
reversal: Weaver et al. (2005) were able to reverse epigenetic
changes to the stress hormone receptor in rats by feeding them a
methyl-rich diet to reverse the demethylation of DNA. In this
study, stress-induced behaviour was also reversed (Weaver et al.
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2005).
Needless to say, epigenetic effects are not necessarily going
to be confined to illegal and addictive drugs: prescribed
medications also have effects - recall the example of the estrogen
mimic DES (in Chapters 5 and 8). Presently though, the evidence
for trans-generational effects has been more thoroughly elucidated
with respect to addictions, and in rodent models.
More and more, we see a combination of the epigenetic
advantages and disadvantages we make for ourselves, and those
that we are born with and born into. Distinguishing between our
choices, what we can control, and our circumstances, at least those
that we cannot control, can be a convoluted puzzle. Let us look
next at a circumstance over which we have no control: our
ethnicity.
7.4 Epigenetics: Race and Ethnicity, or Culture?
7.4.1 Introducing Race and Ethnicity
The terms race and ethnicity, while similar, refer to specific
aspects of the human experience. Race as a concept refers to broad
sets of physical features (such as genetically encoded ranges of
skin colour, facial bone structure) that are associated with the
indigenous people that first flourished in different areas of the
world. Ethnicity, while it is often associated with race, actually
relates to a group of people who express cultural practices, and
who hold beliefs, languages, and family history in common. While
someone who identifies as Irish might have the same race as
someone who identifies as Welsh, their ethnicities inform their
respective cultures much more than their shared “race.”
This distinction is crucial. Ethnicity is a social construction, it
provides cultural and demographic context. Race is arguably also
largely a social construct insofar as people will often self-identify,
but it is only hypothetically a definition that is based upon physical
characteristics – look hard enough at the genome, for example, and
244

Social and Cultural Epigenetics

you will find segregations of specific DNA sequence markers that
correlate with ancestral patterns of dispersion and interbreeding.
These markers, called haplotypes, mix over time, and over
centuries of military, commercial, or social interaction, they have
been exchanged by intermarriage etc. This mixing confuses the
definition of race to the point that for the purposes of our
discussion, it is almost useless. With regard to the mechanistic
processes that contribute to the epigenome, “racial” differences
have been very small and hard to find, and indeed, social
characteristics carry more weight in the identification of factors
that contribute to health predispostions (Kuzawa and Sweet 2009;
Arbour et al. 2012). Ethnicities are useful when looking at a group,
as they give insight into broad traditions or trends that allows for
easier understanding of the actual cause of epigenetic differences.
Racial and ethnic trends are only of interest when used statistically,
almost always when study participants have self-identified
That being said, there is a controversial representation of
racial disparities in the scientific literature as it pertains to
epigenetics. Racial differences are suggested to correlate with
variations in epigenetic profiles in a number of different health
areas. Within a research setting, race is often employed to
determine the etiology and risk factors of diseases. However, the
variability of results that stem from the studies may indicate that
the effectiveness of utilizing race is questionable. Our discussion
will focus on an overview of studies on race that pertain to the
epigenetics of cancer, atherosclerosis, cardiovascular disease, and
methylation alterations made during gestation.
7.4.2 Ethnicity and Epigenetic Studies
One cancer study focused on the tendency for “Hispanic
whites” to have improved survival over “non-Hispanic white” and
“Black” sufferers of non-small cell lung cancer, a cancer that was
addressed above in relation to smoking (Saeed et al. 2012). This
embodied the concept of the “Hispanic paradox”: despite
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demographically existing within the lower socioeconomic tiers
associated with less access to resources, health care, and wealth,
Hispanic whites enjoy a higher survival likelihood. Saeed et al.
(2012) list family structure and lower tendencies to smoke within
this population group as factors in creating this paradox.
Studies with an ethnic dimension have also been conducted on
health issues associated with atherosclerosis and cardiovascular
disease (CVD). Analysis of leukocyte methylation in patients with
atherosclerosis across numerous ethnicities indicates that “white”
and socioeconomically advantaged participants exhibit higher Alu
and lower LINE-1 methylation compared to “African-American”
and “Hispanics” (Subramanyam et al. 2013). Alu and LINE-1
elements are ancestral remnants of retroviral invasion. They were
once thought to be “junk” DNA, but are now known to play a role
in chromosomal structure and gene regulation. They tend to be rich
in CpG sequences and to undergo preferential methylation as a
consequence. The number and distribution of these elements
differs from one individual to the next, as well as between ethnic
groups. Professed shortcomings of this investigation include the
choice of Alu and LINE-1 as the focus of study. They are highly
polymorphic or variable, and their functional significance as
pertains to disease is unknown. As well, leukocytes in the
bloodstream may not necessarily be the direct target of the social
factors of interest in this study, and this could explain the
disparities in results between this and other investigations of
leukocyte methylation (Zhang et al. 2011; Subramanyam et al.
2013). Again, authors list social and cultural behaviours as factors
in shaping the epigenetic differences found in this study
(Subramanyam et al. 2013).
Most of the above studies show correlative relationships
between race and epigenetic alteration patterns. However, an
interesting study conducted on women provides a contrast to the
other investigations addressed thus far. When women across
different racial categories were subjected to controlled folate diets
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(folate has previously been shown to be associated with
methylation – it is part of the vitamin B complex that acts as a
methyl donor), no significant variation in global leukocyte DNA
methylation emerged – a simple dietary supplement superseded al
else (Axume et al. 2007). Thus, race itself was not a significant
factor in the actual mechanism of methylation in humans, rather,
the trends that correlated with race and epigenetic effects more
likely stem from cultural (eg; dietary) differences.
Liu et al. (2010) analyzed 196 individuals from five ethnic
groups - Caucasian, Latino, Native American, African American,
Asian, and mixed populations. They identified a total of four
population specific factors that could differentiate between groups
(Liu et al. 2010). Three of these factors are genetic single
nucleotide polymorphisms (SNPs); differential frequency of each
SNP delineates a different racial category. The fourth was a
population-specific methylation factor. In this case, differential
methylation level was the population determinant: Caucasians had
the highest methylation, followed by Latino and mixed
participants, and lastly Native and African Americans. Despite
this association between race and methylation levels, this factor
only accounted for 0.2% of total methylation variance (Liu et al.
2010). This indicates that despite subtle genetic differences having
an influence on methylation patterns, their role does not appear to
be a large one relative to more substantial factors such as the
environment.
Although this study provides an interesting perspective on
methylation profiles and their connection to race, some aspects
may affect the legitimacy of the results. Firstly, the sample size of
196 participants is small, especially considering the study’s
attempt to divide the individuals into 5-6 ethnic groups. Secondly,
there appears to be a significant over and under-representation of
different ethnicities across the groups: there are numerous
Caucasian and Latino participants while there are few African
American individuals. In the entirety of the study, there is only
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one Asian participant (Liu et al. 2010). These discrepancies in
sample size and quality may have compromised the results and
conclusions of the study.
What can be conveyed by critical analysis of this research
is that racial conclusions in scientific research need to be carefully
evaluated. This does not imply that conclusions linking ethnic
background and epigenetics should be dispelled. Rather, we need
to be sensitive to that fact that multiple elements including
historical background, geography, culture, and social environment
unite to influence epigenetic modifications: race-associated genetic
haplotypes appear to play a relatively minor role.
7.4.3 Race and Geography
Culture is often tied to the geographical location of a
population. This is because cultural traits are learned and
transmitted within both families and communities, and often in
response to environmental cues. As a result, epigenetic alterations
influenced by culture can be patterned in a global sense. The
social and habitual activity of smoking illustrates this connection
between methylation patterns and geography. When comparing
the methylation levels of seven genes associated with non-small
cell lung cancer in Toyooka et al.’s (2002) investigation, the
studied countries were sorted into two groups. Group A consisted
of USA and Australia, while group B encompassed Japan and
Taiwan. Results showed that group A had significantly higher
overall mean methylation index (MI) and higher methylation rates
of the specific genes MGMT and GSTP1 (Toyooka et al. 2003).
Toyooka et al. (2002) cited geography, culture, or race as potential
contributors to the discrepancy.
The data demonstrated
methylation changes that coincide with the act and exposure to
smoking.
Cultural and social norms specific to different
geographic regions may dictate the amount and variety of an
individual’s exposure. Examples of this could include: social
stigmas on smoking near others; whether it is polite to accompany
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someone to smoke; or whether smoking reflects a recreational or
group activity. Relative to smoking health risks, these behaviours
could potentially influence the methylation profile of an individual
or a geographically delimited population.
Just as differences in epigenetics between countries can give
context for the shifts in culture between large populations,
epigenetic anomalies between areas within a country can be vital to
study, especially when dealing with environmental consequences
and xenobiotics (See Chapter 5). Mansfield’s 2012 study of
epigenetics and xenobiotics found that indigenous populations near
bodies of fresh water were exposed to methyl mercury at a high
rate, This toxin has epigenetic consequences and is a common
contaminant of continental fish stocks. Indigenous people are more
likely to be the most frequent consumers of fish as a result of their
economic and cultural status: their proximity to the rivers and fish
stocks that are exploited for subsistence or traditional fishing is an
accident of economics, culture, and geography (Mansfield 2012).
For these populations, fish is a vital and necessary food source.
Government health advisories dispensed advice against fishing in
the waters, but the information given out not only ignores the
cultural dietary patterns of Native Americans, it places the burden
of avoiding the xenobiotic on the people living by the water rather
than the companies or processes that are polluting the lakes. Native
Americans were given a warning that did not accurately reflect
their needs. Moreover it was a warning that they could not act
upon for economic and cultural reasons. In fact, the warning
simply gave the polluters more support: someone ignorant of the
cultural reality of the people affected could make the argument that
the populations were warned against methyl mercury levels. The
burdens of change should not be placed on those who are
powerless to change them.
7.5 Conclusions
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Policymakers and scientists must be incredibly careful that
they understand the intricacies of ethnicity and race, especially as
the world becomes more globalized and diverse. Research needs to
focus on cultures instead of races, and include countries outside of
North America so that we can collectively benefit by knowing the
relationship between epigenetics and cultural factors such as diet,
socioeconomic status, and even the way children are raised. You
cannot change one aspect of society without causing a ripple
effect, and all too often cultural factors reinforce themselves in
feedback loops that are difficult to escape. There are no easy
answers when dealing with the interaction between culture and our
epigenome.
With its focus upon DNA alterations, biology of the
epigenome has been necessarily reductionist in nature:
anthropologist Jorg Niewohner argues that it will be necessary to
broaden perspectives and to question assumptions if the full
complexity and complexion of inputs is to be fully accommodated
(Niewöhner 2011). Niewohner proposes the idea of the “embedded
body”; an entity through which the cumulative contributions of the
social, political, historical, environmental, evolutionary, and
numerous other spheres can be adequately assessed. This method
of redefining the body and the self as an entanglement of external
contexts will guide scientists to expand their field of research
beyond the restrictive focus on purely biomechanical machinery.
He is not alone in his appeal – the genome scientists themselves
are beginning to reference a new concept – the “interactome” (Li et
al. 2014). It is difficult to design experiments that can take such a
myriad of factors into account, but as the field of epigenetics
grows, so too will our understanding of the interaction between the
outside world and the individual’s interior complement of
packaged genes.
Provocative Questions:
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Will holding parents societally responsible for the
epigenetic health of their children disproportionately
burden marginalized or disadvantaged groups?
Will epigenetic research be used to dispel racial
biases, or reinforce them?
Should we alter our epigenome to program a social or
behavioral advantage?
What policies should the government follow
regarding data collection on the epigenetic trends of
certain ethnicities? Should policies be developed to
manipulate epigenetic trends?
Should criminals be treated differently if they are
epigenetically predisposed to crime?
Stress causes epigenetic damage – should all bullying
or intimidation be defined as a form of physical
abuse?
To what extent should governments, healthcare,
social, legal, and educational systems intervene to
educate or even moderate parenting skills and styles?
If there is a family history of addictive behavior,
would it be ethical to market or to administer medical
interventions to treat offspring not yet addicted?

Possible Solutions
 Early education about epigenetics to parents and
children
 Education for policy and law makers
 Epigenetic information freely available and tailored to
specific cultures
 Research focusing on diverse populations across
countries
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Chapter 8
Epigenetics and Law: The Quest For
Justice
Florida Doci, Clare Venney, Candace Spencer, and
Kendall Diemer
Abstract
Epigenetic cases pose problems within the current legal
system. When epigenetic harms occur, individuals should have
recourse to legal action. Laws regarding who can take legal action,
the time frames in which it can be taken, and the roles of various
parties are examined using the challenges of diethylstilbestrol
(DES) as a case study. We examine the ability of the legal system to
encompass epigenetics within the context of statutory limits,
dilution of liability, victim attenuation, and the challenges in
identifying records and of proving direct causation. We then look at
epigenetic harms with respect to testing policies and the directions
in which they should be developed. These include establishing tests
that look at not only epigenetic effects upon individuals, but also
upon the reproductive and trans-generational effects a product might
have. Finally, the chapter considers how privacy law and epigenetic
cases intersect.

8.1 Introduction
Presently, epigenetics is not a term, mechanism, or process
that is explicitly enshrined in law – the concepts and science are
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simply too new, and the implications are too poorly understood.
As we discussed in Chapters 1 and 2, epigenetics involves
modifications to chromatin structure that alter the way that genes
behave without altering the sequence of DNA itself. The
modifications are to attached chemical groups and to associated
proteins, and the informational complexity of the "histone code"
exceeds that of DNA. Some epigenetic imprints are heritable, and
they permit us to record experience of our environment upon the
packaging of genes to alter/prime subsequent behaviour. Diet,
drugs, environmental chemicals, traumatic experience, socioeconomic status, parental care, even education, can affect your
epigenome, and this has implications for your future health.
While genetics has been explicitly addressed in the United
States under the Genetic Information Non-Discrimination act
(GINA), there have been no cases to define whether or not
epigenetics will fall into this same category and be protected. For
example, epigenetic alterations do not change DNA sequence, so
genetic non-discrimination may not apply to epigenetic cases. If
the legal term genetics was expanded to include chromatin – the
assemblage of DNA, RNA, and protein molecules that comprise
chromosomes, then epigenetics would be covered under the act. A
definition of genetic has not been fully explored by the courts. The
few instances where epigenetics has been tested indirectly are in
tort law.
The establishment of liability has specific requirements. A
plaintiff must prove: that a harm has occurred; that the defendant
was, through their inaction or negligent practice, the direct cause;
that the defendant knew, should have known, or was negligent of
the risks to which the plaintiff was exposed; that the complaint is
made within statutory limits. Given the long lag time before
epigenetic effects might become obvious, this class of case will
present huge challenges for injured parties seeking remedy or
compensation. In both the United States as well as in Canada, the
principle of discoverability can introduce a loophole to strict
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statutory limits. Instead, a suit must be brought within a
reasonable timeframe following the first discovery of an effect,
even if this occurs after normal statutory limits have expired.
Epigenetic effects tested to date have become manifest well after
statutory limits have expired, and since they are sometimes transgenerational in nature, the issue of dilution also comes into play. It
can be hard to reconstruct who prescribed, manufactured, or
dispensed a drug, and given the complex and combinatorial nature
of epigenetic imprints, it is also hard to demonstrate direct and
unadulterated cause and effect. The litigation surrounding
diethylstilbestrol (DES) is illustrative of the complexities.
8.1.1 Diethylstilbestrol (DES): a case study in Tort Law
Beginning in 1938 diethylstilbestrol (DES), an
unpatented, low cost synthetic estrogen was being distributed as a
remedy drug for menopausal symptoms, senile and gonorrheal
vaginitis, excessive menstrual bleeding and to suppress lactation
(Downey and Gulley 1983; t Hoen and Dukes 2007). Many
manufacturers that were producing DES eventually began
promoting it for use in the prevention of miscarriage. The FDA
requested that the manufacturers agree upon a standard chemical
formula and uniform labeling, which in 1941 led these companies
to form the “Small Committee” (Downey and Gulley 1983). DES
was widely prescribed to pregnant women for the next three
decades even though there were indications as early as 1947 that
there was a threat of cancer to the user (Mascaro 1991). Women
who had taken DES experienced a 30 – 40 % increased risk of
breast cancer, preterm delivery, pre-eclampsia and miscarriage,
while in utero daughters and sons suffered increased risk of genital
defects and infertility. Between five and ten million individuals
affected by the drug are prone to more than twelve medical
conditions including a higher risk of cancers and infertility (NCI
2011).
The drug was withdrawn in 1971 after it was found to be
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ineffective in preventing miscarriages and was found to be
carcinogenic (t Hoen and Dukes 2007). However only recently, in
the light of epigenetics, have studies revealed the mechanism that
underlies the trans-generational impact of DES including, but not
limited to, increased incidences of cancers and infertility (NCI
2011). DES is known to affect the methylation and therefore the
regulation (but not the DNA sequence), of genes that encode
proteins in the estrogen production pathway. Whether or not it is
these changes that leads to later defects in function remains to be
determined.
8.1.2 Legal Action Concerning DES Effects
One of the first examples of epigenetic harms being
addressed by the legal system occurred in the United States when
mothers and daughters exposed to diethylstilbestrol (DES) began
suing manufacturers for damages due to reproductive problems and
cancers in the exposed daughters. After successful first- and
second-generation claims (mother and daughter exposed in utero
respectively), third-generational claims were made by the
granddaughters of DES-exposed mothers. However, the courts
ruled that the manufacturers of DES were only responsible for the
first and second generation effects of DES due to victim
attenuation; the granddaughters were too far removed, or
attenuated, from the initial offence (Rothstein et al. 2009b). Since
the effects of DES were not evident until later in the daughters’
lives, the statute of limitations – the time span in which legal
claims are valid and pursuable – had to be extended in order for the
individuals affected to be compensated. The courts also decided
that the statute of limitations for the DES cases begins when the
effects of exposure become evident or might reasonably be
expected to cause notice, not when the actual exposure takes place
(Rothstein et al. 2009b).
In 1990, a DES son filed a lawsuit against a drug company
in the U.S. alleging that his in utero exposure to DES caused his
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daughter’s cancer (Mascaro 1991). This appears to be a precedentsetting lawsuit that claims DES caused injury to third generation
victims. There have also been other third-generation DES cases for
premature births where the babies were born with severe physical
disabilities (Mascaro 1991). However, in his 2009 article,
Rothstein notes that “claims brought by the granddaughters of the
women who took DES have not been successful due primarily to
the courts’ unwillingness as a matter of tort theory… to extend
liability…” (Rothstein et al. 2009b). For example, in New York,
decisions flip flopped until the NY Supreme Court cited a
precedent setting case where pre-conception injury was deemed
ineligible as a basis for liability (Karen Enright, An Infant & C., Et
Al., Respondents, V. Eli Lilly & Company, Et Al., Appellants.77
N.Y.2d 377, 570 N.E.2d 198, 568 N.Y.S.2d 550 (1991)).
Unrecognized in the legal quagmire was that the infant did not
solely receive injury indirectly because of physical harm done to
the mother, but was likely to bear a significant and direct harm of
an epigenetic nature herself. In other words, the harm was
probably not caused by a physical deformity of the mother
impinging that impinged upon fetal growth, but rather, was likely
due to inherited patterns of altered gene activity.
8.2 Statute of Limitations
Statutory limits and repose present substantial constraints
that prevent the system from dealing with epigenetic liability cases.
Legally, the period for litigating claims is limited, and in most
cases it runs out before any of the epigenetic harms manifest
themselves (Khan 2010). Epigenetic harms can have a transgenerational impact, and the harms are sometimes unknown until
after one or two generations have been born and displayed the
effects of a harmful agent. For instance, it took years before the
side effects of DES became known. Many of the women who took
the drug are now deceased; yet many of the side effects are only
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just now being encountered in their daughters and sons, as well as
grand-daughters and grand-sons. Only time will tell if adverse
effects will extend to further generations. It is this long latency
period that makes it more difficult to accurately identify the
product responsible for the harm, or even to assign blame for the
negative epigenetic outcomes (Khan 2010). The imposition of
strict time limits could eliminate future generations from filing
claims. On the other hand, the absence of limitations could render
the long-term nature of the economic environment too insecure to
support vibrant business and product development.
Richard Abood discusses the pharmacist’s Statute of
Limitations in his book Pharmacy Practice and the Law. “The
purpose of the statute of limitations is to prevent the litigation of
stale claims years after the events that allegedly led to the harm,
after memories have faded and witnesses have disappeared”
(Abood 2010). While scientific tests might eventually confirm the
effects of, say, a specific drug, the doses administered, the form
they took, the identification of the specific manufacturing licensee,
physician, pharmacist, could be difficult, and the degree of patient
compliance might quite difficult to establish. Abood also reports
that public policy favours the unencumbered practice of healing
arts, “without fear of groundless and unjustified malpractice
lawsuits, [which] has led to the enactment in many jurisdictions of
reform laws that reduce the number of years a statute of limitations
for medical malpractice” (Abood 2010). In many jurisdictions,
there is a “discovery rule” which means the time limit does not
start until the harm is discovered. For example in Ontario Canada,
the Ontario Limitations Act 2002 provides for a two year period
following discovery for litigation to be pursued. By contrast, some
jurisdictions have a “statute of repose” which limits the discovery
rule to prevent litigation decades after a drug’s use (Abood
2010). This would prevent the claimant, especially second and
third generation victims, from suing the individual doctor or
pharmacist. Thus the chances of pursuing an epigenetics-related
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claim against an pharmacy is almost impossible.
Some states have introduced changes to their legislation
with regards to statute of limitations to make second and third
generation claims more sustainable in courts (Rothstein et al.
2009a). Yet, even so, it is uncertain when statutory limits should
expire, and for how many decades is it reasonable to hold a
company liable. Perhaps, a potential defendant should not be
exposed to the threat of indefinite liability, which is why statute of
repose protects manufacturers (Khan, 2010). In instance of
epigenetic effects, the statute of repose sometimes runs out even
before the injury or harm itself has been noticed or identified, thus
making it impossible to assign blame to anyone for the epigenetic
harms (Khan 2010). The DES cases have proven an interesting
testing ground in this instance – second generation claims have
been permitted in some jurisdictions and under specific
circumstances.
8.3 Tort Law
8.3.1 Liability
The next concern is how to hold parties legally responsible
for epigenetic harms. Responsibility can belong to an individual, to
an employer or state responsible for occupational or environmental
exposure, or to a group of people working towards a common
purpose, termed a collective (Hedlund 2012). Assigning legal
responsibility to any of these types of groups requires causal
responsibility – that the actions of the individual or collective
involved directly caused the adverse outcome of interest (Hedlund
2012). While no laws currently exist regarding epigenetics and
assigning responsibility for the causation of epigenetic insults,
some believe that the tort system could be modified to address
these issues.
Tort law is enforced to ensure public health and safety,
thus it could potentially be used to address harms to the
epigenome, but the requirements of tort law cases pose additional
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problems for the victims of epigenetic insults (Khan 2010). In tort
law, the victim is required to prove that the harm was a direct
result of the defendant’s actions by more than 50% probability
(Khan 2008). Since individuals are exposed to thousands of
different chemicals, and to the same chemicals from several
different sources, it can be difficult to prove that exposure to a
single product resulted in negative epigenetic effects (Khan 2010).
Similarly, there has been little research on the epigenetic effects of
the chemicals we are exposed to in everyday life, and the
generation of such knowledge would be beyond the abilities of
most plaintiffs (Khan 2010).
With current tort law, injury is only recognized when it
affects an individual at or above the cellular level. Thus, epigenetic
mutations introduced by chemical exposure would not be
considered harmful unless they resulted in observable negative
effects (Khan 2010). This poses a problem since epigenetic
changes may not have noticeable effects for years or, in some
cases, for generations. Can a company only be held liable if its
actions result in epigenetic effects which are immediately
observable? (Khan 2010; Rothstein et al. 2009b). Diseases are
often viewed as binary, but epigenetic alterations can lead to a
predisposition to developing a given disease: is this still grounds
for a lawsuit (Khan 2010)? Finally, if the epigenetic effects a
defendant has caused can be reversed by medication or other
genomic intervention, does the defendant owe anything to the
plaintiff? (Hedlund 2012). Should companies be held liable for
causing epigenetic changes only when they have detrimental
effects, or if any epigenetic alterations are proven? In addition,
assuming that one is able to pinpoint and prove the fault of one
particular manufacturer (defendant), how do you prove that the
product is the sole cause of the outcomes? We are exposed to so
many different chemicals and substances, thus making it difficult
to establish one sole culprit (Khan 2010). Moreover, it is often
difficult to pinpoint one product or actor responsible when there
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are multiple manufacturers licensed to produce the same
merchandise (Khan 2010).
It has been argued that it is unfair to put blame on current
individuals for harms caused by past actors (Khan 2010). Since
there can be a long latent period between exposure and effects, the
makeup of individuals within a company producing an offensive
chemical can completely change by the time the plaintiff makes a
claim. Since the makeup of the collective could be entirely
different, it becomes unclear if the collective can still be held
legally responsible for the actions of its predecessors. Similarly, if
a company that once produced harmful substances now only
produces beneficial substances, it is uncertain whether the deadline
of the statute of repose should be extended and the company held
liable, as this could detract from the good the company is currently
doing (Khan 2010).
Joint venture liability suits have also been filed for DES
related cases. In these suits, all the companies who manufactured
or sold DES are held jointly responsible and therefore
proportionately liable for damages incurred irrespective of which
manufacturer’s doses were prescribed to a specific patient
(Downey and Gulley 1983). In the Netherlands, collective
settlements have been reached using a joint venture prosecution. A
fund for victims was set up, however, it took 20 years to reach the
agreement and the compensation has proven to be too low as the
settlement has to be spread among multiplying claimants who
subsequently discover side effects (t Hoen and Dukes 2007).
Another concern is whether preconception torts are
legitimate claims for epigenetic cases. Preconception torts are
claims made by offspring who are negatively affected by their
parents’ or physicians’ actions before they were conceived,
excluding existing genetic conditions or unintentional
environmental exposures (Weiner 2010). These claims are similar
to claims of wrongful life, in which parents are sued for knowingly
conceiving and bringing a child into the world with a low quality
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of life due to a predictable disability or other illness (Weiner
2010). Mothers have also been charged with child abuse when
their actions during pregnancy, such as drug abuse, threaten the life
and health of their child (Smith et al. 2013). Could cases such as
that of DES be considered under preconception and pre-natal torts,
thereby putting blame on the grandmothers and/or mothers for
taking the drug while pregnant.
While these previous tort cases lend weight to the idea of
preconception torts, there are many concerns with holding parents,
physicians, or companies liable for their actions before conception.
The parents could be held liable indefinitely due to their actions
long before they ever thought of having children (Weiner 2010).
As well, the legal system would need to clearly define what acts
are considered harmful and punishable by tort law (Weiner 2010).
Successful preconception torts would also raise concerns about the
rights of the mother during pregnancy and at which point a
developing fetus becomes recognized as a human being: this would
have implications for abortion laws (Smith et al. 2013; Weiner
2010). Finally, given the latency of epigenetic effects and the lack
of knowledge on the effects of substances on the epigenome, it is
unclear whether unforeseeable negative effects could be punished
by tort law (Weiner 2010).
Others have argued that pre-conception torts need not be
dismissed out of hand if they argue a genetic basis for injury
(Goldberg 2007). Moreover, genetic predisposition to be
susceptible to an industrial toxin might help plaintiffs to meet the
two-fold “more likely to have been affected than not” standard
required for successful litigation in cases pertaining to toxins
(Marchant 2006). By extension, epigenetic torts might also enjoy
an opportunity to see their day in court since, like genes
themselves, they can also embody both the measureable harm and
the predisposition to injury.
8.3.2 Proving Causation and Obtaining Records
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A further legal concern with respect to epigenetic cases has
been the ability to prove that a drug caused the negative epigenetic
effects. A plaintiff in any tort case should be able to identify the
specific product that caused the harm and the causal chain of
events that led to the injury must be unambiguous. This becomes
difficult when the causal stimulus and the revealed effect are
separated by 20 or more years, as is often the case for transgenerational epigenetic effects. How does one retrieve
prescriptions that are that old, and demonstrate that a plaintiff was
compliant with regard to the use of the drug?
Additionally, accessing medical records has proven to be
another concern for epigenetic legal cases. The request to access
personal health records requires that you know where the records
are kept and in cases involving deceased progenitors, the executor
of the estate must give permission. In Ontario, medical
information is protected for 120 years after the record was created
or 50 years after the person’s death (IPC 2008; Personal Health
Information Protection Act, 2004, S.O. 2004, c. 3, Sched.
A). However, laws regarding how long medical professionals have
to retain a patient’s medical records vary greatly from 5-10 years
depending where the person lived. In Ontario, the College of
Physicians and Surgeons requires that records be retained for 10
years, but recommends 15. When you are making a second or third
generation claim, which is the case in most epigenetic claims, it is
difficult to have all the required information on hand to track the
record, and sometimes a record might no longer even exist.
8.4 Models for Assigning Responsibility
It is a common idea that one should be held accountable for
one’s decisions, and up until today, our legal and regulatory
framework has been concerned with assigning responsibility in a
retrospective manner (i.e. blaming causally responsible
stakeholders, when unfavourable outcomes are identified) (Gesche
2010; Hedlund 2012). However, when this model is applied to
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epigenetic harms, identifying those to blame will prove to be a
challenging task.
Some might argue that it is an individual’s responsibility to
make healthy choices with respect to diet and nutrition, exercising,
or other major lifestyle choices. For that matter, where should the
cost-benefit analysis place the threshold for advisable use of
pharmaceuticals when the trans-generational consequences may be
unknown? Thus, should there be any epigenetic side effects or
potential health risks resulting from these choices, the individual
should be held responsible to remedy these effects. Others argue
that sometimes an individual may lack the knowledge required to
make intelligent and healthy decisions, or may lack the socioeconomic means to make better lifestyle choices to remedy their
situation (Hedlund 2012). Moreover, the disadvantageous
epigenetic side effects might be so profound or insidious that the
cost of correction is unaffordable for the individual or his/her
family. How is responsibility and blame assigned when more than
one individual or group is involved? Although there are ways in
which percentage blames can be assigned, the constantly changing
and inherently complex nature of the epigenome likely means that
the assignment of proportional responsibility will be difficult if not
impossible to determine with exactitude. In addition, how does one
deal with responsibility when there are structural conditions
(social, economic and political) that affect the well-being of the
individual and their life choices, and which contribute to epigenetic
side effects? Finally, can it be regarded as fair to hold individuals
responsible for the behaviour and habits of their ancestors – these
too affect an epigenetic imprint? The complex combinatorial
interplay of epigenetic influences also makes it difficult to assign a
specific cause to an effect.
All of these factors shift the moral responsibility from the
individual to society and the government, which will ultimately
bear much of the cost associated with ill health and lowered
productivity (Hedlund 2012). This raises the issue of collective
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responsibility – how can this be managed?
One model of assigning blame is the prospective
responsibility model. This model takes into account structural
conditions and to some extent frees the disadvantaged from total
responsibility (Hedlund 2012). An example of this type of program
is the Finnish “Baby Box” program that was developed to entice
and reward expectant mothers to attend early pregnancy
consultations with medical professionals. The program was
fundamental to a marked reduction in maternal and fetal mortality,
and is discussed at greater length in Chapter 10.
The prospective model acknowledges that even if
individuals are complicit in damaging their own interests, this
creates costs to society in terms of health and productivity, not
merely insofar as the individual is concerned, but also for
successive generations who ought not to be punished. Prospective
responsibility accounts for the multiple other inputs from the
economy, geography, society that play a part in the epigenetic
effects. The model also requires contributors to debate policy
formulation: these may include individuals who have a wealth of
knowledge, and researchers who study the field of epigenetics
(Hedlund 2012).
In summary, because of the complexity of epigenetics and
the number of interests and stakeholders that contribute to the
system, it is difficult to determine the boundaries of responsibility
between the individual and society, so it is economically and
procedurally simpler to facilitate better health via societal support
than by assigning individual blame.
8.5 Protection and Prevention: Adapting Testing Policies
In the U.S., Food and Drug Administration (FDA) rules and
regulations are designed to prevent medical tragedies. Similar
agencies perform a like function in other countries – in Canada for
example, Health Canada performs this function. Many argue that it
is time to bring new changes forward considering that our genome
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is now known to respond to external signals in a diverse and
complicated way (Szyf 2007). Xenobiotics affect us in many
different ways, but their activity and pathways can also be different
from individual to individual (Szyf 2007). Pre-market and license
testing should therefore be required to address the epigenetic side
effects of each drug, as well as to predict changes in the metabolic
mechanisms whereby xenobiotics themselves could be modulated
by varied epigenomes (Szyf 2007). Such testing should include
both drugs that may have unintended epigenetic side effects, as
well as the drugs that intend to cause an epigenetic modification as
a pathway to treat a certain disease or condition. It is
understandable why tests would be needed in the former case,
where epigenetic side effects are unwanted and unexpected. Yet,
testing the drugs that are intended to cause epigenetic
modifications is necessary to ensure that such modifications are
gene-specific, and not random and uncontrolled (Rothstein et al.
2009a).
Not only is testing a necessary measure, but there also is
need for regulation regarding how and where the testing is done.
Considering that epigenetic modifications are species specific, it is
important to choose the right model organism for testing and if
extrapolating to include humans, to do so cautiously (Rothstein et
al. 2009a). Furthermore, testing drugs for epigenetic side effects
should be considered with skepticism. Results from such tests may
suggest epigenetic modifications that are not accompanied by
symptoms, or that may not necessarily have a negative influence
on an individual’s health (Rothstein et al. 2009a). Since it has
been previous shown that trans-generational epigenetic effects may
not be immediately observable it is important to revisit tests in
order to account for this. As such the results should not be taken as
the final word, but rather, they should be seen as a guide, and
further investigation should follow to determine possible long term
effects.
Another precautionary regulation that might mitigate some
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of the risks associated with epigenetics is trans-generational
monitoring. Not only should a clinical trial assess the reproductive
side effects of a specific substance, but it should also track the
effects of the substance for at least one more generation to reveal,
characterize, predict, and prevent further trans-generational harms.
It is impractical to make human cross generational studies a part of
the approval process - this could render the development of drugs a
lengthy and impossibly expensive process – clearly cell and animal
models will have to be developed to prognosticate potential pit
falls, while simultaneously, longitudinal studies on humans should
be required even after the drugs come to market.
8.6 Law and Taxation Models
Clearly, epigenetic testing, diagnosis, treatment, and
remedy will come at a cost – how will the new expenses be borne ?
With regards to taxation, three justice models have been suggested
to correct for epigenetic disadvantages – the luck-egalitarian
model, the luck-prioritarian model, and the Rawlsianegalitarian model (Loi et al. 2013). These models would serve as
a guide for taxation and redistribution of funds towards health care
and other assets.
Engaging the luck-egalitarian model would serve as a
social and economic leveler of sorts. The model operates to reduce
inequalities to those that arise solely due to the choices an
individual makes. Any other inequalities, for example due to
genetics, parental legacy, or social status are corrected and
subsidized. This includes the use of subsidized therapies to
equalize epigenetic advantages when such therapies become
available (Loi et al. 2013). This model would equalize social and
genetic disadvantages so that similarly inclined individuals would
have the same opportunities for success regardless of their starting
position in society or genetic predispositions.
Luck-prioritarianism is similar to luck-egalitarianism as it
requires genetic and social intervention to equalize opportunity.
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However, luck-prioritarianism requires that helping individuals in
the worst genetic and/or social state takes precedence over helping
all other individuals. Thus, those in worse condition would receive
a greater degree of aid and/or treatment than individuals who are
slightly better off genetically, epigenetically, or socially (Loi et al.
2013).
The third justice model is Rawlsian-egalitarianism, or
moderate egalitarianism. Unlike luck-egalitarianism and luckprioritarianism, Rawlsian-egalitarianism would aid those in need
only via social tools – for example, through tax cuts or subsidized
education. Genetic and epigenetic inequalities would be viewed as
the loss of a “natural lottery” and would be equalized, at most, by
the redistribution of monetary assets and social aid in the favour of
those less fortunate genetically (Loi et al. 2013).
Regardless of the justice model invoked, it has been
suggested that a tax be levied on prospective parents to subsidize
the genetic and/or social interventions for disadvantaged offspring.
The tax would be collected for each offspring and the pooled
money would be distributed either by a luck-egalitarian, luckprioritarian, or Rawlsian-egalitarian system of social justice. Such
a system would remove the burden of equalizing opportunities
from society as a whole and place it on those who opt to have
children (Weiner 2010). The practicality of taxing families when
they are just starting out, and when family resources are relatively
small seems dubious. Moreover, society has an interest in
propagating new generations to replace and support the older ones,
so why build in reproduction disincentives? The tax would
discourage financially limited families from having children - a
concern due to low birth rates already threatening many developed
countries. The taxation of parents would also privilege wealthy
people: only they might be able to afford to have children. Finally,
such a tax would fuel the debate regarding abortion since
financially unstable couples could find themselves in the
unenviable position of having to choose between terminating the
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pregnancy and of digging themselves into a financial hole.
Since one of the major concerns with imposing epigenetic
liability is the lack of knowledge regarding the epigenetic effects
of products on the market, some theorists have suggested placing a
hefty “epigenetic tax” on products. The tax would increase the
costs of producing such chemicals, and this additional expense
would no doubt be passed on to consumers. So, taxes would
undoubtedly increase the costs of production and decrease sales.
How could companies be given incentive to ensure epigenetic
safety? Taxation rates could be inversely tied to investment in
research and prevention. This would benefit companies by
decreasing both the taxes levied, as well as the potential liability
costs of their product. Not incidentally, the program could be
designed to expand knowledge of epigenetic risks and benefits
(Khan 2008).
The pros and cons of shifting the burden of care from
society to the individual, or vice versa, must be considered, as well
as taxes levied to encourage epigenetic research on exposure to
seemingly innocuous products. Eventually both stakeholders
should be encouraged to promote environmental and social
responsibility
8.7 Privacy Law
Aside from the legal concerns which arise in epigenetic
cases, privacy law also has importance where epigenetic effects are
concerned. Current law does not include any policies or acts which
directly encompass epigenetics. The Canadian Privacy Act
includes “information about an identifiable individual that is
recorded in any form including…information relating to the
education or the medical, criminal or employment history…”
under its definition of personal information (Privacy Act of
Canada, 2014). Loosely one could consider epigenetic information
to be included under this if that epigenetic information is recorded
in a form considered to be medical history.
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With the significant role epigenetics can have on
individuals and groups of people, assuming it can be categorized
under the act is not enough. This is especially the case when many
individuals are affected by unexpected negative epigenetic effects
such as those resultant from taking DES. Inclusion of epigenetics
within laws for genetics may be an option. In the United States,
for example, the definitions of ‘genetics’ used in the existing
genetic privacy laws presently might not encompasses epigenetics
(Rothstein et al. 2009a). With the growing prominence of the field,
and with legal cases of epigenetic harms presenting themselves, the
inclusion of epigenetics into privacy law is crucial for the
protection of individuals including for prevention of epigeneticbased discrimination. Privacy laws should be adapted and clearly
define how epigenetics is encompassed, and how the privacy of
individuals should be protected. Those who bring forth epigenetic
legal cases should not fear breaches of their personal privacy with
respect to their epigenetic information, especially when legal
battles ensue and media involvement occurs, and even more so
when information released concerning one individual can be used
to make inferences either about either progenitors or descendants.
We will discuss privacy more in Chapter 9.
8.8 Conclusion
With cases of epigenetic harms presenting themselves in
court, the explicit inclusion of epigenetics into law will become
necessary, especially because it affects so many realms of human
health and opportunity. The uncertainty and challenges that have
arisen in the DES litigations indicate that current law is inadequate
to handle epigenetics. Moreover, those who present and adjudicate
cases will need education to understand the new concepts and
implications. Individuals who are affected by epigenetic side
effects should have a right to obtain justice and to present an
epigenetic case within a legal system which is suited to handle it.
In order to provide justice and ensure that those who are liable are
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held responsible, indeed to prevent future harms from occurring,
laws that acknowledge the implications and effects of epigenetics
must be discussed and formed.
Provocative Questions
 If the current legal system is not suited to deal with
epigenetic cases, how can individuals obtain justice, and
those responsible for them be held to account?
 How quickly can the legal system adapt to fit the needs of
epigenetic cases? Will laws and policies concerning
genetics be adapted or will new epigenetic-specific laws be
formed?
 What are the implications of required epigenetic testing,
for organizations, such as pharmaceutical companies? How
will liability and costs be balanced to avoid impeding
progress?
 Will laws for epigenetic harms due to medications or
environmental effects be expanded to encompass epigenetic
harms due to nutrition and lifestyle choices?
 Should those without the socio-economic means to
change their lifestyles be offered assistance to present legal
cases of epigenetic harm against the government?
 Will lack of epigenetic educational resources be a feasible
argument for a legal case of epigenetic harm?
 How will the cross-jurisdictional nature of globally
distributed pollutants with epigenetic effects be dealt with?
 How will the privacy of individuals and families affected
by harmful epigenetic influences be protected when legal
battles ensue?
Solutions
 Education in the field of epigenetics, and in previous legal
cases of negative epigenetic effects.
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 Acceptance of epigenetics requiring its own place within
law
 Formation and discussion of epigenetic laws – locally,
provincially, federally, and internationally – there are a lot
of cross-jurisdictional issues that will require a
comprehensive approach.
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Chapter 9
Epigenetic Privacy: Hacking Your Health?
Kendall Diemer and Melissa Woghiren

Abstract
Our improved understanding of epigenetics and how it
can lead to ill health raises questions regarding how to acquire,
store, manipulate, and access epigenetic health data. Like other
types of medical and personal records, we need to consider how
to handle information associated with a person’s epigenetic
status, however, this field of privacy and privilege is peculiarly
vulnerable to exposure in additional ways that we will
enumerate. Although pre-existing experimental standards have
been adapted to ensure privacy for both patients and epigenetic
study participants, vulnerabilities have been identified in the
management of epigenetic data, especially with the growing
affiliation of digital platforms and the use of internet tools to
distribute, store, analyze and present data. The rapidly evolving,
loosely regulated online environment could threaten
confidentiality in ways unforeseen by both researchers and
participants. Moreover, diverse online sources can be mined for
additional information that could permit unscrupulous surveyors
to infer your epigenetic status. Large data sets, thus assembled
from diverse sources, can provide additional insights into an
individual’s epigenetic and prospective health status. Innocent
online interactions could lead to exploitation of epigenetic data
for manipulation and gain. The threats of unwarranted access by
opportunistic enterprises, limited research, medical, and
computational resources, and violation of privacy afforded by
reverse association, emphasizes the need for epigenetic data
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protection. Discussion of the implications of the current social
and legal environments, and the increasing use of digital
networks in epigenetic study and medicine, has made privacy a
pressing issue.

9.1 Introduction
Patients have the reasonable expectation that their data from medical visits, prescriptions, participation in health surveys,
or simply providing background health information - will be
handled with care and discretion. Despite the best of intentions,
however, there have been some recent and spectacular breaches of
this confidentiality. For example, in the United Kingdom, the
National Health Service (NHS) was revealed to be selling highly
classified information to many of the nation's insurance companies
(Donnelly 2014). Although the data had been anonymized,
apparently none of the civil servants involved had realized that
insurance companies could compare their own records with those
of the NHS to connect heath records to specific patients. Moreover,
the sale of such information had no effect on improving patient
care, but quite the reverse: compromised patients could risk being
denied insurance coverage. The hazards of the aggregation of large
medical data sets have already been articulated (Anderson 1995).
With epigenetics becoming a more prominent field, and the
number of studies increasing, it will only be a matter of time
before the detailed characterization an individual’s epigenetic
status becomes commonplace. Epigenetics is distinct from genetic
data: it does not involve changes to DNA sequences per se, but to
how those sequences are packaged and consequently behave. As
we saw in Chapters 1 and 2, epigenetic changes to chromosomal
architecture can take many forms, and the informational
complexity, the differential distribution of these characteristics in
different cell types, tissues, and individuals, and the constantly
changing nature of an epigenome (with age, exposure and
experience of different diets, environments, social activities etc),
mean that epigenomic data sets will be much larger than those
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describing genome sequences. They will also need periodic
updating for each individual.
The absence of epigenetics as an explicitly defined term in
regulation and law, the characteristics that make it both
mechanistically and conceptually different from genetics, and its
novelty in health practices means that few of the privacy issues and
challenges that attend this new field have been identified, let alone
discussed. We will attempt to remedy these deficits, and will show
how epigenetic data not only embodies many of the same
challenges as other large medical and genetic data files, but
manifests other vulnerabilities as well. We will start with the
issues of informed consent and epigenetic data collection,
handling, storage, access and processing. We will conclude by
outlining the accessory and somewhat novel means by which
unscrupulous operators might develop a relatively accurate
assessment of your epigenetic status and prospective health
predisposition.
9.2 Data Collection
9.2.1 Collection and Data Housing Challenges in Epigenetic
Studies
As with all large sets of biological data, privacy is important at
all stages - from the assessment of the epigenome, to the storage of
data, transfer and sharing, through to its computation, analysis, and
presentation. Who is allowed access, to what data sets, and what
security and protective measures should be in place, are allimportant questions concerning participant privacy in epigenetic
medicine and research.
Ethical practices are a constant concern in scientific research.
Practice guidelines developed and enforced by research ethics and
regulatory bodies ensure compliance. Defining ethics in humanrelated research requires attention to the participant’s contribution,
and an understanding of its possible implications for the
participant's life (Ludwin and Frideres 2014). It is the
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responsibility of the researcher to conduct research in an ethical
manner that is not at the expense of the individual studied (Ludwin
and Frideres 2014). As interest in epigenetics continues to grow, an
adjustment of ethical standards will be necessary in order to
maintain data integrity. Privacy in epigenetic research is a matter
of individual well-being that may be grouped with other, even
physical, threats (Ludwin and Frideres 2014).
Prior to analysis, data collection is the driving force of any
scientific study. Collection concerns and data handling are not
unique to epigenetics (Kalapesi 2013), however, like genetic data
repositories, epigenetic research often contains incomprehensibly
large data sets or big data (Lohr 2013). Maintaining security
throughout the screening process can be challenging as a result.
Indeed, privacy assurance has been debated and proposed as a
possible hindrance to scientific advancement (Kalapesi 2013).
Still, the exact nature of personal risk in epigenetic studies has yet
to be elucidated, as the implications have yet to be characterized.
A good researcher will understand why participant permission
is not to be assumed, nor should it derived through manipulation or
coercion (Ludwin and Frideres 2014). It is a matter of obtaining
informed consent (Jallo et al., 2013) built upon the principle of
respect for the participant while understanding the gravity of their
commitment to the study (Ludwin and Frideres 2014). The
challenges inherent in accumulating, storing, and making sense of
big data, as well as the globalization of data curation, analysis, and
research, present new issues in regulating data collection (Lohr
2013). Globally, there is a trend toward societal and digital
decentralization: this is important to note when formulating
privacy legislation (Kalapesi 2013). In such geographically and
politically distributed structures, reliance upon a single governing
body is difficult, especially when the objective is to regulate
information sharing among diverse international entities. In these
collaborations, sharing often involves third party tools that
introduce additional risks since third party motives and intentions
282

Epigenetics and Privacy Threats

are not always identical to those of the persons invested in the
study.
Although it is simple to regulate those directly involved in
epigenetic study under scientific standards, it becomes difficult to
hold third parties to the same standards as their goals are different
(Kalapesi 2013). Third-party regulation is further complicated
when the services cross jurisdictional boundaries. For example,
the lack of international policies presents an impediment to
regulation and enforcement: for example, privacy laws in Canada
will carry no weight in France and vice versa. If some part of your
data is stored, processed, or analysed in a different jurisdiction,
there is little that either you or your physician/researcher can do in
the event of a breach of privacy. While accepting the inherently
different goals of third parties and the tools they provide,
investigators seeking to take advantage of these resources must
account for these differences and limitations.
Data is now created and collected in new and distributed ways
via connected and social communities (Kalapesi 2013). The
traditional need for formal study approval to collect data is easily
circumvented by harvesting from, for example, social media.
Participants may not be aware that their personal data is being
used, nor what it might divulge. Participant consent and privacy
are lost in the implicit consent engendered by online posts or
browser histories (Kalapesi 2013). A post to social media could
provide a means for investigators or agencies to infer epigenetic
status without the user’s knowledge or consent.
9.2.2 Privacy and Informed Consent of Participants in
Epigenetic Studies
Before privacy in storage and sharing of epigenomic data
can be considered, it is important to understand how data is
obtained. One method is collection through traditional participantbased studies. Due to the confidential nature of an individual’s
epigenome, researchers will have to gain informed consent. As for
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any other medical or social science study, participants should
understand the ways that their data will be stored, shared, and
used: this is critical to building trust and public support for
epigenetic studies. What constitutes informed consent? During the
recruitment process, consent is usually defined as having two
components. The first component is the participant-signed consent
form that provides participants with written information on the
study and the protocol that will be followed. The second
component requires the research team to provide information and
answer questions (Jallo et al. 2013).
Though the foundations of informed consent can be
outlined for the researchers, there are still many obstacles to
obtaining it from the participants. Some of these obstacles can
include a lack of knowledge of the study or field of epigenetics,
mistrust of the purpose of the study, language and literacy barriers,
and health and socioeconomic status. These obstacles can limit the
diversity of study participants (Jallo et al., 2013). Another issue
that arises is related to the consent of individuals who are below
the defined age of consent, as well as individuals who are unable to
provide consent for themselves due to health problems or
disabilities. Who has the right to consent for these participants? If
inferences about an individual can be made from one individual’s
data do all relatives need to provide consent in order for data to be
obtained for a study? One need only look to the clumsy publication
of the HeLa cell genome to see how hurtful inferences can be
made: relations of the person from whom the cell line was obtained
were neither consulted nor informed (Hudson and Collins, 2013).
Additionally, with the increasing use of open-access and wide
ranging data sharing, will these individuals have the option to
withdraw their epigenome data if they wish to in the future?
Informed consent can be promoted through different
methods. It will be critical to provide study information in
language stripped of scientific jargon, and with metaphors
deployed to help clarify various epigenetic concepts. A FAQ sheet
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can help participants to feel it is normal to have concerns and to
ask questions pertaining to the study itself as well as to their
privacy and anonymity concerns. Researchers should focus on
allowing the participants to attain a better understanding, and
should encourage questions. These methods have been shown to
improve study enrollment rates to 89% compared to the wide range
of 15-84% common to efforts that fail to promote informed
consent (Jallo et al. 2013).
9.2.3 Access and Release of Epigenetic Data
Effectively safeguarding sensitive personal information goes
beyond maintaining respect for the individual providing it. The
definition of protection must have the plasticity and resilience to
survive the challenge of increasingly integrated digital societies
where respect for privacy has become more of an artifice then an
actual practice (Kalapesi 2013). The traditionally accepted ethical
model of data collection involves obtaining explicit consent
directly from the owner (Ludwin and Frideres 2014): this involves
the education necessary to make the consent informed, and it
reaffirms the intentions of the researcher to expand current
knowledge for the benefit of others and society alike. Online
scientific resources for data could formerly be considered to enjoy
informed consent provisions as one could reasonably expect that
the participant was informed of all potential uses (Kalapesi 2013).
Yet, in contemporary societies, data banks are no longer just
collections of curated information associated with traditional
bioinformatic tools. Our extended connections have created a new
source of readily accessible and personal “big data”. With the
evolution of data mining of nontraditional sources, informed
consent is often assumed to be unnecessary, however the uses to
which the data might be put is often not transparent to the “donor”
(Kalapesi 2013).
Since data may now be derived in many different ways, the
various methods of its acquisition must be evaluated separately to
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determine appropriate use (Kalapesi, 2013). For example, a recent
initiative by Kaiser Permanente to retrospectively survey patient
records and make associations regarding the health of offspring
serves to indicate where the rules of ethical consent may be subject
to intrusive abuse. The data had not been collected for this
purpose, but had potential to reveal insights that might otherwise
be unavailable. Informed consent was assumed irrelevant as the
inferred data was obtained derivatively through family members
(Kalapesi 2013). The study, however, could be considered a
violation of personal privacy in the traditional sense. Does the
benign purpose of the study justify the questionable means of its
data use/collection? The aforementioned example of the NHS
privacy breach serves to indicate how informed consent can fail,
and the incident should warn us why strict restrictions on data use
must be upheld.
Good intentions should not be assumed of any private
entity as the pursuit of profit may incentivize circumvention of the
intent of permission – transparency regarding the uses that data
will be put to needs work (Kalapesi, 2013). Data privacy
provisions should be adaptable, while still adhering to good ethics
of collection: models that govern data use will have to adapt to
accommodate the potential of constant access rather than attenuate
future collection in order to protect privacy (Kalapesi 2013).
The United Nations recently attempted to suggest regulation to
prevent privacy violations that are facilitated by interpolation of a
person’s everyday digital activity, and to account for the new
methods by which data may be collected (UN 2013). While
promising, this report acknowledges that it will be difficult to
globally enforce privacy resolutions – the inter-jurisdictional
nature of the problem means that the regulations could only serve
as a category of moral request rather than act with the binding
power of law. Voluntarily, UN-associated states may agree in
principle to abide by such regulations, this agreement does not
necessarily ensure compliance. Regional interests may supersede
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global statements of principle regardless of consequence, rendering
such resolutions somewhat ineffective.
Although some regional governments have developed privacy
legislation intended to extend borders, such as European Union
agreements (Klein 2008), Canada's Personal Information
Protection and Electronic Documents Act (PIPEDA) is an example
of legislation that recognizes a need for transferability (OPCC
2014a). The PIPEDA, building upon the principles of Canada's
Privacy Act has been continuously expanded to protect health
privacy. Yet, recent case law and government statements have
made it clear that there is a preference for maintaining and growing
international relations over ensuring cross-jurisdictional protection
(Klein, 2008). This creates an avenue for international businesses
to exploit loopholes and thereby bypass privacy provisions. We
risk unnecessarily jeopardizing individuals’ privacy, liberty, and
equality of opportunity by privileging economic growth. Gaining a
global consensus on privacy will take time to realize:
advancements in our understanding of epigenetics will no doubt
ensue over the interim, and protections will inevitably lag.
9.3 Data Handling
9.3.1 Online Networking and Epigenetics
The internet, as envisioned by Tim Berners-Lee, the man
credited with its creation, was intended to provide a path to open,
long distance information sharing, specifically of research
materials (Owen 2014). More than 25 years later, it has evolved
with other networks to provide fast connections and easy access to
large stores of data. Initially, privacy was not considered an
important factor. Nonetheless, privacy has become a main concern
(Owen 2014). While the internet provides a convenient way to
drive global collaboration between researchers, it is not without a
degree of risk when it comes to fielding sensitive information.
Aside from the sharing of epigenetic data from online storage
databases, there are many opportunities for data sharing through
287

online networking, social media, and mobile apps. For researchers
and physicians, online networking is an increasingly important
communication tool. Social media and online networks allow for
these professionals to communicate with the public and each other
with greater ease without the limitations of time-based
appointments, and irrespective of geographic distances. There is
even a ‘Facebook of Science’, a social network site called
ResearchGate which allows data sharing among scientists to
facilitate collaboration and the exchange of information (Gujarathi
and Costa 2014). The use of online communication for nonscientists is also becoming a common way for individuals to obtain
health information, share similar experiences through forums, and
to participate in pharmaceutical clinical studies. The difficulty
with this increased use of online networking is that many people
are naïve or do not understand the relatively unregulated nature of
privacy regulations and practices.
Governing the flow of
epigenetic data or information throughout all areas of online
networking - social media, discussion forums, and through mobile
apps, and patterns of digital device use - seems a near impossible
task. A 2014 study on the issue summarized this by stating:
“Privacy issues have been the prime disadvantage for the use of the
internet and online data storage” (Gujarathi and Costa 2014)
Research boards and ethics committees can often review
specific projects but when data becomes widely shared and
accessible online, the intervention and regulation by these groups
becomes difficult. Consideration as to how these governing bodies
can be adapted to regulate and deal with online networking privacy
issues is urgent. If adaptation of these agencies is not immediate or
palatable, then new models for regulation should be considered.
The individual responsibility of participating researchers and
health companies must also be enforced. “Medical professionals
who use social networking sites have unique responsibilities, since
information posting and sharing could violate patient privacy. Life
sciences companies should also consider that communication on
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social networks is highly public, which allows small issues to
escalate into public incidents” (Gujarathi and Costa 2014).
Additionally, the individuals who share their own epigenetic
information or that of family members online must also understand
the implications that this distribution of data might have. They
need to keep in mind that there are privacy implications for
relatives, and that breaches may also last for generations if transgenerational epigenetic effects are involved.
9.3.2 Epigenetic Privacy vs. Genetic Privacy
Since epigenetics has yet to reach a level of public
awareness equivalent to genetics, many papers and studies are
currently examining privacy concerns solely with respect to
genetics and genomic data but not epigenetics. It is not clear yet
what direction should be taken for epigenetics and privacy whether it should be considered in conjunction with genetics or as
a discrete challenge and issue. Certainly, epigenetics does not fit
into the current “DNA sequence” definition of some genetic
privacy legislation (see below). Since epigenetics encompasses a
wide range of factors and topics, it seems that the subject should
have its own discussion and legislative treatment. In this regard it
might be beneficial to look at how genetics is being handled, and
to use genetic legislation as a model to build upon for formation of
epigenetic-specific regulation.
In the U.S., GINA (Genetic Information Nondiscrimination
Act), and various other policies could be critiqued, improved upon,
and adjusted to include elements that pertain to epigenetic privacy
concerns. This would require broad consultation with diverse
stakeholders and experts. The structure the GINA and the
distinguishing reversibility/plasticity of epigenetic changes means
that existing policy will not provide enough protection. GINA’s
disregard for phenotype (Rothstein, 2008) will have greater
bearing in epigenetic protection considering the wider range of
variation and of timing that can result from epigenetic alterations.
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Policy-makers that seek to use GINA or any genetic privacy
legislation must recognize this pitfall.
9.4 Storage and Access
9.4.1 Storage, Sharing, and Use of Epigenome Data
Once informed consent has been established, and the
relevant epigenomic data of the individual is quantified and
characterized, the data obtained will be stored, shared and
analyzed. It is more common to store big data sets such as
epigenomic data using cloud-based systems and databases. Privacy
concerns play a major role at this stage due to the wide availability,
distribution, and open-access nature of these systems, which,
although constructed to promote data sharing and collaboration
among researchers and physicians, they also engender a new
dimension of perils.
Before online data storage, obtaining health records and
study findings was time-consuming, limited geographically, and
expensive in terms of housing physical copies of files. The degree
of ease and speed with which online data can be accessed has
changed how frequently data is shared and transferred. “Big data”
sets have presented a profound storage issue. “Although both
computers and the internet have become faster, there is a lack of
computational infrastructure that is needed to generate, maintain,
transfer, and analyze large-scale information securely...” (Costa
2013). Cloud computing has been suggested as the only solution
which is viable to accommodate the scale of data collected over the
course of epigenetic studies (Costa 2013). While some initiatives
aim to embed privacy protection into the function of cloud
computers (Lohr 2013), there are presently no formal industry
standards. This is not the only cloud-based challenge. Data
analysis, presentation, and delivery might also use distributed
servers, agencies, and third-party tools. Moreover, given the
complexity and specialization of analysis and presentation
software, it might be the case that service providers are few in
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number and geographically remote. Without even considering the
risks that attend file transfers to remote locations, what regulations
pertain to the privacy of data that is collected in Canada, housed
via cloud computing in the United States or Europe, and analysed
using software provided by a company in Iceland?
Does the concept of privacy need to be revised? Can an
individual’s data really be confidential and can its use in other
studies be regulated? Online data storage and the subsequent
global sharing of data has eliminated the idea of data being used
for a single study, or by a single group of researchers. Will consent
always be obtained for each use of the data once it is present in the
open-access database? A recent study has asked some of these
questions. “One approach is for the researcher to move from
guaranteeing (and so protecting) privacy to practicing veracity,
explaining to potential participants that their data will be accessed
by, and shared with, others; those consenting to research have to be
open to this.” (Clarke et al. 2012). If data sharing is occurring on a
global level, these privacy considerations need to not only be
legislatively addressed in each area, but the regulation of these
laws must also acknowledge and encompass cross-jurisdictional
considerations.
One method currently in place to protect the privacy of an
individual’s data in online storage is de-identification. This
process separates identifiable markers from an individual’s data to
prevent the data from being traced back to them specifically.
Studies of genetic data have shown that re-identification is
possible: researchers were recently able to identify about 50
participants who donated to the 1000 Genomes Project of
“anonymized” genetic information (Hayden 2013). It has been
proposed that re-identification methods be used as tests for the
privacy protecting ability of various data storage systems (Malin
and Sweeney 2004). Industry leaders have nevertheless identified
the reality of digital storage vulnerabilities and instead support the
call for research transparency: both researchers and subjects will
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likely need to recognize the impossibility of complete privacy in
research that utilizes online tools (Hayden 2013). Online data
storage will force the re-evaluation of what is possible and
plausible when assurances are given regarding online privacy. It
can no longer be assumed that anonymized information is safe.
9.4.2 The Social Media Problem
The environment in which the data originates will dictate its
handling, storage and access, and should be the focus of regulation,
especially since many of the tools, mechanisms, and uses to which
the data will be put are far from transparent to the provider. We are
more connected than ever, and information sharing is no longer
necessarily an intimate occurrence: blanket privacy protection at
the point of collection is no longer practical (Kalapesi 2013).
Many retailers and large corporations use data mining to drive
statistical research on current or potential clients (Duhigg 2012).
Predictive analytics models consumer behaviour and personal
events in order to understand future needs. While much of this
information is collected by one's transactions with these
companies, some may be bought from data banks that also mine a
variety of sources including online social activity (Duhigg 2012).
Surveys are one of the easiest sources from which to gather
information as they tend to reveal a variety of lifestyle elements.
This sort of strategic analysis could be extended to reveal
epigenetic status and prospective health. Slight decreases in
genomic methylation, indicative of epigenetic status and health,
have been linked to groups with low socioeconomic status
(McGuinness et al. 2012). Even the nature of one's job correlates to
methylation patterns and presumably, to disease risk (McGuinness
et al. 2012). Combined social and commercial predictive data
analysis can be cross-referencing with social, geographical, and
employment data. Governments and commercial interests could
conceivably derive a highly accurate picture of your epigenetic
status and future health predispositions. Imagine how much
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information could be gleaned and accurately predicted if the
websites that were mined included blogs or chat rooms where
people compared notes on depression, smoking, wine tasting, etc.
Imagine how much more might be inferred about your general
level of activity and fitness if your patterns of web surfing, movie
streaming, or online gaming were assessed. Finally, inaccuracies
within this mined data set are inevitable. How are researchers to go
about validating mined information when no controls for variances
are set in place, and how might citizens correct errors in the data
that will affect their algorithmic quantification (Kalapesi 2013)?
9.4.3 Privacy Protection and Epigenetic Discrimination
Data-mining is valuable in surveillance and investigations,
yet also provides a means for private dataveillance (collection and
analysis of a person’s digitally encoded actions) (Rubenstein et al.
2008). Loose online regulation provides for the essentially
unregulated, if unethical, means to collect and store large data sets
(Rubenstein et al. 2008). Without globally enforceable online
privacy provisions, data-mining companies could take advantage
of disingenuous end-users and threaten their privacy. The issue of
privacy being subordinated to cross-jurisdictional interests is
highlighted by a recent ruling of the European Court of Justice in
which Austrian Max Schrems took issue with Facebook
transferring his digital information to U.S. based servers (European
Court of Justice, 6 Oct. 2015). The additional problems of online
sharing in conjunction with re-identification threats further violates
epigenetic privacy.
Privacy regulations must also take into account the potential
for one’s epigenetic data to be used as a means of discrimination.
Whether third parties such as employers or insurance companies
should have access to an individual’s epigenomic data is an
important question to address. While researchers and physicians
utilize epigenetic data to better understand the factors that can aid
in medical care, the intentions of third parties may not be as clear.
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What questions or data should employers or insurance companies
have a right to ask or access, if any? How can the use of such
information by these companies be regulated, and monitored to
ensure no discrimination is taking place? Should they be permitted
to make inferences and discriminate based upon your educational
record, your geographical location, your cultural habits and
practices, or the socioeconomic status of your parents? For
example, in Arizona, the Pima County Board of Supervisors
recently voted to rule job applicants who were smokers ineligible
to fill job vacancies… The potential for insurance services or job
opportunities to be declined to individuals, or even their relatives,
if their epigenetic data shows predispositions to certain health
complications or diseases, should create a sense of unease.
The NHS scandal exemplifies a particularly egregious lapse of
judgment that had the potential to harm the personal privacy anD
opportunities of clients, but it is not the only “anonymized” data
set in circulation. Indeed, releases of information like this are
increasingly common. Newborn screening (NBS) programs, for
example, are viewed as integral to effective postnatal care in the
U.S. (Roberts et al. 2014). However, as with many other U.S.
federal programs, screening results are publicly accessible. The
original purpose was to provide early treatment for detected
diseases: the health and societal benefits of this information as a
predictive tool are obvious.
With the development of more advanced screening tools and
the potential incorporation epigenetic information, complete
epigenetic profiling may not be subject to privacy protection in the
near future. Although informed consent and consent manipulation
are topics hotly debated, the public health benefits of large scale
surveys may have inadvertently provided an avenue for illicit
exploitation (Roberts et al. 2014). Furthermore, direct-toconsumer genetic testing may not only facilitate the
misinterpretation of one’s genetic identity, and eventually
epigenetic identity, but it also provides an additional resource for
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third parties to link genetic to epigenetic information (Roberts et
al. 2014). A prime example of this is the consumer DNA profiling
company 23andMe that has already entered into agreements with
pharmaceutical giants such as Pfizer to grant access to troll through
their databases. Germany has recognized this as a threat and
banned direct-to-consumer genetic testing services based on the
public health implications. Still, these services remain widely
available elsewhere. Open accessibility to these data stores has
enabled the identification of individuals who made a point to be
stay anonymous in certain aspects of their lives (Hayden 2013)
Additionally, if insurance companies provide extra services
for epigenetic related issues there is a possibility for falsification of
identity in order to obtain these services. If an individual’s data is
publicly accessible online or not stored securely, others who are
unable to afford the insurance coverage may utilize the data in
order to get the services for themselves. Aside from the financial
implications this can have on the individual whose epigenetic
identity is stolen in malicious computer hacker operations. It has
been proposed that “…identity breaches can deleteriously affect
the quality of care. Incorrect information can infiltrate the
beneficiary’s medical record and corrupt later medical decision
making.” (Taitsman et al. 2013). The idea that failure to protect an
individual’s privacy can also affect the quality of healthcare the
individual may receive is disquieting and shows the significance of
privacy in epigenetic research.
9.4.4 Epigenetics and Advertisements
The use of third-party tools in the form of networks, servers,
and processing and storage systems is inevitable when it comes to
epigenetic data. This raises the concern that all epigenetic data
transactions have the potential to be monitored. Packet-sniffing
(Ansari et al. 2002) is a powerful administrative tool to evaluate
network function, however this tool also provides a method to
analyze all shared information across a particular network,
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sensitive or otherwise (Ansari et al. 2002). One category of
business that utilizes packet-sniffing that could present a threat to
epigenetic privacy is embodied by advertising agencies and
marketing corporations. How would you feel if your health
information was reflected by targeted ads over every web page you
visited? What if billboards and TV advertisements were geared
towards your personal health status as determined by analysis of
your browser history or epigenomic data, or if your mailbox was
flooded with ads and promotions related to your personal medical
conditions? If third-party companies phoned you or came to your
residence with offers for products or services all based on medical
data you would consider private, how would you feel? This level
of intrusion already occurs.
Google, and other search engines, monitor search inquiries as
of way customizing advertising to each user. However, it is a part
Google's privacy policy to refrain from ads targeted toward health
and other sensitive identifiers (OPCC 2014b). Nevertheless, a man
alleged that Google collected his private health information as a
means to advertise to him after he had left webpages that he had
visited (Lawton, 2014). In response to an admonition levied by the
Canadian Federal Privacy Commissioner, Google asserted that the
ad targeting was the result of remarketing campaigns (OPCC
2014b) and non-compliant corporate users of its services. The case
raises questions about the shortfalls of online privacy regulation.
Despite legislation that affords health privacy protection in
countries like Canada where the aforementioned man was from,
U.S. based companies are not held to the same standard of care and
confidentiality. It is, however, promising that Google has taken
steps to enforce the corporate privacy rules that it has set forth for
its clients, some of whom are not subject to Canadian privacy law,
as they are based outside of Canada. Still, this does not prohibit a
company based in a country with lax privacy protection to take
advantage and overstep the personal boundaries of end-users in the
pursuit of profit.
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Privacy measures to regulate the access these companies
have as well as acts and laws to regulate the ways in which they
utilize epigenetic data are vital. “The prospect of internet-based
marketing corporations using access to research data and to
electronic health records as an opportunity to market more
products seems both manipulative and cynical.” (Clarke et al.
2012). A further concern with advertising agencies utilizing
personal epigenetic data is that they can present the public with
infomercial-type advertising that most people will lack the critical
tools to evaluate. If individuals are unable to distinguish between
credible epigenetic medicines or services versus scams, unethical
companies will enjoy a golden opportunity to profit by taking
advantage of the ill-informed and unaware.
9.5 Conclusions
Epigenetics presents challenges that are distinct from any
other branch of health: there are presently so many additional and
commonly accessible means to assess one’s epigenetic status and
health predisposition. Many of these avenues of assessment are
unregulated and exposed. Privacy regarding a person’s epigenetic
and long term health is open to inference and interpretation in
ways that that other aspects of your health and life are not. Privacy
advocates, individuals, and legislators need to take rapid action if
they are to protect our access and opportunity to enjoy good jobs,
healthcare, insurance, security, and privacy.

Provocative Questions
 In regions less concerned with individual rights, use of
open sourced epigenetic information could propagate
human rights violations. How can this be controlled or
discouraged?
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Will lack of de-identification safeguards lead to
discrimination and the imposition of unfair government
standards?
Can the Wild West of cross-jurisdictional data flow be
regulated to protect privacy?
How can individual responsibility for personal and
extended familial epigenetic data protection be balanced
with rights to freedom of expression?
Online governance inherently undermines the principles of
the internet and entrenched ideals of net neutrality.
Regulatory activity tends to be reactive, not proactive. How
can this be changed quickly in order to contain the possible
damage?
Some of the largest curators of data storage are not arms’
length and disinterested parties – they are multinational
corporations with vested interests and are uniquely
positioned to exploit consumer data. How can this be
controlled internationally?
Can private scientific networks be sufficiently protected
against intrusion?
How can consumers be endowed with tools to detect and
correct errors in their profiles?
How can the comprehensive and extensive nature of the
privacy threat be conveyed without eliciting a knee jerk
reaction?
With the growing privatization of many social services and
a move towards business-focused models of running public
institutions, is any organization truly focussed on public
service and well-being?

Possible Solutions
 Protection of epigenetic privacy will be most effective
through proactive measures. Direct linking of privacy
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requests have been proposed in the scientific community as
a way of giving the information owner greater control over
their data (Lohr, 2013).
Epigenetic privacy provisions must be flexible to
accommodate the rapid pace of technical and scientific
change.
Education will be the greatest tool to protect privacy. It is
not enough to educate the public - researchers and
government officials must also be trained on the
implications of use.
Data storage security must be made a priority.
Individuals must also understand their responsibilities must
understand the potential risks, show some restraint, and
consider the privacy implications of their actions for
extended family and descendants.
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Chapter 10
Where Do We Go From Here?
Michael Crawford
Abstract
Recent discoveries in the emerging field of epigenetics
will impinge in a profound way upon reproductive, medical, and
environmental ethics. These discussions have implications for
the role of the state in our homes and in our lives. What we do in
our lives, how we live, the opportunities that we are afforded these manifest as epigenetic traits and dispositions that can be
modified and transmitted to offspring without changes being
made to our DNA sequences. Environment, diet, toxins, and
even human relations can alter an epigenetic imprint for
generations. Inevitably, political, legal, and social discourse will
focus upon where to balance individual rights and obligations
versus societal costs and imperatives. I will argue that the
complexity, longevity and time lag of epigenetic effects mitigate
against a simple allocation of responsibility for injury or health.
To clarify the scope of legislative and policy challenges, I will
suggest the limitations of tort law to deal with injury, and deliver
some of the perspectives, temptations, and directions for ethical
solutions that will be brought to bear.

10.1 A Bioethical Agenda For Consideration
None of us chose our parents, no matter how much we
might like to take the credit or avoid the blame. We enjoyed
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control neither over our birth, early childhood economic,
familial, educational, nor nutritional environment. Who then
bears responsibility for repairing the health, economic, and
environmental disparities that can exert long-term reproductive
consequences? Whose interest is served by improvements that
will better subsequent generations? Parents? Children? The
state?
Clearly, we all should all do our best to respect and
nurture our bodies. They are the vessels that we ride into old
age, and they are the machines that help to build future
generations. For our own sakes, as well as for our progeny, we
need to respect and care for ourselves as best we can. Exerting
the necessary discipline is often hard, but if epigenetics tells us
anything, it is that we might not be as autonomous and
unencumbered in our proclivities and predispositions as we
might formerly have supposed.
At present, the legal system does not explicitly recognize
epigenetic effects let alone the interaction that exists between
epigenetic imprinting and the environment. However, the
environment has always influenced the genome and the health
of individuals, and it is becoming clear that improvements to
the environment can translate to improvements in human
health and prosperity (Dupras et al., 2012; Guthman and
Mansfield, 2012). With epigenetics we have a window to see
the mechanism by which environmental wellbeing is
connected to individual health: the complex interactions
between the two could offer a tool to improve societal health
(Dupras et al., 2012). Such a mindset would link improved
individual health to environmental stewardship as well as the
propagation of better medical and environmental health
through future generations (Rothstein, 2013).
With advances in diagnostics and epigenetic testing, the
detrimental effects of the environment could be identified and
possibly even corrected before they propagate to future
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generations (Loi et al., 2013). With increased attention to the
prevention of disease, rather than the treatment of conditions
after development, the remedy of disadvantages early in life
should take precedence. The emphasis should shift to the early
treatment of social, educational, dietary, and genomic
challenges: epigenetic interactions are likely to amplify health
deficits that are the consequence of these any of these area
over time and across generations (Loi et al., 2013). However,
this will require a shift in strategy. Preventive treatments or
“wellness” and education programs have the potential to
drastically improve the quality of health care offered to
patients yet they may introduce new forms of inequality. If
epigenetic assessment and diagnosis is not affordable and
accessible, the likelihood is that greater inequities regarding
quality, efficacy, and availability of health will arise
(Rothstein, 2013). As a consequence, enjoyment of health, life,
and opportunities will become stratified, and productivity of
the community at large will be hampered.
There is still much to be determined with regard to the
place of epigenetics in the legal system, tax system, and health
care systems. A change in perspective, extensive consultation,
and increased public knowledge of epigenetics is necessary for
changes to take place.
We can illustrate the convoluted complexion of the
challenge, and the inadequacies of current frameworks to
contend with epigenetic issues, using the example of tort law
discussed in Chapter 8. In tort law, the difficulties that attend
identification of the origin of an imprint will prove daunting in
assigning liability. For example, people will inherit genetic
and epigenetic predispositions from their parents, and then
they will themselves add to this historical baggage via
behaviour, experiences, and choices. Quite aside from the fact
that a child has yet to successfully sue a parent for wrongful
life (indeed since some jurisdictions have ruled it repugnant to
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assign a compensatory value for birth-associated defects that
would place a differential value on lives) (Karpin, 2010),
demonstrating a causal relationship between an individual’s
actions and their consequences is too fraught with variables to
survive close scrutiny. For example, obesity has often been
regarded as the product of over-indulgence on the part of
parents or individuals. Similarly, addicts, while arguably at
least partially the product of their environment, have been
regarded as the authors of their own dissolution. Recently it
has become clear that there are genetic and epigenetic factors
that need to be considered (Delport and Pollard, 2010; Byrnes
et al., 2013): people who indulge in self-harming behavior may
be the victim of proclivities and impulses that have a more
complex etiology than formerly supposed.
While individuals cannot be excluded from exerting
significant control over their epigenetic status, neither can they
be assigned sole responsibility. Given that assignment of
blame for epigenetic damage to individuals and businesses is
likely to prove difficult under tort law, similarly, one must ask
how ethical considerations can be gauged and how practical
assignments of responsibility can be allocated? Where does the
balance lie between state and citizen? Indeed epigenetic causes
and effects are so complex, so temporally extended in their
manifestations, and so subject to multiple influences, that for
reasons of both political as well as practical, it might be better
to ignore where, in the spectrum of interactions between
individuals, the state, and businesses, ethical responsibility
actually lies. Perhaps we need to focus instead upon how
ethics can guide our practical responses.
Maria Hedlund makes an interesting observation: she
points out when epigenetic responsibility is assigned
retrospectively, individuals will tend to be identified and
blamed (Hedlund, 2012). By contrast, she argues that when
responsibility is viewed prospectively, the structural and
306

An Agenda for Change

contextual nature of a problem demands action by political and
social organs.
Let us reduce the equation solely to factors of economics
and practicality: an argument can be made for shifting some of
the onus of responsiveness and responsibility for epigenetic
health from individuals to businesses and the state. The longterm consequences of epigenetic perturbation are costly, so by
facilitating good practices, businesses and states can position
themselves to control heath care costs and to minimize future
encumbrances upon labour availability and efficiency. Given
the difficulty of demonstrating a simple causal link between
individual lifestyle choices and imprinting effects,
interventions that are facilitative rather than proscriptive seem
most likely to succeed and to provide efficiencies for both
health and societal success.
Facilitative experiments have met with success in the past,
albeit with no knowledge of the epigenetic consequences of
the programs at the time. The Finnish “Baby Box” program
was installed in 1939 with the objective of reducing infant
mortality among the poor. The program is still running and
delivers a box of useful goods to parents on condition that they
seek free prenatal medical advice and examinations. The
program was universalized in 1948 (Lee, 2013; Söderblom and
Kela, 2013). Parents have the option to ignore the program,
and even to receive monetary compensation in place of the
boxed goods. Nevertheless, nearly everybody uses the
program, and parents receive both a high standard of prenatal
and delivery healthcare as well as a wealth of baby clothes,
diapers, blankets etc.. The boxes are regarded as a “good deal”
and the rate of infant and mortality has dropped. Similarly, in
the State of Hawaii, intervention was forced when a cohort of
impoverished teens was identified as poorly served by the
existing QUEST/Medicaid programs. The cycle of addiction,
obesity, diabetes, and teen pregnancy presented both
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immediate and long term risks that were addressed by
extending post partum health coverage from 8 weeks to 6
months or more (Partika et al., 2008).
10.2 An Agenda for Consideration
So where do ethicists, social engineers, scientists, business
people, and government meet to allocate resources and
responsibility?
Where might ethics help to guide our
response? The comprehensive and overlapping nature of
epigenetics effects mitigates against a piecemeal approach.
Gesche argues for a carefully integrated approach to analysis
and policy development: she argues that it will require
transformation of public health policy (Gesche, 2010). We’d
argue that the scope needs expansion further still and that it
would help to commence with discussions that pertain to
purely practical measures:
1. Government agencies need to coordinate centrally to
gather and then disseminate information and advice. A
Standing Committee should serve as a nexus for information
and policy development, and all stakeholders should have a
means to articulate concerns. This necessitates an interdisciplinary approach, and presumably one guided by
professional ethicists. Given the breadth, complexity, and
ever-changing nature of the information landscape, such a
committee needs to be constituted not merely of well-educated
representatives of science, social policy, medicine, and
economics, but to have additional positions that are occupied
by topically relevant short-term “floaters.” Epigenetics will
continue to surprise, so the participants need to be flexible and
engaged in learning on the fly. Operational principles of such a
Committee would have to reflect the need for this evolution of
education and compositional flexibility.
2. Governments, through their agencies, need to
undertake a rapid and fulsome practical education of their
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agents, as well as of the media, and public at large. To this
end, initially, open participation conferences with plenary
speakers from multiple disciplines (ethics, science,
government, economics, healthcare delivery, business, law)
might be a good place to start. More especially, practical
information needs to drill down to family physicians,
expectant mothers, and children in elementary school on
upwards.
3. Individuals need help to make good lifestyle
decisions. Options to facilitate this beyond merely educating
might include: better labeling of food contents; “sin taxes” on
foods that are commercially prepared and/or comprising high
fat content and/or high glycemic index; tax credits for
participation in clubs and organizations that promote fitness
(especially for pre-pubescent children); better public transit
combined with more expensive parking for cars etc.; in-fill and
public space development in cities to render them more walkable and accessible for shopping, living, playing.
4. Should incremental health service cost increases or
service restrictions apply to individuals who abuse themselves,
or who refuse to control unhealthy behaviour? Seeking help
should be rewarded, and failure to succeed should not
necessarily result in a sanction. Educative support would have
to account for options that might be excluded by economic or
cultural context. There is a geographical, economic, and
cultural dimension to epigenetics - no absolute metrics are
likely to be practical or effective. The ethical debate and social
policies that derive will need to be managed in a sensitive
manner.
5. Should states reconsider the thresholds at which they
intervene to protect children from abuse, and to encourage full
parental engagement and support? The definition of abuse
should be re-examined beyond the scope of purely physical.
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Diet and parenting are clearly of trans-generational, not merely
familial importance.
6. Consideration should be given to maternal health and
dietary support both pre-term and post delivery, and to
investment in feeding and food education programs at schools
where the habits of a lifetime may still prove open to
modification. Given the onerous financial and human cost of
the growing plague of obesity and diabetes, the cost of such
early life social supports seems paltry by comparison.
7. Consider developing a directed taxation structure
whereby companies that produce new categories of materials,
drugs, and waste, help to build an autonomous and protected
investment fund for the purpose of offsetting potential
generational consequences of unforeseen health issues.
8. Ensure that companies are regulated and insured to
cover the true costs of environmental degradation. It is hard to
predict in advance what wastes will have an effect, so all
effluents and emissions should be factored into an accounting.
Who could have predicted that PCBs or endocrine mimics
would exert trans-generational effects?
9. Research in humans needs to redress a recent gender
bias in the literature. Paternal and parental care studies in
rodents demonstrate that females are not necessarily privileged
in conveying an imprint to offspring.
The recent
preponderance of focus upon human maternal effects risks
burdening women with an unfair share of responsibility for
generational health. The effects of pre-conception activities
upon later fetal health might also impinge upon our perception
of how to balance individual rights and long-term reproductive
obligations.
10. Medical, social, environmental, and economic
policy experts need to conference to both learn about
epigenetics, and to begin developing policies to mitigate extant
as well as developing challenges. Little recognition has been
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paid to this field or to the long-term health and economic costs
that will arise. By way of example, if, as rodent studies
suggest, the presence of endocrine disruptors in our food and
drinking water exerts a subliminal and persistent effect, we
could be in for interesting times. How and where to
effectively marshal resources to maintain and improve
equitable access to good health will be a complex problem,
and initiating discussions pertaining to health and social ethics
is a good place to start.
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acetylation involves the addition of an
acetyl group (C2H3O) to a molecule.
In epigenetics, acetylation of the tail
of histone H1 is associated with a lax
nucleosomal conformation that is
conducive to gene activity.
acute myelogenous leukemia – also
known as Acute myeloid leukemia or
acute
nonlymphocytic
leukemia
(ANLL). It the most common type of
blood system cancer. White blood cells
proliferate in the bone marrow and
inhibit the production of other blood
cell types.
Alcoholism – type I The tendency is to
drink excessively in response to a
stress. Alcoholics of this type can
avoid abuse for extended periods of
time, but can fall into an abuse spiral.
Type I alcoholics usually feel guilt and
fear of their addiction.
Alcoholism – type II This category of
alcoholics tend to start drinking from
an early age and often have an older
male family member who also abuse
alcohol.
Drinking tends to be
continuous, and considerable control
over ingestion can be exerted.
algorithm:
computer
science;
programming logic to efficiently
provide output based on input.
Alu elements or sequences are, like LINE
elements, remnants of retroviral
invasion, and they constitute roughly

11% of the genomebut are somewhat
shorter in length than LINES.
apoptosis is a technical term that describes
genetically programed cell death in
response to injury, senescence, or as
part
of
normal
embryological
development.
autism spectrum disorder (ASD)
encompasses
neurodevelopmental
disorders that result in varying degrees
of social or communication deficits,
sensory and cognitive disorders, and a
tendency to repetitive or stereotyped
behavior.
big data: a large, complex collection of
data that requires special processing
considerations
due
its
size.
Computational analysis of these data
sets attempt to reveal trends or
behaviors, especially with regard to
human commerce or behavior.
bioinformatics:
intersection
between
computer science and biology; using
computational methods to analyze
biological information.
bioinformatic tools: computer software
developed for the processing and
analysis of biological systems and data
Bisphenol-A (BPA) is used in the
production of plastics and can leach
from containers into food products.
BPA can act as an estrogen mimic.
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brain-derived
neurotrophic
factor
(BDNF) is a growth factor that is
required for neural growth, stability,
and synapse formation. Mis-regulation
of BDNF is linked to depression,
schizophrenia,
addiction,
and
Alzheimer’s disease.
chemopreventive reversers is a substance
that reverses the effects of an
environmental toxin.
chromatin: The “stuff” of chromosomes,
chromatin is an assembly of DNA,
RNA, and proteins such as histones.
Chromatin is the higher order, flexible,
and dynamic architecture of
our
genome.
chronic lymphocytic leukemia is a disease
of the bone marrow stem cell
population
that
contributes
lymphocytes (white blood cells). The
disease develops slowly with most
tuning into an acute form of B-cell
leukemia.
chronic physical aggression (CPA)
describes a pattern of behaviour where
young children display physical
aggression and who fail to moderate it
between the ages of three and four. The
pattern of aggressive behavious persists
throughout school years and into
adulthood.
It is associated with
histories of child abuse, and/or family
disfunction.
circRNA molecules do not encode proteins
but help to regulate the activity of
miRNAs which in turn regulate the
transcription and translation of mRNAs
thereby ultimately affecting proteins
synthesis.

cirrhosis is a sign of advanced liver disease
and can be the product of alcohol
abuse, hepatitis or other diseases. It
represents a scaring or regenerative
response to stressors.
clear cell adenocarcinomas are a rare
form of tumour, usually associated with
the female uro-genital tract. The
tumours usually have a glandular origin
cloud computing: large, connected
networks of servers to allow fast data
processing and storage through a single
shell access point.
coeliac disease is an autoimmune disorder
of the small intestine that is triggered
by gluten-containing foods. It results in
diarrhea, weight loss, anemia, fatigue,
and disorders in other organs.
collective responsibility is a philosophical
concept that defines a social and moral
duty to accommodate or remedy larger
scale and collective harms. Groups
such as governments, businesses etc.,
might be argued to hold collective
responsibility for harms to individuals
or groups.
CpG sites of dinucleotides: shorthand for
cytosine-phosphate-guanine, a DNA
sequence that is a preferred site for
DNA methylation.
CpG islands are CG-rich regions, usually
located in the 5’ upstream regulatory
regions of genes. They are a frequent
site of DNA methylation.
Crohn’s disease or syndrome is an
incurable
inflammatory
bowel
condition that can result in pain, weight
loss, diarrhea, fever, bowel obstruction,
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rash, and a predisposition to bowel
cancer.
cytokines are small secreted proteins used
by cells to communicate. They are
often associated with responses to
stress or with cells of the immune
system.
data mining: analyzing large sets of
information for specific points of
significance.
dataveillance: information technology;
constant analysis and collection of data
transferred over a network for purposes
other than diagnostics.
decentralization: dispersing functions
from a central point among many
entities for shared responsibility.
developmental programming, also known
as Barker’s hypothesis posits that a
mother’s diet - and fetal exposure during pregnancy will have an effect
upon the onset of diseases later in the
life of her offspring.
diethylstillbestrol (DES) is a synthetic
non-steroidal estrogen. It has a history
of use in cattle, and in humans as: a
cancer treatment, chemical castration
agent (Alan Turing), and it was
erroneously prescribed as a fertility
enhancer from the late 1930 until the
1970s.
de-identification: bioinformatics; removal
of all markers that could be used to
identify the owner of a biological data
set.

direct-to-consumer
genetic
testing:
purchasable services to analyze and
receive information on one’s genome.
ie. 23andme.com
DNA methylation occurs when methyl
groups are attached, usually to the Cnucleotide in GCG-rich regions of gene
regulatory regions. DNA methylation
is usually, but not always, associated
with gene inactivation.
DNA methyltransferases (DNMTs) are
the enzymes that catalyze addition of
methyl groups to DNA. They tend to
inactivate genes.
DNA sequencing determines the order of
nucleotides that comprise a DNA
fragment or a genome. The readout is
then assembled and compared against a
database to identify genes etc.
eclampsia defines a health condition in
women either during or shortly after
pregnancy where high blood pressure,
organ failure, or high blood protein
levels lead to convulsions.
endocrine typically describes hormones or
the glands that produce them. Typically
endocrine products are secreted into
and circulated by the circulatory
system, but they tend to have specific
target tissues upon which they exert
their effect.
end-user: computer science; the person
who is meant to access a network or
system after it has been fully developed
and released to market.
environmental toxicants are toxic
substances that we ingest from the
environment via direct contact, food,
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water, or air.
Examples include
mercury, PCBs, DDT, lead, asbestos,
etc.
epididymal cysts are benign fluid-filled
cysts that develop in the male
reproductive tract at the top of the
testes.
epiphenotypes
encompass
the
morphologies,
behaviours,
or
characteristics
embodied
in
an
organism by the superimposition of
factors other than genes. Epiphenotypes
are often considered to be more or less
heritable.
erythroleukemic cells represent a less
common form of blood system cancer
where the progenitors of red blood cells
are affected.
estrogens are steroidal hormones that are
of primary importance in female
reproductive
development
and
reproductive function and behaviour.
Their function is mediated by receptors
that signal the activation of specific
downstream genes.
euchromatin is the more loosely packed
structure of chromatin, and it often
encompasses genomic regions where
genes are active.
feed-forward control loops result in the
transmission of an external cue to elicit
a defined response, but without
monitoring or moderating how it reacts.
fetal programing, also known as Barker’s
hypothesis
posits that a mother’s
healthy diet during pregnancy will help
to control the onset of diseases later in
the life of her offspring.

gametogenesis is the process by which the
gametes, sperm or egg (oocyte), are
derived from stem cell populations in
the gonads.
glia,
also known as neuroglial cells,
support neurons in the central nervous
system. Recent evidence suggests that
they can participate in the transmission
of nerve impulses, and that they secrete
substances that modify or stimulate the
connections made by neighboring
neurons.
global methylation is the averaged
estimate of DNA methylation that is
determined by analyzing methylation,
usually of DNA, detectable in blood
samples. It does not predict the
epigenetic status of specific genes, nor
of specific cell types and tissues other
than blood – is serves as a general
marker of epigenetic health or age.
hematopoietic stem cells have the capacity
to proliferate and differentiate to
populate blood.
heterochromatin is the densely packed
conformation of chromatin, and is
usually associated with areas where
genes are tightly packed and inactive.
hippocampus is a part of the limbic brain
and plays a role in short and long term
memory consolidation, and in spatial
navigation. The hippocampus is
especially sensitive to stress and its
shrinkage is thought to play a role or be
caused of post traumatic stress disorder.
histone acetylase or histone acetyle
transferase (HAT) enzymes add
acetyle groups to histones, often with
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the result that associated DNA
sequences (genes) become more active.
histone deacetylase (HDAC) enzymes
remove acetyl groups from histones
which often results in lower activity
from the associated DNA sequence
(gene).
histone acetylation usually occurs on the
COOH-terminal tail of histones H1. It
affects the intimacy of histone-DNA
interacyion in nucleosomes, and this in
turn regulates gene activity.

hypoplastic testes: under-developed or
smaller than normal testes
immunoprecipitation employs antibodies
that recognize a specific antigen to
bind, immobilize, precipitate, and
permit the identification, purification,
or modification of a specific target
molecule.
inferred data: information derived
indirectly on an individual from
relatable sources.

histone methylation occurs when methyl
groups are added to histones. Within
the context of chromatin structure, this
can have the effect of either activating
or
repressing
associated
DNA
sequences (genes).

informed consent: permission received
from an individual after they have been
well
educated
regarding
an
investigation or procedure and its likely
effects.

histone methyltransferase adds methyl
groups to histone proteins. This can
have the consequence of either
activating or repressing the activity of
associated DNA sequences.

joint venture liability encompasses
partners who combine resources in a
business venture to make a profit.
They share liability for failures of
product integrity, efficacy, or safety.

histone proteins: the five main classes of
histone proteins (H1, H2A, H2B, H3A,
H3B) assemble into groups of eight
(octamers) and serve as the substrate
around which DNA is wound into the
higher order structures constituting
chromatin.

LINE elements are Long Interspersed
Nuclear Elements that represent
roughly 20% of the human genome and
likely constitute remnants of retroviral
invasion.

hydatidiform moles, also known as
trophoblastic disease, are a gestational
anomaly that occurs when an egg loses
its genome and is inseminated by one
or more sperm. The consequence of a
solely paternal genome is that there is
over-development of chorionic preplacental
tissues,
usually
in
combination with an absence of fetal
tissue.

lncRNA (long non-coding RNA) molecules
represent a new and poorly understood
class of RNA that do not encode
proteins, but appear to act as regulators
of gene transcription and translation.
luck-egalitarianism is a model of
distributive justice that maintains that
people ought to be held responsible
only for those things that they exercise
control, not over inherited economic,
genetic, or other factors.
Some
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normalizing element must enter into the
equation to make justice equitable.

produce enough blood cells – patients
can become anemic.

luck-prioritarian models argue that the
less fortunate (those with bad luck)
ought to receive priority in any
distribution or resources. Justice argues
for resources where they will make the
biggest difference.

ncRNA is any category of RNA that does
not encode a protein.
Examples
include lncRNA, rRNA, tRNA,
telRNA, miRNA, circRNA etc..

mass spectrometry is a tool used
analytical chemistry that uses
abundance of gas phase ions and
mass-charge ratio of molecules
identify chemical modifications to,
amount, or the identity of samples.

in
the
the
to
the

methylation refers to the addition of a
methyl group (CH3) to other molecules
such as DNA or histones. Highly
methylated DNA tends to be inactive,
while methylated histones can cause
associated gene sequences to be either
active or inactive.
microbiota describes the community of
bacteria, yeast, viruses and other
microscopic organisms that populate
our bodies
miRNA molecules are a class of short
RNA molecules that do not encode
proteins help regulate the activity of
other RNA transcripts.
motif: any DNA, RNA, or protein
sequence that is shared by related
species of molecule, and that is
associated with a functional or
operational significance. eg; a receptor
binding site.
myelodysplatic syndrome is a disease of
bone marrow resulting in a failure to

mRNA is the RNA transcript that transmits
information from genes to ribosome
where they encode the amino acid
sequence of proteins. They are often
edited (spliced) prior to being
translated to protein. mRNA molecules
are usually characterized by a polyadenylated tail and a 5’-Cap.
multivariate – having multiple component
parts or contributing factors that may or
may not interact directly.
net neutrality: information technology; to
view all data and access via the internet
in an egalitarian manner so that special
privileges will not be taken or granted
with respect to its access or transfer.
neural tube is the embryonic precursor to
the spinal cord and brain. Defects in its
development and progression rank
among the most common of birth
defects.
nucleosome: one of the fundamental units
that contributes to chromatin, the
higher order organization of DNA.
Each nucleosome is embodied by DNA
wrapped around eight histones protein
subunits.
nucleotide: one of the fundamental
constitutents or building blocks of RNA
and DNA. The molecule comprises a
nitrogenous base, at least one
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phosphate, and either a ribose or
deoxyribose sugar.

events in order to understand future
needs (Duhigg, 2012).

oestrogens are steroidal hormones that are
of primary importance in female
reproductive
development
and
reproductive function and behaviour.
Their function is mediated by receptors
that signal the activation of specific
downstream genes.

progesterone is a steroid hormone
involved in the menstrual cycle,
pregnancy, and human development
and sexual maturation.

packet-sniffing: information technology;
analyze data transferred over a network
for diagnostic and quality control
purposes.
phosphorylation occurs when phosphate
groups are added to a protein, usually
by a kinase enzyme. Depending upon
context, this can either activate or
repress activity of the protein.
polymerase chain reaction (PCR) is a
process whereby a thermo-stable DNA
polymerase is used to reiteratively
make copies of a DNA template
sequence.
placental previa is an obstetrical condition
where the placenta is placed near to the
cervix and is prone to shearing or
bleeding under the weight of the fetus.
preconception torts are a category of law
suit in which the litigant makes claims
for injuries sustained before they were
even conceived and born. Instances
might include suing for negligent
advice given by a physician to
presumptive parent regarding genetic
risks s.
predictive analytics: the act of modeling
consumer behaviour and personal

prospective responsibility acknowledges
that in the real world, every time we go
somewhere or o something, it comes
with an attendant risk for which we
must bear some responsibility. In
epigenetics, the term has a pregnant
meaning: both individuals and society
share an obligation to provide
circumstances that are conducive to
healthy epigenomes,
even
preconception.
Rawlsian-egalitarian model of justice is a
variation of luck egalitarianism that
requires the playing field be leveled so
that everybody can compete on equal
footing for opportunities. Social
inequalities need to be configured to
benefit the least advantaged, but not so
much that they remove incentive to
strive.
re-identification: analysis of anonymous
data and cross-referencing with other
data sources to find similarities and
markers that can identify the original
producer of the information.
remarketing campaigns: recording enduser behaviour in order to effectively
advertise to the user based on their
suspected interests
ResearchGate: “Facebook of Science”
(Gujarathi & Costa, 2014); a social
medial network that facilitates global
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interaction between those in the STEM
fields.
retrotransposons
are
mobile
viral
remnants that retain the capacity to
rtranscribe from our DNA (genome)
into RNA, then reverse transcribe back
to DNA, and finally to reinsert into the
genome, often at a different location.
retroviral
elements
derive
from
retroviruses., a category of RNA virus
that encodes, among other products, the
enzymes necessary to reverse transcribe
to DNA and then to integrate
parasitically into a host’s genome.
rRNA are RNA molecules that constitute
part of the ribosomal complex – a
larger assembly of RNA and proteins
that serve to build polypeptide chains
(proteins)
single nucleotide polymorphisms (SNPs)
embody some of the DNA sequence
variation between individuals. They are
used as markers that associate with
specific gene alleles (ie; the normal or
the mutant allele for a trait)
sires are the male parent in animals
statutory of limits or statutes of limitations
and repose define a period of time
beyond which a person or agency
cannot be prosecuted. The idea is to
ensure that a trial can rely upon fresh
evidence that has not deteriorated with
the passage of time. Limits also ensure
a
reasonable
expectation
that
individuals, agencies and businesses
can enjoy an environment that is free of
unforeseeable long term liabilities.

stress tests are used in rodent studies and
involve restraining the animal in a tube
for a period of time, usually ranging
from 15 to 30 minutes.
striatum is a subcortical region of the brain
responsible for regulating fine motor
coordination.
swim stress is a test commonly used to
elicit or study neurological function or
endocrine stress responses in rodents.
Essentially it is a monitored tank filled
with water in which the animals must
swim to keep their head above the
surface.
telomeres are structures that protect the
ends of chromosomes and that are
comprised of repetitive DNA and RNA
sequences as well as proteins.
Telomeres generally shorten with age
leading to chromosomal instability.
telRNA molecules are a class of noncoding RNA that binds to the ends of
chromosomes (telomeres) to preserve
chromosomal integrity.
tort law is the civil branch of law where
rights, obligations and remedies are
argued. Litigants sue for remedy or
relief from harms that are alleged to be
the responsibility of the defendant.
transparency: business and social
sciences; openness of actions that
facilitates honesty and accountability.
tRNA are the species of RNA molecules
that shuttle amino acids to ribosomes to
help in the construction of new
polypeptides (proteins).
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trophoblast comprises the outer layer of
cells in a pre-implantation embryo.
These cells are the first to differentiate
and will contribute to development of
the placenta.
trophoblastic disease, also known as
hydatidiform moles, are a gestational
anomaly that occurs when an egg loses
its genome and is inseminated by one
or more sperm. The consequence of a
solely paternal genome is that there is
over-development of chorionic preplacental
tissues,
usually
in
combination with an absence of fetal
tissue.
victim attenuation – a concept of
diminished effect or liability due to
distance between cause and effect. This
term can cover indirect injuries, or
injuries that do not become readily
apparent due to transmission across
generation.

white hat (hacking): computer science;
purposeful but not malicious violations
of network security usually to identify
and correct network vulnerabilities.
X-Chromosome inactivation. The human
X chromosome contains many more
genes than the Y chromosome. Human
males are normally XY, and females
XX. In order to maintain a similar
dosage of active genes in females,
during early development, one of the
two X chromosomes is inactivated by
making
it
extremely
compact
(heterochromatic) thereby rendering the
majority of its genes inactive. The
resultant structure is called a Barr body.
xenobiotics are foreign chemicals or
substances that are not normally
produced in nature or ingested under
normal circumstances. The term is
sometimes used to describe compounds
that are detectable at high levels when
they are normally only found at trace
concentrations.
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This book arose as a collaboration among students of disciplines as
diverse as biological sciences, literature, political science,
psychology, and computer science. The group met at the
University of Windsor to workshop topics to highlight, in
accessible language, the social, political, ethical, and legal
ramifications of epigenetics. The aim was to translate the science
to a comprehensive, exhaustive, and up-to-date resource for policy
and law makers, teachers, other students, and for the public at
large.
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